WO2015020399A1 - Organic compound and organic electroluminescent light emitting diode comprising same - Google Patents
Organic compound and organic electroluminescent light emitting diode comprising same Download PDFInfo
- Publication number
- WO2015020399A1 WO2015020399A1 PCT/KR2014/007223 KR2014007223W WO2015020399A1 WO 2015020399 A1 WO2015020399 A1 WO 2015020399A1 KR 2014007223 W KR2014007223 W KR 2014007223W WO 2015020399 A1 WO2015020399 A1 WO 2015020399A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- mmol
- aryl
- mol
- synthesis
- Prior art date
Links
- DDGPPAMADXTGTN-UHFFFAOYSA-N Clc1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Clc1nc(-c2ccccc2)nc(-c2ccccc2)n1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 3
- DUYHZUXXKSZUPC-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc2[nH]c(ccc(-c3cccc4c3[nH]c3c4cccc3)c3)c3c2c2)c2[s]1 Chemical compound c(cc1)ccc1-c1nc(cc2[nH]c(ccc(-c3cccc4c3[nH]c3c4cccc3)c3)c3c2c2)c2[s]1 DUYHZUXXKSZUPC-UHFFFAOYSA-N 0.000 description 3
- MTCSLCLNHCXTGC-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2c3)c4[nH]c2ccc3-c2cccc3c2[nH]c2c3cccc2)c4[s]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2c3)c4[nH]c2ccc3-c2cccc3c2[nH]c2c3cccc2)c4[s]1 MTCSLCLNHCXTGC-UHFFFAOYSA-N 0.000 description 3
- GPGIIKKUKINTGW-UHFFFAOYSA-N Brc1nc(-c2ccccc2)cc(-c2ccccc2)n1 Chemical compound Brc1nc(-c2ccccc2)cc(-c2ccccc2)n1 GPGIIKKUKINTGW-UHFFFAOYSA-N 0.000 description 2
- SFKMVPQJJGJCMI-UHFFFAOYSA-N Clc1nc2ccccc2c(-c2ccccc2)n1 Chemical compound Clc1nc2ccccc2c(-c2ccccc2)n1 SFKMVPQJJGJCMI-UHFFFAOYSA-N 0.000 description 2
- ORPVVAKYSXQCJI-UHFFFAOYSA-N [O-][N+](c(cccc1)c1Br)=O Chemical compound [O-][N+](c(cccc1)c1Br)=O ORPVVAKYSXQCJI-UHFFFAOYSA-N 0.000 description 2
- AZTGJHUEBZVYIN-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc5c4[nH]c4ccccc54)c2)c2)[n]3-c3ccccc3)c2[o]1 Chemical compound c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc5c4[nH]c4ccccc54)c2)c2)[n]3-c3ccccc3)c2[o]1 AZTGJHUEBZVYIN-UHFFFAOYSA-N 0.000 description 2
- DPSIEAFESYSUPT-UHFFFAOYSA-N c(cc1)ccc1-c1nc2ccc(c3cc(-c(cc4)cc5c4[nH]c4c5cccc4)ccc3[nH]3)c3c2[s]1 Chemical compound c(cc1)ccc1-c1nc2ccc(c3cc(-c(cc4)cc5c4[nH]c4c5cccc4)ccc3[nH]3)c3c2[s]1 DPSIEAFESYSUPT-UHFFFAOYSA-N 0.000 description 2
- GPAARUYJBUMILT-UHFFFAOYSA-N Brc(cc1)cc2c1NC(c1ccccc1)=S[BrH]2 Chemical compound Brc(cc1)cc2c1NC(c1ccccc1)=S[BrH]2 GPAARUYJBUMILT-UHFFFAOYSA-N 0.000 description 1
- YVZIBDQASKHGFK-UHFFFAOYSA-N Brc(cc1)cc2c1nc(-c1ccccc1)[o]2 Chemical compound Brc(cc1)cc2c1nc(-c1ccccc1)[o]2 YVZIBDQASKHGFK-UHFFFAOYSA-N 0.000 description 1
- AJYSRGZKHNITSH-UHFFFAOYSA-N Brc(cc1)cc2c1nc(-c1ccccc1)[s]2 Chemical compound Brc(cc1)cc2c1nc(-c1ccccc1)[s]2 AJYSRGZKHNITSH-UHFFFAOYSA-N 0.000 description 1
- AYHGAQGOMUQMTR-UHFFFAOYSA-N Brc(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Brc(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 AYHGAQGOMUQMTR-UHFFFAOYSA-N 0.000 description 1
- JPSFJDICLQWRGI-UHFFFAOYSA-N Brc1cc(-c2ccc3[s]c4ccccc4c3c2)ccc1 Chemical compound Brc1cc(-c2ccc3[s]c4ccccc4c3c2)ccc1 JPSFJDICLQWRGI-UHFFFAOYSA-N 0.000 description 1
- IJXDLFJKGQNBEJ-UHFFFAOYSA-N Brc1cc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Brc1cc(-c2ccccc2)nc(-c2ccccc2)n1 IJXDLFJKGQNBEJ-UHFFFAOYSA-N 0.000 description 1
- CRJISNQTZDMKQD-UHFFFAOYSA-N Brc1ccc2[o]c(cccc3)c3c2c1 Chemical compound Brc1ccc2[o]c(cccc3)c3c2c1 CRJISNQTZDMKQD-UHFFFAOYSA-N 0.000 description 1
- SEJXMTZDWABFDE-UHFFFAOYSA-N Brc1cccc(-c(cc2)cc(c3c4)c2[nH]c3cc2c4[s]c(-c3ccccc3)n2)c1 Chemical compound Brc1cccc(-c(cc2)cc(c3c4)c2[nH]c3cc2c4[s]c(-c3ccccc3)n2)c1 SEJXMTZDWABFDE-UHFFFAOYSA-N 0.000 description 1
- CTPUUDQIXKUAMO-UHFFFAOYSA-N Brc1cccc(I)c1 Chemical compound Brc1cccc(I)c1 CTPUUDQIXKUAMO-UHFFFAOYSA-N 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C Chemical compound CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- AJUXKNHHZFVBKX-UHFFFAOYSA-N CC1(C)OB(c(cc2)cc(c3c4)c2[nH]c3cc2c4[s]c(-c3ccccc3)n2)OC1(C)C Chemical compound CC1(C)OB(c(cc2)cc(c3c4)c2[nH]c3cc2c4[s]c(-c3ccccc3)n2)OC1(C)C AJUXKNHHZFVBKX-UHFFFAOYSA-N 0.000 description 1
- IQEVNKKVBHVLBO-UHFFFAOYSA-N CC1(C)OB(c2cc(-c(cc3c(cc4)c5c6c4nc(-c4ccccc4)[o]6)ccc3[n]5-c3ccccc3)ccc2)OC1(C)C Chemical compound CC1(C)OB(c2cc(-c(cc3c(cc4)c5c6c4nc(-c4ccccc4)[o]6)ccc3[n]5-c3ccccc3)ccc2)OC1(C)C IQEVNKKVBHVLBO-UHFFFAOYSA-N 0.000 description 1
- WIKAJTPCBLDBBV-UHFFFAOYSA-N CC1(C)OB(c2cc(-c3ccc4[nH]c(c5c(cc6)nc(-c7ccccc7)[o]5)c6c4c3)ccc2)OC1(C)C Chemical compound CC1(C)OB(c2cc(-c3ccc4[nH]c(c5c(cc6)nc(-c7ccccc7)[o]5)c6c4c3)ccc2)OC1(C)C WIKAJTPCBLDBBV-UHFFFAOYSA-N 0.000 description 1
- FUBBIMKGJUIOCJ-UHFFFAOYSA-N CC1(C)OB(c2ccc3nc(-c4ccccc4)[o]c3c2)OC1(C)C Chemical compound CC1(C)OB(c2ccc3nc(-c4ccccc4)[o]c3c2)OC1(C)C FUBBIMKGJUIOCJ-UHFFFAOYSA-N 0.000 description 1
- GHHIOUMYJJZPRA-UHFFFAOYSA-N CNCc(cc1c2c3cccc2)cc(-c(cc2)cc(c(c4c5)cc6c5nc(-c5ccccc5)[o]6)c2[n]4-c2ccccc2)c1[n]3-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound CNCc(cc1c2c3cccc2)cc(-c(cc2)cc(c(c4c5)cc6c5nc(-c5ccccc5)[o]6)c2[n]4-c2ccccc2)c1[n]3-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 GHHIOUMYJJZPRA-UHFFFAOYSA-N 0.000 description 1
- SISQKQNJHCDULL-UHFFFAOYSA-N COC(c1ccccc1)=N Chemical compound COC(c1ccccc1)=N SISQKQNJHCDULL-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- TXPOSODBCCBORG-UHFFFAOYSA-N Nc1nc(-c2ccccc2)c(cccc2)c2n1 Chemical compound Nc1nc(-c2ccccc2)c(cccc2)c2n1 TXPOSODBCCBORG-UHFFFAOYSA-N 0.000 description 1
- LQIRCTOMOACULW-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1cc(-c(cc2)cc3c2[nH]c2c4[s]c(-c5ccccc5)nc4ccc32)ccc1)=O Chemical compound [O-][N+](c(cccc1)c1-c1cc(-c(cc2)cc3c2[nH]c2c4[s]c(-c5ccccc5)nc4ccc32)ccc1)=O LQIRCTOMOACULW-UHFFFAOYSA-N 0.000 description 1
- HCFJDGRIJYSOEF-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1cc(-c(cc2c(cc3)c4c5c3nc(-c3ccccc3)[o]5)ccc2[n]4-c2ccccc2)ccc1)=O Chemical compound [O-][N+](c(cccc1)c1-c1cc(-c(cc2c(cc3)c4c5c3nc(-c3ccccc3)[o]5)ccc2[n]4-c2ccccc2)ccc1)=O HCFJDGRIJYSOEF-UHFFFAOYSA-N 0.000 description 1
- BJIMYHRNGAUVDO-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1cc(-c(cc2c3ccc4nc(-c5ccccc5)[s]c4c33)ccc2[n]3-c2ccccc2)ccc1)=O Chemical compound [O-][N+](c(cccc1)c1-c1cc(-c(cc2c3ccc4nc(-c5ccccc5)[s]c4c33)ccc2[n]3-c2ccccc2)ccc1)=O BJIMYHRNGAUVDO-UHFFFAOYSA-N 0.000 description 1
- YEQSIQONFVCQFZ-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1cc(-c2ccc3[nH]c(c4c(cc5)nc(-c6ccccc6)[o]4)c5c3c2)ccc1)=O Chemical compound [O-][N+](c(cccc1)c1-c1cc(-c2ccc3[nH]c(c4c(cc5)nc(-c6ccccc6)[o]4)c5c3c2)ccc1)=O YEQSIQONFVCQFZ-UHFFFAOYSA-N 0.000 description 1
- CRHKMDNJJKVIGP-UHFFFAOYSA-N c(cc1)ccc1-c([o]c1c2)nc1cc1c2c2cc(-c(cc3c4ccccc44)ccc3[n]4-c(cc3)cc4c3[o]c3ccccc43)ccc2[n]1-c1ccc2[o]c3ccccc3c2c1 Chemical compound c(cc1)ccc1-c([o]c1c2)nc1cc1c2c2cc(-c(cc3c4ccccc44)ccc3[n]4-c(cc3)cc4c3[o]c3ccccc43)ccc2[n]1-c1ccc2[o]c3ccccc3c2c1 CRHKMDNJJKVIGP-UHFFFAOYSA-N 0.000 description 1
- HBTMYDZFNODLQH-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5c6cccc5)c4[n]6-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)c2)c2)[n]3-c3ccccc3)c2[o]1 Chemical compound c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5c6cccc5)c4[n]6-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)c2)c2)[n]3-c3ccccc3)c2[o]1 HBTMYDZFNODLQH-UHFFFAOYSA-N 0.000 description 1
- OICJHGVVBWUMOQ-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5c6cccc5)c4[n]6-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)c2)c2)[n]3-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)c2[s]1 Chemical compound c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5c6cccc5)c4[n]6-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)c2)c2)[n]3-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)c2[s]1 OICJHGVVBWUMOQ-UHFFFAOYSA-N 0.000 description 1
- APQVBBNLJGHIGK-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5ccccc55)c4[n]5-c4nc(cccc5)c5c(-c5ccccc5)n4)c2)c2)[n]3-c3nc(-c4ccccc4)c(cccc4)c4n3)c2[s]1 Chemical compound c(cc1)ccc1-c1nc(cc(c(c2c3ccc(-c4cccc(c5ccccc55)c4[n]5-c4nc(cccc5)c5c(-c5ccccc5)n4)c2)c2)[n]3-c3nc(-c4ccccc4)c(cccc4)c4n3)c2[s]1 APQVBBNLJGHIGK-UHFFFAOYSA-N 0.000 description 1
- FJYUOWWORGPMPY-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cc(c(c2cc(-c3cccc(c4ccccc44)c3[n]4-c3cc(-c4ccc5[s]c(cccc6)c6c5c4)ccc3)ccc22)c3)[n]2-c2cc(-c4ccc5[s]c(cccc6)c6c5c4)ccc2)c3[s]1 Chemical compound c(cc1)ccc1-c1nc(cc(c(c2cc(-c3cccc(c4ccccc44)c3[n]4-c3cc(-c4ccc5[s]c(cccc6)c6c5c4)ccc3)ccc22)c3)[n]2-c2cc(-c4ccc5[s]c(cccc6)c6c5c4)ccc2)c3[s]1 FJYUOWWORGPMPY-UHFFFAOYSA-N 0.000 description 1
- FMGPELIXADMHGW-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2c3)c4[nH]c2ccc3-c(cc2)cc3c2[nH]c2ccccc32)c4[o]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2c3)c4[nH]c2ccc3-c(cc2)cc3c2[nH]c2ccccc32)c4[o]1 FMGPELIXADMHGW-UHFFFAOYSA-N 0.000 description 1
- JXKGGPLXWDNIOK-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2cc(-c(cc3)cc(c4ccccc44)c3[n]4-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[o]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2cc(-c(cc3)cc(c4ccccc44)c3[n]4-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[o]1 JXKGGPLXWDNIOK-UHFFFAOYSA-N 0.000 description 1
- OPSJIDWNYLFYLQ-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2cc(-c(cc3)cc(c4ccccc44)c3[n]4-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[s]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2cc(-c(cc3)cc(c4ccccc44)c3[n]4-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[s]1 OPSJIDWNYLFYLQ-UHFFFAOYSA-N 0.000 description 1
- CRKKPQZFJLKFAP-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2cc(-c(cccc3c4c5cccc4)c3[n]5-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)cc(-c4ccccc4)n2)c3[o]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2cc(-c(cccc3c4c5cccc4)c3[n]5-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)ccc22)c3[n]2-c2nc(-c4ccccc4)cc(-c4ccccc4)n2)c3[o]1 CRKKPQZFJLKFAP-UHFFFAOYSA-N 0.000 description 1
- YNGKZDCKHPEVFQ-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2cc(-c(cccc3c4ccccc44)c3[n]4-c(cc3)ccc3-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c(cc2)ccc2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[s]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2cc(-c(cccc3c4ccccc44)c3[n]4-c(cc3)ccc3-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)ccc22)c3[n]2-c(cc2)ccc2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c3[s]1 YNGKZDCKHPEVFQ-UHFFFAOYSA-N 0.000 description 1
- GDCABLQOQAKSBC-UHFFFAOYSA-N c(cc1)ccc1-c1nc(ccc(c2cc(-c3c4[nH]c(cccc5)c5c4ccc3)ccc22)c3[n]2-c2ccccc2)c3[o]1 Chemical compound c(cc1)ccc1-c1nc(ccc(c2cc(-c3c4[nH]c(cccc5)c5c4ccc3)ccc22)c3[n]2-c2ccccc2)c3[o]1 GDCABLQOQAKSBC-UHFFFAOYSA-N 0.000 description 1
- FGKFYPFXTCYZDV-UHFFFAOYSA-N c(cc1)ccc1-c1nc2ccc(c(cc(cc3)-c4c5[nH]c(cccc6)c6c5ccc4)c3[nH]3)c3c2[o]1 Chemical compound c(cc1)ccc1-c1nc2ccc(c(cc(cc3)-c4c5[nH]c(cccc6)c6c5ccc4)c3[nH]3)c3c2[o]1 FGKFYPFXTCYZDV-UHFFFAOYSA-N 0.000 description 1
- ZCXGNIDEGNPFTF-UHFFFAOYSA-N c(cc1)ccc1-c1nc2ccc(c(cc(cc3)-c4cccc5c4[nH]c4c5cccc4)c3[n]3-c4ccccc4)c3c2[s]1 Chemical compound c(cc1)ccc1-c1nc2ccc(c(cc(cc3)-c4cccc5c4[nH]c4c5cccc4)c3[n]3-c4ccccc4)c3c2[s]1 ZCXGNIDEGNPFTF-UHFFFAOYSA-N 0.000 description 1
- PKGOAWGTAHRXAP-UHFFFAOYSA-N c(cc1)ccc1-c1nc2ccc(c3cc(-c(cccc4c5ccccc55)c4[n]5-c4cccc(-c5ccc6[s]c(cccc7)c7c6c5)c4)ccc3[n]3-c4cccc(-c5ccc6[s]c7ccccc7c6c5)c4)c3c2[s]1 Chemical compound c(cc1)ccc1-c1nc2ccc(c3cc(-c(cccc4c5ccccc55)c4[n]5-c4cccc(-c5ccc6[s]c(cccc7)c7c6c5)c4)ccc3[n]3-c4cccc(-c5ccc6[s]c7ccccc7c6c5)c4)c3c2[s]1 PKGOAWGTAHRXAP-UHFFFAOYSA-N 0.000 description 1
- CVFLVJOFMIOQBO-UHFFFAOYSA-N c(cc1)ccc1-c1nc2ccc(c3cc(-c4ccc5[nH]c6ccccc6c5c4)ccc3[n]3-c4ccccc4)c3c2[s]1 Chemical compound c(cc1)ccc1-c1nc2ccc(c3cc(-c4ccc5[nH]c6ccccc6c5c4)ccc3[n]3-c4ccccc4)c3c2[s]1 CVFLVJOFMIOQBO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B33/00—Electroluminescent light sources
- H05B33/12—Light sources with substantially two-dimensional radiating surfaces
- H05B33/20—Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the material in which the electroluminescent material is embedded
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/15—Hole transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/622—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1051—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K2101/00—Properties of the organic materials covered by group H10K85/00
- H10K2101/10—Triplet emission
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/321—Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
- H10K85/324—Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising aluminium, e.g. Alq3
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
Definitions
- the present invention relates to a novel organic compound and an organic electroluminescent device comprising the same.
- the organic electroluminescent device when a voltage is applied between two electrodes, holes are injected into the organic material layer from the anode and electrons from the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine.
- the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
- the light emitting material may be classified into blue, green, and red light emitting materials according to light emission colors. In addition, it may be divided into yellow and orange light emitting materials required to achieve a better natural color.
- the light emitting material may be formed of a host / dopant system in order to increase the luminous efficiency of the organic electroluminescent device through an increase in color purity and energy transfer.
- the dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. Since the development of the phosphorescent material can theoretically improve the luminous efficiency up to 4 times compared to the fluorescence, attention is focused not only on the phosphorescent dopant but also on the phosphorescent host.
- NPB hole blocking layer
- BCP hole blocking layer
- Alq 3 and the like materials for the hole blocking layer and the electron transporting layer
- anthracene derivatives are known as fluorescent dopant / host materials for the light emitting layer.
- metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 are known as phosphorescent dopant materials
- CBP is known as phosphorescent host materials.
- the materials used in the conventional light emitting layer do not have a satisfactory level in terms of lifespan of the organic EL device because the glass transition temperature is low thermal stability is not good.
- An object of the present invention is to provide an organic compound that can be used as a light emitting layer material, a hole transporting layer material, and a hole injection layer material having excellent light emitting ability, hole transporting ability, and hole injection ability.
- Another object of the present invention is to provide an organic electroluminescent device including the organic compound having a low driving voltage, a high luminous efficiency, and an improved lifetime.
- the present invention provides a compound represented by the following formula (1).
- A is a C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 ⁇ C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 ⁇ C 40 Alkyloxy group, C 6 ⁇ C 60 An aryloxy group, C 3 ⁇ C 40 Alkylsilyl group, C 6 ⁇ C 60 An arylsilyl group, C 1 ⁇ C 40 Alkyl boron group, is selected from the group C 6 ⁇ C 60 aryl group of boron, C 6 ⁇ C 60 aryl phosphine group, C 6 ⁇ C 60 aryl phosphine oxide group, and a C 6 ⁇ C 60 aryl amine, consisting of,
- R 1 and R 2 form a condensed ring with one of R 7 and R 8 , R 8 and R 9 , R 9 and R 10 of Formula 2,
- R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring are the same or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 ⁇ C 40 cycloalkyl group, nuclear hetero atoms 3 to 40 heterocycloalkyl group, C 6 ⁇ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group, C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 60 aryloxy group, C 3 ⁇ C 40 alkylsilyl group, C 6 ⁇ C 60 arylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, C 6 ⁇ C 60 aryl phosphine oxide group and C 6 ⁇ C 60 An arylamine group,
- R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring is a substituent represented by the following Chemical Formula 3,
- X 1 is O or S
- X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32 ) (R 33 ) and Si (R 34 ) (R 35 ),
- L 1 is selected from the group consisting of a single bond, a C 6 ⁇ C 60 arylene group and a heteroarylene group having 5 to 60 nuclear atoms, and L 1 is a position of R 21 to R 28 and a position of R 31 to R 35 Connected to one selected from carbon,
- R 21 to R 28 and R 31 to R 35 which are not connected to L 1 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, C 3 -C 40 heterocycloalkyl group, C 6 -C 60 aryl group, C 5-60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6- C 60 aryloxy group, C 3 ⁇ C 40 alkylsilyl group, C 6 ⁇ C 60 arylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, C 6 ⁇ C 60 aryl phosphine oxide group and C 6 ⁇ C 60 arylamine group,
- the present invention is an organic electroluminescent device comprising an anode, a cathode and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic layer is a compound represented by the formula (1) It provides an organic electroluminescent device comprising.
- the organic material layer including the compound represented by Chemical Formula 1 is selected from the group consisting of a hole transporting layer, a hole injection layer, and a light emitting layer, and may be preferably a light emitting layer.
- the compound represented by Chemical Formula 1 may be a phosphorescent host of the emission layer.
- a benzo [d] oxazole-based moiety or a benzothiazole-based moiety, is condensed to an indole moiety to form a basic skeleton.
- Dibenzothiophene, dibenzofuran, dibenzosilol, carbazole and / or fluorene moiety is bonded to the basic skeleton, characterized in that represented by the formula (1).
- the compound represented by Chemical Formula 1 has a higher molecular weight than the material [for example, 4,4-dicarbazolybiphenyl (hereinafter, referred to as 'CBP')] used in the organic material layer of the organic EL device, and has a high glass transition temperature and thermal As well as stability, it is excellent in hole injection ability, hole transport ability, light emitting ability and the like. Therefore, when the compound represented by Chemical Formula 1 is used in the organic material layer of the organic EL device, driving voltage, efficiency, lifespan, etc. of the organic EL device may be improved.
- the material for example, 4,4-dicarbazolybiphenyl (hereinafter, referred to as 'CBP')
- 'CBP' 4,4-dicarbazolybiphenyl
- the host used in the phosphorescent layer of the organic EL device must have a triplet energy gap higher than the dopant. That is, in order to effectively provide phosphorescence from the dopant, the lowest excited state of the host must be higher in energy than the lowest emitted state of the dopant.
- the compound represented by Formula 1 may be used as a host because a specific substituent is introduced into the condensed indole derivative having a wide singlet energy level and a high triplet energy level, and the energy level is higher than that of the dopant.
- the compound represented by Chemical Formula 1 is a structure in which an electron withdrawal (EWG) having high electron absorbing property is combined, and since the whole molecule has a bipolar characteristic, the binding force between holes and electrons may be increased. Therefore, the compound represented by Chemical Formula 1 may be used as a host of a blue, green, or red phosphorescent light emitting layer of the organic electroluminescent device because of excellent luminescence properties.
- EWG electron withdrawal
- the compound represented by Chemical Formula 1 may improve phosphorescence characteristics, hole injection / transport capability, luminous efficiency, driving voltage, lifetime characteristics, etc. of the organic electroluminescent device, and electron transport ability may also vary depending on the type of substituents introduced. Can be improved. Therefore, the compound represented by Formula 1 according to the present invention is an organic material layer material of the organic electroluminescent device, preferably a light emitting layer material (blue, green and / or red phosphorescent host material), a hole transport layer material and a hole injection layer material, more It is preferably useful as a phosphorescent layer.
- the compound represented by the formula (1) has a variety of substituents, especially aryl groups and / or heteroaryl groups introduced into the basic skeleton significantly increases the molecular weight of the compound, the glass transition temperature is improved to improve the conventional light emitting material (e.g. For example, it may have higher thermal stability than CBP).
- the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer. Therefore, the organic electroluminescent device including the compound represented by Formula 1 according to the present invention can greatly improve performance and lifespan characteristics. As such, the organic EL device having improved performance and lifespan characteristics may maximize the performance of the full color organic light emitting panel.
- the compound represented by the formula (1) of the present invention may be embodied in any one of the compounds represented by the formula (1a) to 1f.
- A, X 1 and R 3 to R 11 are the same as defined in Chemical Formula 1.
- the compound represented by Chemical Formula 1 of the present invention may be any one of the compounds represented by the following Chemical Formulas 1-1 to 1-12, wherein A and R 1 to R 11 are as defined in Chemical Formula 1.
- At least one of R 3 to R 6 and R 7 to R 10 and R 11 which do not form a condensed ring is a substituent represented by the following general formula (3).
- R 4 is preferably a substituent represented by the following formula (3).
- L 1 is preferably a single bond or a substituted or unsubstituted phenylene group.
- X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32 ) (R 33 ) and Si (R 34 ) (R 35 ), which is O, S or N (R 31 ) desirable.
- X 2 is O or S
- the carbon at R 21 or R 23 is bonded to L 1
- X 2 is N (R 31 )
- the carbon at R 23 or R 31 is bonded to L 1 .
- a and R 31 are each independently selected from the group consisting of C 1 ⁇ C 40 Alkyl group, C 6 ⁇ C 60 An aryl group and a heteroaryl group of 5 to 60 nuclear atoms, It is more preferable that it is a substituent represented by following formula (4) or a phenyl group.
- L 2 is preferably a single bond, a C 6 ⁇ be an aryl group and a C 18 nuclear atoms are selected from the group consisting of a hetero arylene of 5 to 18, a single bond, phenylene group or biphenylene group.
- Z 1 to Z 5 are the same as or different from each other, and each independently N or C (R 12 ), wherein at least one of Z 1 to Z 5 is N and when C (R 12 ) is plural, they are each other. Same or different.
- R 12 is hydrogen, deuterium, halogen, cyano group, C 1 ⁇ C 40 alkyl group, C 6 ⁇ C 40 aryl group, nuclear 5 to 40 heteroaryl group, C 6 ⁇ C 40 aryloxy group C 1 ⁇ C 40 alkyloxy group of, C 6 ⁇ C 40 aryl amine group, C 1 ⁇ C 40 groups of the alkyl silyl group, C 1 ⁇ C 40 alkyl, boron, C 6 ⁇ C 40 group of the arylboronic, C 6 ⁇ C 40 aryl phosphine group, C 6 ⁇ C 40 aryl phosphine oxide group, and a C 6 ⁇ C 40 aryl selected from the group consisting of a silyl or, by combining groups adjacent to form a condensed ring.
- Deuterium, halogen, cyano group C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl groups, C 1 to C 40 alkylsilyl groups, C 1 to C 40 al
- Examples of the substituent represented by Formula 4 may be a substituent represented by the following Formula A1 to A15, but is not limited thereto.
- L 2 and R 12 are as defined in Formula 4, wherein a plurality of R 12 are the same or different from each other,
- R 41 is hydrogen, deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 6 -C 40 aryl group, nuclear atom 5-40 heteroaryl group, C 6 -C 40 aryloxy group C 1 ⁇ C 40 alkyloxy group of, C 6 ⁇ C 40 aryl amine group, C 1 ⁇ C 40 groups of the alkyl silyl group, C 1 ⁇ C 40 alkyl, boron, C 6 ⁇ C 40 group of the arylboronic, C 6 to C 40 arylphosphine group, C 6 ⁇ C 40 aryl phosphine oxide group and C 6 ⁇ C 40 arylsilyl group selected from the group consisting of or combined with adjacent groups to form a condensed ring, n is 1 It is an integer of -4.
- R 14 is plural, they are the same as or different from each other.
- alkyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, alkylsilyl group, alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl silyl group of R 41 Deuterium, halogen, cyano group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl groups, C 1 to C 40 alkylsilyl groups, C 1 to C 40 alkylboron groups, C 6 to C 40
- the compound represented by Formula 1 of the present invention may be represented by the following Formulas in more detail, but is not limited thereto.
- Alkyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms, and non-limiting examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl , iso-amyl and hexyl.
- Alkenyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond.
- Non-limiting examples thereof include vinyl, allyl, isopropenyl, 2-butenyl and the like.
- Alkynyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond.
- Non-limiting examples thereof include ethynyl, 2-propynyl and the like.
- Cycloalkyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms (saturated cyclic hydrocarbon).
- Non-limiting examples thereof include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine and the like.
- Heterocycloalkyl of the present invention means monovalent functional groups obtained by removing hydrogen atoms from non-aromatic hydrocarbons (saturated cyclic hydrocarbons) having 3 to 40 nuclear atoms, and preferably at least one carbon in the ring, preferably 1 to 3 carbon atoms. Carbons are substituted with heteroatoms such as N, O or S. Non-limiting examples thereof include morpholine, piperazine and the like.
- Aryl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined.
- the two or more rings may be attached in a simple or condensed form with each other.
- Non-limiting examples thereof include phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthryl and the like.
- Heteroaryl of the present invention is a monovalent functional group obtained by removing a hydrogen atom from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons. Is substituted with a heteroatom such as nitrogen (N), oxygen (O), sulfur (S) or selenium (Se).
- the heteroaryl may be attached in a form in which two or more rings are simply attached or condensed with each other, and may also include a condensed form with an aryl group.
- heteroaryls include six-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl ring; And 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.
- the alkyloxy of the present invention means a monovalent functional group represented by RO-, wherein R is alkyl having 1 to 40 carbon atoms, and may include a linear, branched or cyclic structure.
- R is alkyl having 1 to 40 carbon atoms, and may include a linear, branched or cyclic structure.
- Non-limiting examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
- Aryloxy of the present invention means a monovalent functional group represented by R'O-, wherein R 'is aryl having 6 to 60 carbon atoms.
- R ' is aryl having 6 to 60 carbon atoms.
- Non-limiting examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.
- Alkylsilyl of the present invention means silyl substituted with alkyl having 1 to 40 carbon atoms
- arylsilyl of the present invention means silyl substituted with aryl having 6 to 60 carbon atoms
- arylamine of the present invention is 6 to 60 carbon atoms Amine substituted with aryl.
- Condensed ring of the present invention means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring or a combination thereof.
- the present invention provides an organic electroluminescent device comprising a compound represented by the formula (1).
- the present invention is an organic electroluminescent device comprising an anode (anode), a cathode (cathode) and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic material layer is It includes a compound represented by the formula (1).
- the compound represented by Formula 1 may be used alone or in combination of two or more.
- the one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer, at least one of which may include a compound represented by the formula (1).
- the organic material layer including the compound represented by Chemical Formula 1 is preferably a phosphorescent light emitting layer.
- the light emitting layer of the organic electroluminescent device of the present invention may include a host, and may include a compound represented by Chemical Formula 1 as a host.
- a compound represented by Chemical Formula 1 is included as a material of the light emitting layer of the organic electroluminescent device, preferably a green phosphorescent host, the binding force between the holes and the electrons in the light emitting layer increases, so that the efficiency (light emitting efficiency and power Efficiency), lifespan, brightness, driving voltage and the like can be improved.
- the structure of the organic EL device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked.
- An electron injection layer may be further stacked on the electron transport layer.
- an insulating layer or an adhesive layer may be inserted between the electrode and the organic layer.
- the organic electroluminescent device of the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic material layers (eg, the light emitting layer) is formed to include the compound represented by Chemical Formula 1. .
- the organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
- the substrate used in manufacturing the organic EL device of the present invention is not particularly limited, but a silicon wafer, quartz, glass plate, metal plate, plastic film, or the like may be used.
- the positive electrode material is not particularly limited, but a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black and the like can be used.
- a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof
- Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb
- Conductive polymers such as polythiophene, poly (3-methylthioph
- the negative electrode material is not particularly limited, but may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or alloys thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al and the like.
- 2,4-dibromoaniline 250.9 g, 1.0 mol
- methylene chloride 1,000 ml
- Benzoyl chloride 116 mL, 1.0 mol
- pyridine 161.8 mL, 2.0 mol
- N- (2,4-dibromophenyl) benzamide (251.1 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. .
- 6-bromo-2-phenylbenzo [d] oxazole (147.9 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
- Step 5 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (A) and 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (B) synthesis
- N- (2,4-dibromophenyl) benzamide (266.2 g, 0.75 mol) prepared in ⁇ Step 1> of [Preparation Example 1] was added to the reactor, toluene (3,000 ml) was added thereto, followed by stirring. Thereafter, Lawesson's reagent (229.2 g, 0.53 mol) was added dropwise to the reactor, mixed, and stirred at 110 ° C. for 4 hours.
- N- (2,4-dibromophenyl) benzothioamide (263.5 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. .
- 6-bromo-2-phenylbenzo [d] thiazole (156.6 g, 540.0 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
The present invention relates to an organic compound and an organic electroluminescent light emitting diode, and the organic compound according to the present invention can be used in an organic layer, and desirably, in a light-emitting layer in the organic electroluminescent light emitting diode, thereby improving light-emitting efficiency, driving voltage, and life of the organic electroluminescent light emitting diode.
Description
본 발명은 신규 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound and an organic electroluminescent device comprising the same.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이, 음극에서는 전자가 각각 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥 상태로 떨어질 때 빛이 나게 된다. 유기물층으로 사용되는 물질은 그 기능에 따라 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic material layer from the anode and electrons from the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine. The material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
발광 물질은 발광색에 따라 청색, 녹색 및 적색의 발광 물질로 구분될 수 있다. 또한 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색의 발광 물질로 구분될 수도 있다. 이러한 발광 물질은 색순도의 증가와 에너지 전이를 통해 유기 전계 발광 소자의 발광 효율을 증가시키기 위하여 호스트/도펀트 계로 이루어질 수 있다.The light emitting material may be classified into blue, green, and red light emitting materials according to light emission colors. In addition, it may be divided into yellow and orange light emitting materials required to achieve a better natural color. The light emitting material may be formed of a host / dopant system in order to increase the luminous efficiency of the organic electroluminescent device through an increase in color purity and energy transfer.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에 인광 도판트뿐만 아니라 인광 호스트에 대해서도 관심이 집중되고 있다.The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. Since the development of the phosphorescent material can theoretically improve the luminous efficiency up to 4 times compared to the fluorescence, attention is focused not only on the phosphorescent dopant but also on the phosphorescent host.
현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로 사용되는 물질로는 NPB, BCP, Alq3 등이 알려져 있고, 발광층에 사용되는 물질로는 안트라센 유도체들이 형광 도판트/호스트 재료로 알려져 있다. 또한 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물은 인광 도판트 재료로, CBP는 인광 호스트 재료로 알려져 있다.Hole injection layer, hole transport layer to date. NPB, BCP, Alq 3 and the like are known as materials for the hole blocking layer and the electron transporting layer, and anthracene derivatives are known as fluorescent dopant / host materials for the light emitting layer. In addition, metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 are known as phosphorescent dopant materials, and CBP is known as phosphorescent host materials.
그러나 종래의 발광층에 사용된 물질들은 유리전이온도가 낮아 열적 안정성이 좋지 않기 때문에 유기 전계 발광 소자의 수명 측면에서 만족할만한 수준이 되지 못하고 있다.However, the materials used in the conventional light emitting layer do not have a satisfactory level in terms of lifespan of the organic EL device because the glass transition temperature is low thermal stability is not good.
본 발명은 발광능, 정공 수송능 및 정공 주입능 등이 우수하여 발광층 재료, 정공 수송층 재료 및 정공 주입층 재료로 사용될 수 있는 유기 화합물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide an organic compound that can be used as a light emitting layer material, a hole transporting layer material, and a hole injection layer material having excellent light emitting ability, hole transporting ability, and hole injection ability.
또, 본 발명은 상기 유기 화합물을 포함하여 구동전압이 낮고, 발광 효율이 높으며, 수명이 향상된 유기 전계 발광 소자를 제공하는 것도 목적으로 한다.Another object of the present invention is to provide an organic electroluminescent device including the organic compound having a low driving voltage, a high luminous efficiency, and an improved lifetime.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.The present invention provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에서,In Chemical Formula 1,
A는 C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,A is a C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 ~ C 40 Alkyloxy group, C 6 ~ C 60 An aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 An arylsilyl group, C 1 ~ C 40 Alkyl boron group, is selected from the group C 6 ~ C 60 aryl group of boron, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amine, consisting of,
R1과 R2는 하기 화학식 2의 R7과 R8, R8와 R9, R9와 R10 중 하나와 축합 고리를 형성하며,R 1 and R 2 form a condensed ring with one of R 7 and R 8 , R 8 and R 9 , R 9 and R 10 of Formula 2,
[화학식 2][Formula 2]
R3 내지 R6, 축합고리를 형성하지 않는 R7 내지 R10 및 R11은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring are the same or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear hetero atoms 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group and C 6 ~ C 60 An arylamine group,
다만, R3 내지 R6, 축합 고리를 형성하지 않는 R7 내지 R10 및 R11 중 적어도 하나는 하기 화학식 3으로 표시되는 치환체이며,However, at least one of R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring is a substituent represented by the following Chemical Formula 3,
[화학식 3][Formula 3]
X1은 O 또는 S이고,X 1 is O or S,
X2는 O, S, N(R31), C(R32)(R33) 및 Si(R34)(R35)로 이루어진 군에서 선택되며,X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32 ) (R 33 ) and Si (R 34 ) (R 35 ),
L1은 단일결합, C6~C60의 아릴렌기 및 핵원자수 5 내지 60의 헤테로아릴렌기로 이루어진 군에서 선택되고, L1은 R21 내지 R28의 위치 및 R31 내지 R35의 위치 중에서 선택된 하나의 탄소와 연결되며,L 1 is selected from the group consisting of a single bond, a C 6 ~ C 60 arylene group and a heteroarylene group having 5 to 60 nuclear atoms, and L 1 is a position of R 21 to R 28 and a position of R 31 to R 35 Connected to one selected from carbon,
L1과 연결되지 않은 R21 내지 R28 및 R31 내지 R35는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, R 21 to R 28 and R 31 to R 35 which are not connected to L 1 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, C 3 -C 40 heterocycloalkyl group, C 6 -C 60 aryl group, C 5-60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6- C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group and C 6 ~ C 60 arylamine group,
상기 A, R1 내지 R11, R21 내지 R28 및 R31 내지 R35의 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기와, L1의 아릴렌기, 헤테로아릴렌기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되며, 상기 치환기는 인접한 기와 결합하여 축합 고리를 형성 또는 비형성하고, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.Wherein A, R 1 to R 11, R 21 to R 28 and R 31 alkyl of 1 to R 35, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an aryl Silyl group, alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl amine group, the arylene group and hetero arylene group of L 1 are each independently deuterium, halogen, cyano group, C 1 ~ C 40 An alkyl group, a C 3 to C 40 cycloalkyl group, a nuclear atom of 3 to 40 heterocycloalkyl group, a C 6 to C 60 aryl group, a nuclear atom of 5 to 60 heteroaryl group, a C 1 to C 40 alkyl Oxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide of the group and a C 6 ~ value to one or more of the substituents selected from the group consisting of C 60 arylamine Or unsubstituted ring, and, when the substituent is a bond or an adjacent tile to form a non-form a condensed ring, and the substituent of the plurality, which are the same or different from each other.
또, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.In addition, the present invention is an organic electroluminescent device comprising an anode, a cathode and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic layer is a compound represented by the formula (1) It provides an organic electroluminescent device comprising.
상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 정공 수송층, 정공 주입층 및 발광층으로 이루어진 군에서 선택되며, 바람직하게는 발광층일 수 있다.The organic material layer including the compound represented by Chemical Formula 1 is selected from the group consisting of a hole transporting layer, a hole injection layer, and a light emitting layer, and may be preferably a light emitting layer.
상기 화학식 1로 표시되는 화합물은 상기 발광층의 인광 호스트일 수 있다.The compound represented by Chemical Formula 1 may be a phosphorescent host of the emission layer.
이하, 본 발명을 설명한다.Hereinafter, the present invention will be described.
1. 신규 화합물1. New Compound
본 발명에 따른 유기 화합물은 인돌 모이어티에 벤조옥사졸 모이어티(benzo[d]oxazole-based moiety), 또는 벤조싸이아졸 모이어티(benzo[d]thiazole-based moiety)가 축합되어 기본 골격을 이루며, 이러한 기본 골격에 디벤조싸이오펜, 디벤조퓨란, 디벤조실롤, 카바졸 및/또는 플루오렌 모이어티가 결합된 구조로서, 상기 화학식 1로 표시되는 것을 특징으로 한다. 이러한 화학식 1로 표시되는 화합물은 종래의 유기 전계 발광 소자의 유기물층에 사용되는 재료 [예: 4,4-dicarbazolybiphenyl (이하, 'CBP'라 함)]보다 높은 분자량을 가져 유리전이온도가 높으며, 열적 안정성뿐만 아니라 정공 주입능, 정공 수송능, 발광능 등이 우수하다. 따라서, 상기 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층에 사용할 경우, 유기 전계 발광 소자의 구동전압, 효율, 수명 등이 향상될 수 있다.In the organic compound according to the present invention, a benzo [d] oxazole-based moiety, or a benzothiazole-based moiety, is condensed to an indole moiety to form a basic skeleton. Dibenzothiophene, dibenzofuran, dibenzosilol, carbazole and / or fluorene moiety is bonded to the basic skeleton, characterized in that represented by the formula (1). The compound represented by Chemical Formula 1 has a higher molecular weight than the material [for example, 4,4-dicarbazolybiphenyl (hereinafter, referred to as 'CBP')] used in the organic material layer of the organic EL device, and has a high glass transition temperature and thermal As well as stability, it is excellent in hole injection ability, hole transport ability, light emitting ability and the like. Therefore, when the compound represented by Chemical Formula 1 is used in the organic material layer of the organic EL device, driving voltage, efficiency, lifespan, etc. of the organic EL device may be improved.
한편, 유기 전계 발광 소자의 인광 발광층에 사용되는 호스트는 삼중항 에너지 갭이 도펀트보다 높아야 한다. 즉, 도펀트로부터 효과적으로 인광 발광을 제공하기 위해서는 호스트의 가장 낮은 여기 상태가 도펀트의 가장 낮은 방출 상태보다 에너지가 더 높아야 한다. 상기 화학식 1로 표시되는 화합물은 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 축합 인돌 유도체에 특정의 치환기가 도입되어, 에너지 준위가 도펀트보다 높기 때문에 호스트로 사용될 수 있다.On the other hand, the host used in the phosphorescent layer of the organic EL device must have a triplet energy gap higher than the dopant. That is, in order to effectively provide phosphorescence from the dopant, the lowest excited state of the host must be higher in energy than the lowest emitted state of the dopant. The compound represented by Formula 1 may be used as a host because a specific substituent is introduced into the condensed indole derivative having a wide singlet energy level and a high triplet energy level, and the energy level is higher than that of the dopant.
또한, 상기 화학식 1로 표시되는 화합물은 전자 흡수성이 큰 전자 끌개기(EWG)가 결합된 구조로, 분자 전체가 바이폴라(bipolar) 특성을 가지기 때문에 정공과 전자의 결합력을 높일 수 있다. 따라서, 화학식 1로 표시되는 화합물은 발광 특성이 우수하기 때문에 유기 전계 발광 소자의 청색, 녹색, 또는 적색의 인광 발광층의 호스트로 사용될 수 있다.In addition, the compound represented by Chemical Formula 1 is a structure in which an electron withdrawal (EWG) having high electron absorbing property is combined, and since the whole molecule has a bipolar characteristic, the binding force between holes and electrons may be increased. Therefore, the compound represented by Chemical Formula 1 may be used as a host of a blue, green, or red phosphorescent light emitting layer of the organic electroluminescent device because of excellent luminescence properties.
이와 같이 상기 화학식 1로 표시되는 화합물은 유기 전계 발광 소자의 인광 특성, 정공 주입/수송 능력, 발광 효율, 구동 전압, 수명 특성 등을 향상시킬 수 있고, 도입되는 치환체의 종류에 따라 전자 수송 능력도 향상시킬 수 있다. 따라서, 본 발명에 따른 화학식 1로 표시되는 화합물은 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료(청색, 녹색 및/또는 적색의 인광 호스트 재료), 정공 수송층 재료 및 정공 주입층 재료, 더 바람직하게는 인광 발광층 재료로 유용하다.As such, the compound represented by Chemical Formula 1 may improve phosphorescence characteristics, hole injection / transport capability, luminous efficiency, driving voltage, lifetime characteristics, etc. of the organic electroluminescent device, and electron transport ability may also vary depending on the type of substituents introduced. Can be improved. Therefore, the compound represented by Formula 1 according to the present invention is an organic material layer material of the organic electroluminescent device, preferably a light emitting layer material (blue, green and / or red phosphorescent host material), a hole transport layer material and a hole injection layer material, more It is preferably useful as a phosphorescent layer.
또한, 상기 화학식 1로 표시되는 화합물은 기본 골격에 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리 전이온도가 향상되어 종래의 발광 재료(예를 들어, CBP)보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다. 따라서, 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자는 성능 및 수명 특성이 크게 향상될 수 있다. 이와 같이 성능 및 수명 특성이 향상된 유기 전계 발광 소자는 결과적으로 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.In addition, the compound represented by the formula (1) has a variety of substituents, especially aryl groups and / or heteroaryl groups introduced into the basic skeleton significantly increases the molecular weight of the compound, the glass transition temperature is improved to improve the conventional light emitting material (e.g. For example, it may have higher thermal stability than CBP). In addition, the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer. Therefore, the organic electroluminescent device including the compound represented by Formula 1 according to the present invention can greatly improve performance and lifespan characteristics. As such, the organic EL device having improved performance and lifespan characteristics may maximize the performance of the full color organic light emitting panel.
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물 중 어느 하나로 구체화될 수 있다.The compound represented by the formula (1) of the present invention may be embodied in any one of the compounds represented by the formula (1a) to 1f.
[화학식 1a][Formula 1a]
[화학식 1b][Formula 1b]
[화학식 1c][Formula 1c]
[화학식 1d][Formula 1d]
[화학식 1e][Formula 1e]
[화학식 1f][Formula 1f]
상기 화학식 1a 내지 화학식 1f에서,In Chemical Formulas 1a to 1f,
A, X1 및 R3 내지 R11은 상기 화학식 1에서 정의한 바와 같다.A, X 1 and R 3 to R 11 are the same as defined in Chemical Formula 1.
구체적으로 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1-1 내지 1-12로 표시되는 화합물 중 어느 하나 일 수 있고, 이때 A 및 R1 내지 R11은 상기 화학식 1에서 정의한 바와 같다.Specifically, the compound represented by Chemical Formula 1 of the present invention may be any one of the compounds represented by the following Chemical Formulas 1-1 to 1-12, wherein A and R 1 to R 11 are as defined in Chemical Formula 1.
상기 화학식 1-1 내지 화학식 1-12에서,In Chemical Formulas 1-1 to 1-12,
R3 내지 R6 및 축합고리를 형성하지 않는 R7 내지 R10 및 R11 중 적어도 하나는 하기 화학식 3으로 표시되는 치환체이다. 구체적으로, R4가 하기 화학식 3으로 표시되는 치환체인 것이 바람직하다.At least one of R 3 to R 6 and R 7 to R 10 and R 11 which do not form a condensed ring is a substituent represented by the following general formula (3). Specifically, R 4 is preferably a substituent represented by the following formula (3).
[화학식 3][Formula 3]
상기 화학식 3에서,In Chemical Formula 3,
L1은 단일결합, 또는 치환 또는 비치환된 페닐렌기인 것이 바람직하다.L 1 is preferably a single bond or a substituted or unsubstituted phenylene group.
X2는 O, S, N(R31), C(R32)(R33) 및 Si(R34)(R35)로 이루어진 군에서 선택되는데, O, S 또는 N(R31)인 것이 바람직하다. 예컨대, X2가 O 또는 S일 경우 R21 또는 R23 위치의 탄소는 L1과 결합하고, X2가 N(R31)일 경우 R23 또는 R31 위치의 탄소가 L1과 결합한다.X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32 ) (R 33 ) and Si (R 34 ) (R 35 ), which is O, S or N (R 31 ) desirable. For example, when X 2 is O or S, the carbon at R 21 or R 23 is bonded to L 1 , and when X 2 is N (R 31 ), the carbon at R 23 or R 31 is bonded to L 1 .
L1에 연결되지 않은 R21 내지 R28 및 R31 내지 R35은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택될 수 있다.R 21 to R 28 and R 31 to R 35 not connected to L 1 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, C 3 -C 40 heterocycloalkyl group, C 6 -C 60 aryl group, C 5-60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6- C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group may be selected from the group consisting of C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl group of an amine of.
또한, 상기 화학식 1에서, A 및 R31은 각각 독립적으로 C1~C40의 알킬기, C6~C60의 아릴기 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택되는 것이 바람직하며, 페닐기 또는 하기 화학식 4로 표시되는 치환체인 것이 더욱 바람직하다.In addition, in Formula 1, A and R 31 are each independently selected from the group consisting of C 1 ~ C 40 Alkyl group, C 6 ~ C 60 An aryl group and a heteroaryl group of 5 to 60 nuclear atoms, It is more preferable that it is a substituent represented by following formula (4) or a phenyl group.
[화학식 4][Formula 4]
상기 화학식 4에서,In Chemical Formula 4,
L2는 단일결합, C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택되는데, 단일결합, 페닐렌기 또는 비페닐렌기인 것이 바람직하다.L 2 is preferably a single bond, a C 6 ~ be an aryl group and a C 18 nuclear atoms are selected from the group consisting of a hetero arylene of 5 to 18, a single bond, phenylene group or biphenylene group.
Z1 내지 Z5는 서로 동일하거나 상이하고, 각각 독립적으로 N 또는 C(R12)이며, 이때, Z1 내지 Z5 중 적어도 하나는 N이고, C(R12)가 복수인 경우, 이들은 서로 동일하거나 상이하다.Z 1 to Z 5 are the same as or different from each other, and each independently N or C (R 12 ), wherein at least one of Z 1 to Z 5 is N and when C (R 12 ) is plural, they are each other. Same or different.
R12는 수소, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성한다.R 12 is hydrogen, deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, nuclear 5 to 40 heteroaryl group, C 6 ~ C 40 aryloxy group C 1 ~ C 40 alkyloxy group of, C 6 ~ C 40 aryl amine group, C 1 ~ C 40 groups of the alkyl silyl group, C 1 ~ C 40 alkyl, boron, C 6 ~ C 40 group of the arylboronic, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl selected from the group consisting of a silyl or, by combining groups adjacent to form a condensed ring.
상기 R12의 알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되고, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.Alkyl group of the R 12, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an aryl silyl group Deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl groups, C 1 to C 40 alkylsilyl groups, C 1 to C 40 alkylboron groups, C 6 to C 40 arylboron groups, C 6 to C 40 arylphosphine groups, C 6 to C 40 is an aryl phosphine oxide groups and ring pins C 6 ~ C a substituted or unsubstituted by one or more substituents selected from the group consisting of aryl silyl group of 40, when the plurality of the substituents, these are equal to each other hageo It is different.
상기 화학식 4로 표시되는 치환체의 예로는 하기 화학식 A1 내지 A15로 표시되는 치환체일 수 있는데, 이에 한정되지는 않는다.Examples of the substituent represented by Formula 4 may be a substituent represented by the following Formula A1 to A15, but is not limited thereto.
상기 화학식 A1 내지 A15에서,In Formulas A1 to A15,
L2 및 R12는 상기 화학식 4에서 정의한 바와 같고, 이때, 복수의 R12는 서로 동일하거나 상이하며,L 2 and R 12 are as defined in Formula 4, wherein a plurality of R 12 are the same or different from each other,
R41은 수소, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성하며, n은 1 내지 4의 정수이다. 또한 R14가 복수일 경우, 이들은 서로 동일하거나 상이하다.R 41 is hydrogen, deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 6 -C 40 aryl group, nuclear atom 5-40 heteroaryl group, C 6 -C 40 aryloxy group C 1 ~ C 40 alkyloxy group of, C 6 ~ C 40 aryl amine group, C 1 ~ C 40 groups of the alkyl silyl group, C 1 ~ C 40 alkyl, boron, C 6 ~ C 40 group of the arylboronic, C 6 to C 40 arylphosphine group, C 6 ~ C 40 aryl phosphine oxide group and C 6 ~ C 40 arylsilyl group selected from the group consisting of or combined with adjacent groups to form a condensed ring, n is 1 It is an integer of -4. In addition, when R 14 is plural, they are the same as or different from each other.
상기 R41의 알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되며, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.The alkyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, alkylsilyl group, alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl silyl group of R 41 Deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl groups, C 1 to C 40 alkylsilyl groups, C 1 to C 40 alkylboron groups, C 6 to C 40 arylboron groups, C 6 to C 40 arylphosphine groups, C 6 to C is unsubstituted or substituted with at least 40 aryl phosphine oxide of the group and a C 6 ~ C 40 selected from the group consisting arylsilyl one kind of substituent, if the substituent is a plurality, they are equal to each other hageo It is different.
본 발명의 화학식 1로 표시되는 화합물은 보다 구체적으로 하기 화학식들로 나타낼 수 있으나, 이들로 한정되는 것은 아니다.The compound represented by Formula 1 of the present invention may be represented by the following Formulas in more detail, but is not limited thereto.
본 발명의 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 이의 비제한적인 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등이 있다.Alkyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms, and non-limiting examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl , iso-amyl and hexyl.
본 발명의 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있다.Alkenyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Non-limiting examples thereof include vinyl, allyl, isopropenyl, 2-butenyl and the like.
본 발명의 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있다.Alkynyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Non-limiting examples thereof include ethynyl, 2-propynyl and the like.
본 발명의 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 시클로프로필, 시클로펜틸, 시클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine)등이 있다.Cycloalkyl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms (saturated cyclic hydrocarbon). Non-limiting examples thereof include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine and the like.
본 발명의 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비제한적인 예로는 모르폴린, 피페라진 등이 있다.Heterocycloalkyl of the present invention means monovalent functional groups obtained by removing hydrogen atoms from non-aromatic hydrocarbons (saturated cyclic hydrocarbons) having 3 to 40 nuclear atoms, and preferably at least one carbon in the ring, preferably 1 to 3 carbon atoms. Carbons are substituted with heteroatoms such as N, O or S. Non-limiting examples thereof include morpholine, piperazine and the like.
본 발명의 아릴은 단독 고리 또는 2 이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이때, 2 이상의 고리는 서로 단순 부착되거나 축합된 형태로 부착될 수 있다. 이의 비제한적인 예로는 페닐, 비페닐, 터페닐(terphenyl), 나프틸, 페난트릴, 안트릴 등이 있다.Aryl of the present invention means a monovalent functional group obtained by removing a hydrogen atom from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. In this case, the two or more rings may be attached in a simple or condensed form with each other. Non-limiting examples thereof include phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthryl and the like.
본 발명의 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기로서, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 질소(N), 산소(O), 황(S) 또는 셀레늄(Se)과 같은 헤테로원자로 치환된다. 이때, 헤테로아릴은 2 이상의 고리가 서로 단순 부착되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함할 수 있다. 이러한 헤테로아릴의 비제한적인 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등이 있다.Heteroaryl of the present invention is a monovalent functional group obtained by removing a hydrogen atom from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons. Is substituted with a heteroatom such as nitrogen (N), oxygen (O), sulfur (S) or selenium (Se). In this case, the heteroaryl may be attached in a form in which two or more rings are simply attached or condensed with each other, and may also include a condensed form with an aryl group. Non-limiting examples of such heteroaryls include six-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl ring; And 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.
본 발명의 알킬옥시는 RO-로 표시되는 1가의 작용기를 의미하며, 상기 R은 탄소수 1 내지 40개의 알킬로서, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 이러한 알킬옥시의 비제한적인 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 있다.The alkyloxy of the present invention means a monovalent functional group represented by RO-, wherein R is alkyl having 1 to 40 carbon atoms, and may include a linear, branched or cyclic structure. . Non-limiting examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
본 발명의 아릴옥시는 R'O-로 표시되는 1가의 작용기를 의미하며, 상기 R'는 탄소수 6 내지 60의 아릴이다. 이러한 아릴옥시의 비제한적인 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다.Aryloxy of the present invention means a monovalent functional group represented by R'O-, wherein R 'is aryl having 6 to 60 carbon atoms. Non-limiting examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.
본 발명의 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴을 의미하며, 본 발명의 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미하고, 본 발명의 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.Alkylsilyl of the present invention means silyl substituted with alkyl having 1 to 40 carbon atoms, arylsilyl of the present invention means silyl substituted with aryl having 6 to 60 carbon atoms, arylamine of the present invention is 6 to 60 carbon atoms Amine substituted with aryl.
본 발명의 축합 고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.Condensed ring of the present invention means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring or a combination thereof.
이러한 본 발명의 화학식 1로 표시되는 화합물의 합성 과정은 후술하는 합성예에서 구체적으로 설명하도록 한다. Synthesis process of the compound represented by the formula (1) of the present invention will be described in detail in the synthesis examples described later.
2. 유기 전계 발광 소자2. Organic electroluminescent device
본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention provides an organic electroluminescent device comprising a compound represented by the formula (1).
구체적으로, 본 발명은 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화학식 1로 표시되는 화합물은 단독 또는 2 이상 혼합되어 사용될 수 있다.Specifically, the present invention is an organic electroluminescent device comprising an anode (anode), a cathode (cathode) and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic material layer is It includes a compound represented by the formula (1). In this case, the compound represented by Formula 1 may be used alone or in combination of two or more.
상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 이 중 적어도 하나 이상이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 인광 발광층인 것이 바람직하다.The one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer, at least one of which may include a compound represented by the formula (1). The organic material layer including the compound represented by Chemical Formula 1 is preferably a phosphorescent light emitting layer.
즉, 본 발명의 유기 전계 발광 소자의 발광층은 호스트를 포함할 수 있는데, 이때 호스트로서 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 상기 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 발광층의 재료, 바람직하게는 녹색의 인광 호스트로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등이 향상될 수 있다.That is, the light emitting layer of the organic electroluminescent device of the present invention may include a host, and may include a compound represented by Chemical Formula 1 as a host. When the compound represented by Chemical Formula 1 is included as a material of the light emitting layer of the organic electroluminescent device, preferably a green phosphorescent host, the binding force between the holes and the electrons in the light emitting layer increases, so that the efficiency (light emitting efficiency and power Efficiency), lifespan, brightness, driving voltage and the like can be improved.
본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 상기 전자 수송층 위에는 전자 주입층이 추가로 적층될 수 있다. 또, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입될 수 있다.The structure of the organic EL device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked. An electron injection layer may be further stacked on the electron transport layer. In addition, an insulating layer or an adhesive layer may be inserted between the electrode and the organic layer.
본 발명의 유기 전계 발광 소자는 상기 유기물층 중 적어도 하나 이상(예컨대, 발광층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는 당업계에 알려진 재료 및 방법을 이용하여 제조될 수 있다. 여기서 유기물층은 진공 증착법이나 용액 도포법으로 형성될 수 있는데, 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있다.The organic electroluminescent device of the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic material layers (eg, the light emitting layer) is formed to include the compound represented by Chemical Formula 1. . The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명의 유기 전계 발광 소자 제조 시 사용되는 기판은 특별히 한정되지 않으나, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 등이 사용될 수 있다.The substrate used in manufacturing the organic EL device of the present invention is not particularly limited, but a silicon wafer, quartz, glass plate, metal plate, plastic film, or the like may be used.
또, 양극 물질은 특별히 한정되지 않으나, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 사용될 수 있다.In addition, the positive electrode material is not particularly limited, but a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black and the like can be used.
또, 음극 물질은 특별히 한정되지 않으나, 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 사용될 수 있다.The negative electrode material is not particularly limited, but may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or alloys thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al and the like.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples. However, the following examples are merely to illustrate the invention, the present invention is not limited by the following examples.
[준비예 1] BOC-1 & BOC-2의 합성Preparation Example 1 Synthesis of BOC-1 & BOC-2
<단계 1> N-(2,4-Dibromophenyl)benzamide의 합성Step 1 Synthesis of N- (2,4-Dibromophenyl) benzamide
반응기에 2,4-dibromoaniline (250.9 g, 1.0 mol) 을 투입하고, methylene chloride (1,000 ml)를 가한 후 교반한다. 반응기에 benzoyl chloride (116 mL,1.0 mol), pyridine (161.8 mL, 2.0 mol)을 적가하고 혼합하고 상온에서 2시간 동안 교반하였다.2,4-dibromoaniline (250.9 g, 1.0 mol) was added to the reactor, and methylene chloride (1,000 ml) was added thereto, followed by stirring. Benzoyl chloride (116 mL, 1.0 mol) and pyridine (161.8 mL, 2.0 mol) were added dropwise to the reactor, mixed, and stirred at room temperature for 2 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 N-(2,4-dibromophenyl)benzamide (252.1 g, 수율 71%)를 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride and then water was removed using MgSO 4 , and purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain N- (2,4-dibromophenyl) benzamide ( 252.1 g, yield 71%) was obtained.
1H-NMR: δ7.52 (d, 1H), 7.59 (d, 1H), 7.63 (dd, 2H), 7.70 (t, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 9.15 (b, 1H) 1 H-NMR: δ 7.52 (d, 1H), 7.59 (d, 1H), 7.63 (dd, 2H), 7.70 (t, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 9.15 (b, 1H)
<단계 2> 6-Bromo-2-phenylbenzo[d]oxazole의 합성<Step 2> Synthesis of 6-Bromo-2-phenylbenzo [d] oxazole
질소 기류 하에서 N-(2,4-dibromophenyl)benzamide (251.1 g, 710 mmol), K2CO3 (196.3 g, 1420 mmol) 및 DMSO (7100 ml)를 혼합하고, 140℃에서 1.5시간 동안 교반하였다.N- (2,4-dibromophenyl) benzamide (251.1 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. .
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 6-bromo-2-phenylbenzo[d]oxazole (147.9 g, 수율 76%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 9: 1 (v / v)) and purified by 6-bromo-2-phenylbenzo [d] oxazole. (147.9 g, yield 76%) was obtained.
1H-NMR: δ7.41 (t, 1H) 7.43 (s, 1H), 7.51 (m, 3H), 7.60 (d, 1H), 8.05 (d, 2H) 1 H-NMR: δ 7.41 (t, 1H) 7.43 (s, 1H), 7.51 (m, 3H), 7.60 (d, 1H), 8.05 (d, 2H)
<단계 3> 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole의 합성<Step 3> Synthesis of 2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole
질소 기류 하에서 6-bromo-2-phenylbenzo[d]oxazole (147.9 g, 540.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.6-bromo-2-phenylbenzo [d] oxazole (147.9 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole (133.5 g, 수율 77%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to 2-phenyl-6- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole (133.5 g, yield 77%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H) , 7.75 (s, 1H), 8.05 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 ( d, 2H)
<단계 4> 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole의 합성Step 4 Synthesis of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole
질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole (133.5 g, 415.8 mmol), 4-bromo-2-iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole (133.5 g, 415.8 mmol), 4-bromo-2 under nitrogen stream -iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O ( 400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole (138 g, 수율 84%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole (138 g, Yield 84%).
1H-NMR: δ7.41 (t, 1H) 7.48 (s, 1H), 7.51 (dd, 2H), 7.68 (d, 1H), 7.72 (s, 1H), 7.79 (d, 1H), 7.98 (d, 1H), 8.05 (d, 2H), 8.21 (d, 1H) 1 H-NMR: δ 7.41 (t, 1H) 7.48 (s, 1H), 7.51 (dd, 2H), 7.68 (d, 1H), 7.72 (s, 1H), 7.79 (d, 1H), 7.98 ( d, 1H), 8.05 (d, 2H), 8.21 (d, 1H)
<단계 5> 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole (A)과 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole (B)의 합성Step 5: 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (A) and 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (B) synthesis
질소 기류 하에서 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole (138g, 349 mmol)과 triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene 1500 ml를 넣은 후, 12시간 동안 교반하였다.1,500 ml of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole (138 g, 349 mmol) and triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene under nitrogen stream Stir for hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 A (70.1g, 수율 53 %)와 B (41.0g, 수율 31 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain target compounds A (70.1 g, yield 53%) and B (41.0 g, yield 31%). Obtained.
화합물 A의 1H-NMR : δ7.23 (d, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR of Compound A: δ7.23 (d, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 8.05 (m, 3H) , 8.12 (d, 1H), 10.1 (b, 1H)
화합물 B의 1H-NMR : δ7.40 (s, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 7.55 (s, 1H), 8.05 (m, 3H), 10.1 (b, 1H) 1 H-NMR of Compound B: δ 7.40 (s, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 7.55 (s, 1H) , 8.05 (m, 3H), 10.1 (b, 1H)
<단계 6> 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole의 합성Step 6 Synthesis of 2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 7-bromo-2-phenyl-10H-oxazolo[5,4-a]carbazole (70.1 g, 193.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd(dppf)Cl2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) 및 1,4-Dioxane (1000 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7-bromo-2-phenyl-10H-oxazolo [5,4-a] carbazole (70.1 g, 193.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd (dppf) Cl 2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) and 1, 4-Dioxane (1000 ml) was mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 수율 81%)을 얻었다. After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to obtain 2-phenyl-7- (4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, yield 81%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H) , 7.75 (s, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 ( d, 2H), 10.1 (b, 1H)
<단계 7> 7-(3-bromophenyl)-2-phenyl-10H-oxazolo[5,4-a]carbazole의 합성Step 7 Synthesis of 7- (3-bromophenyl) -2-phenyl-10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 156.2 mmol), 1-bromo-3-iodobenzene (48.6 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 m mol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, 156.2 mmol) under nitrogen stream ), 1-bromo-3-iodobenzene (48.6 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 m mol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(3-bromophenyl)-2-phenyl-10H-oxazolo[5,4-a]carbazole (60.4 g, 수율 88%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (3-bromophenyl) -2-phenyl-10H-oxazolo [5,4-a] carbazole (60.4 g, yield 88%) was obtained.
1H-NMR: δ7.23 (d, 1H) 7.41-7.56 (m, 7H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR: δ7.23 (d, 1H) 7.41-7.56 (m, 7H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 8.12 (d, 1 H), 10.1 (b, 1 H)
<단계 8> 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole의 합성<Step 8> 2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole Synthesis of
질소 기류 하에서 7-(3-bromophenyl)-2-phenyl-10H-oxazolo[5,4-a]carbazole (60.4 g, 137.5 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (39.4 g, 151.2 mmol), Pd(dppf)Cl2 (15.9 g, 13.8 mmol), KOAc (38.8 g, 412.5 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7- (3-bromophenyl) -2-phenyl-10H-oxazolo [5,4-a] carbazole (60.4 g, 137.5 mmol), 4,4,4 ', 4', 5,5,5 'under nitrogen stream , 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (39.4 g, 151.2 mmol), Pd (dppf) Cl 2 (15.9 g, 13.8 mmol), KOAc (38.8 g, 412.5 mmol ) And 1,4-Dioxane (500 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (52.2 g, 수율 78%)을 얻었다.After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)), and 2-phenyl-7- (3- (4 , 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole (52.2 g, yield 78%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.23 (d, 1H) 7.41 (t, 1H), 7.51-7.52 (m, 4H), 7.66-7.77 (m, 4H), 8.05 (d, 2H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.23 (d, 1H) 7.41 (t, 1H), 7.51-7.52 (m, 4H), 7.66-7.77 (m, 4H), 8.05 (d, 2H ), 8.12 (d, 1H), 10.1 (b, 1H)
<단계 9> 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-oxazolo[5,4-a]carbazole 의 합성Step 9 Synthesis of 7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (52.2 g, 107.3 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd(PPh3)4 (6.21 g, 5.37 mmol), K2CO3(37.1 g, 268.3 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole ( 52.2 g, 107.3 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd (PPh 3 ) 4 (6.21 g, 5.37 mmol), K 2 CO 3 (37.1 g, 268.3 mmol), 1, 4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-oxazolo[5,4-a]carbazole (42.9 g, 수율 83%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-oxazolo [5, 4-a] carbazole (42.9 g, yield 83%) was obtained.
1H-NMR: δ7.23 (d, 1H) 7.41-7.77 (m, 10H), 7.87-8.00 (m, 3H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR: δ7.23 (d, 1H) 7.41-7.77 (m, 10H), 7.87-8.00 (m, 3H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H )
<단계 10> BOC-1과 BOC-2의 합성Step 10 Synthesis of BOC-1 and BOC-2
질소 기류 하에서 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-oxazolo[5,4-a]carbazole (42.9g, 89.1 mmol)과 triphenylphosphine (58.4 g, 222.7 mmol), 1,2-dichlorobenzene 500 ml를 넣은 후, 12시간 동안 교반하였다.7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-oxazolo [5,4-a] carbazole (42.9 g, 89.1 mmol) and triphenylphosphine (58.4 g, 222.7 mmol) under nitrogen stream, 1, 500 ml of 2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BOC-1 (24.4g, 수율 56 %)과 BOC-2 (10.4g, 수율 24 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and the residue was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain BOC-1 (24.4 g, yield 56%) and BOC-2 (10.4 g, yield) as target compounds. 24%) was obtained.
BOC-1의 1H-NMR : δ7.23-7.29 (m, 2H), 7.41 (t, 1H) 7.50-7.51 (m, 3H), 7.63-7.87 (m, 7H), 8.05-8.12 (m, 4H), 10.1 (b, 2H) 1 H-NMR of BOC-1: δ7.23-7.29 (m, 2H), 7.41 (t, 1H) 7.50-7.51 (m, 3H), 7.63-7.87 (m, 7H), 8.05-8.12 (m, 4H), 10.1 (b, 2H)
BOC-2의 1H-NMR : δ7.23-7.51 (m, 7H), 7.63-7.87 (m, 5H), 8.05-8.12 (m, 5H), 10.1 (b, 2H) 1 H-NMR of BOC-2: δ7.23-7.51 (m, 7H), 7.63-7.87 (m, 5H), 8.05-8.12 (m, 5H), 10.1 (b, 2H)
[준비예 2] BOC-3 & BOC-4의 합성Preparation Example 2 Synthesis of BOC-3 & BOC-4
<단계 1> 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 [준비예 1]의 <단계 5>에서 제조된 8-bromo-2-phenyl-5H-oxazolo[4,5-b]carbazole (41.0 g, 112.9 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd(dppf)Cl2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) 및 1,4-Dioxane (700 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.8-bromo-2-phenyl-5H-oxazolo [4,5-b] carbazole (41.0 g, 112.9 mmol), 4,4,4 ', prepared in <Step 5> of Preparation Example 1 under a nitrogen stream; 4 ', 5,5, 5', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd (dppf) Cl 2 (13.1 g, 11.3 mmol ), KOAc (31.9 g, 338.7 mmol) and 1,4-Dioxane (700 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 수율 85%)을 얻었다. After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to obtain 2-phenyl-8- (4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, yield 85%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.41 (d, 1H), 7.40 (s, 1H), 7.51 (m, 3H), 7.55 (s, 1H) , 7.63 (d, 1H), 7.98 (s, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.40 (s, 1H), 7.51 (m, 3H), 7.55 (s, 1H), 7.63 (d, 1H), 7.98 ( s, 1H), 8.05 (d, 2H), 10.1 (b, 1H)
<단계 2> 8-(3-bromophenyl)-2-phenyl-5H-oxazolo[4,5-b]carbazole의 합성Step 2 Synthesis of 8- (3-bromophenyl) -2-phenyl-5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 96.0 mmol), 1-bromo-3-iodobenzene (29.9 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, 96.0 mmol) under nitrogen stream ), 1-bromo-3-iodobenzene (29.9 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(3-bromophenyl)-2-phenyl-5H-oxazolo[4,5-b]carbazole (37.5 g, 수율 89%)을 얻었다. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 8- (3-bromophenyl) -2-phenyl-5H-oxazolo [4,5-b] carbazole (37.5 g, yield 89%) was obtained.
1H-NMR: δ7.40-7.56 (m, 9H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 7.40-7.56 (m, 9H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H)
<단계 3> 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole의 합성<Step 3> 2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole Synthesis of
질소 기류 하에서 8-(3-bromophenyl)-2-phenyl-5H-oxazolo[4,5-b]carbazole (37.5 g, 85.4 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (23.8 g, 93.9 mmol), Pd(dppf)Cl2 (9.87 g, 8.54 mmol), KOAc (24.1 g, 256.2 mmol) 및 1,4-Dioxane (300 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.8- (3-bromophenyl) -2-phenyl-5H-oxazolo [4,5-b] carbazole (37.5 g, 85.4 mmol), 4,4,4 ', 4', 5,5,5'under nitrogen stream , 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (23.8 g, 93.9 mmol), Pd (dppf) Cl 2 (9.87 g, 8.54 mmol), KOAc (24.1 g, 256.2 mmol ) And 1,4-Dioxane (300 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (34.1 g, 수율 82%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)), and 2-phenyl-7- (3- (4 , 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole (34.1 g, 82% yield) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.40-7.41 (m, 2H), 7.51-7.55 (m, 5H), 7.66 (s, 1H), 7.69 (s, 1H), 7.71(d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.40-7.41 (m, 2H), 7.51-7.55 (m, 5H), 7.66 (s, 1H), 7.69 (s, 1H), 7.71 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H)
<단계 4> 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-oxazolo[4,5-b]carbazole 의 합성Step 4 Synthesis of 8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (34.1 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd(PPh3)4 (4.05 g, 3.51 mmol), K2CO3 (24.2 g, 175.3 mmol), 1,4-dioxane/H2O (80 ml/20 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole ( 34.1 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd (PPh 3 ) 4 (4.05 g, 3.51 mmol), K 2 CO 3 (24.2 g, 175.3 mmol), 1, 4-dioxane / H 2 O (80 ml / 20 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-oxazolo[4,5-b]carbazole (29.0 g, 수율 86%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-oxazolo [4, 5-b] carbazole (29.0 g, yield 86%) was obtained.
1H-NMR: δ7.40-7.77 (m, 12H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H), 10.1 (b, 1H) 1 H-NMR: δ 7.40-7.77 (m, 12H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H), 10.1 (b, 1H)
<단계 5> BOC-3과 BOC-4의 합성Step 5 Synthesis of BOC-3 and BOC-4
질소 기류 하에서 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-oxazolo[4,5-b]carbazole (29.0 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol), 1,2-dichlorobenzene 300 ml를 넣은 후, 12시간 동안 교반하였다.8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-oxazolo [4,5-b] carbazole (29.0 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol) under nitrogen stream, 1, 300 ml of 2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응 종료 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BOC-3 (13.8g, 수율 51 %)과 BOC-4 (7.60g, 수율 28 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and the residue was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain BOC-3 (13.8g, yield 51%) and BOC-4 (7.60g, yield) as target compounds. 28%) was obtained.
BOC-3의 1H-NMR : δ7.29 (dd, 1H), 7.40-7.77 (m, 11H), 7.86-7.87 (m, 2H), 8.05-8.12 (m, 3H), 10.1 (b, 2H) 1 H-NMR of BOC-3: δ 7.29 (dd, 1H), 7.40-7.77 (m, 11H), 7.86-7.87 (m, 2H), 8.05-8.12 (m, 3H), 10.1 (b, 2H )
BOC-4의 1H-NMR : δ7.29-7.77 (m, 11H), 7.86-7.87 (m, 2H), 8.05-8.12 (m, 4H), 10.1 (b, 2H) 1 H-NMR of BOC-4: δ 7.29-7.77 (m, 11H), 7.86-7.87 (m, 2H), 8.05-8.12 (m, 4H), 10.1 (b, 2H)
[준비예 3] BOC-5 & BOC-6의 합성Preparation Example 3 Synthesis of BOC-5 & BOC-6
<단계 1> 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole의 합성Synthesis of 2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 [준비예 1]의 <단계 6>에서 제조된 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 156.2 mmol), Iodobenzene (21.0 mL, 187.44 mmol), CuI (3.0 g, 15.6 mmol), 1,10-phenanthroline (5.6 g, 31.2 mmol), Cs2CO3 (101.8 g, 312.4 mmol) 및 nitrobenzene (500 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (66.9 g, 수율 88%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [prepared in <Step 6> of [Preparation Example 1] under a nitrogen stream. 5,4-a] carbazole (64.1 g, 156.2 mmol), Iodobenzene (21.0 mL, 187.44 mmol), CuI (3.0 g, 15.6 mmol), 1,10-phenanthroline (5.6 g, 31.2 mmol), Cs 2 CO 3 (101.8 g, 312.4 mmol) and nitrobenzene (500 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to give 2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 10H-oxazolo [5,4-a] carbazole (66.9 g, yield 88%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.23 (d, 1H), 7.41-7.58 (m, 9H), 7.94-7.98 (m, 2H), 8.05 (d, 2H), 8.12 (d, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.23 (d, 1H), 7.41-7.58 (m, 9H), 7.94-7.98 (m, 2H), 8.05 (d, 2H), 8.12 (d, 1H )
<단계 2> 7-(3-bromophenyl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole의 합성<Step 2> Synthesis of 7- (3-bromophenyl) -2,10-diphenyl-10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (66.9 g, 137.4 mmol), 1-bromo-3-iodobenzene (42.7 g, 151.1 mmol), Pd(PPh3)4 (7.94 g, 6.87 mmol), K2CO3(47.5 g, 343.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (66.9 g, under a nitrogen stream 137.4 mmol), 1-bromo-3-iodobenzene (42.7 g, 151.1 mmol), Pd (PPh 3 ) 4 (7.94 g, 6.87 mmol), K 2 CO 3 (47.5 g, 343.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(3-bromophenyl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole (63.0 g, 수율 89%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (3-bromophenyl) -2,10-diphenyl-10H-oxazolo [5,4-a ] carbazole (63.0 g, yield 89%) was obtained.
1H-NMR: δ7.23 (d, 1H) 7.40-7.58 (m, 12H), 7.77 (s, 1H), 8.00-8.05 (m, 3H), 8.12-8.18 (m, 2H) 1 H-NMR: δ7.23 (d, 1H) 7.40-7.58 (m, 12H), 7.77 (s, 1H), 8.00-8.05 (m, 3H), 8.12-8.18 (m, 2H)
<단계 3> 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole의 합성<Step 3> 2,10-diphenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a ] Synthesis of carbazole
질소 기류 하에서 7-(3-bromophenyl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole (63.0 g, 122.3 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (34.2 g, 134.5 mmol), Pd(dppf)Cl2 (14.1 g, 12.2 mmol), KOAc (34.5 g, 366.9 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7- (3-bromophenyl) -2,10-diphenyl-10H-oxazolo [5,4-a] carbazole (63.0 g, 122.3 mmol), 4,4,4 ', 4', 5,5, under a stream of nitrogen 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (34.2 g, 134.5 mmol), Pd (dppf) Cl 2 (14.1 g, 12.2 mmol), KOAc (34.5 g, 366.9 mmol) and 1,4-Dioxane (500 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (60.2 g, 수율 87.5%)을 얻었다. After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to give 2,10-diphenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] carbazole (60.2 g, yield 87.5%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.23 (d, 1H) 7.41-7.58 (m, 10H), 7.66-7.71 (m, 2H), 7.77 (s, 1H), 8.00-8.05 (m, 3H), 8.12-8.18 (m, 2H) 1 H-NMR: δ 1.24 (s, 12H), 7.23 (d, 1H) 7.41-7.58 (m, 10H), 7.66-7.71 (m, 2H), 7.77 (s, 1H), 8.00-8.05 (m , 3H), 8.12-8.18 (m, 2H)
<단계 4> 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole의 합성Step 4 Synthesis of 7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-oxazolo [5,4-a] carbazole
질소 기류 하에서 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-oxazolo[5,4-a]carbazole (60.2 g, 107.0 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd(PPh3)4 (6.21 g, 5.37 mmol), K2CO3(37.1 g, 268.3 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,10-diphenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-oxazolo [5,4-a] under nitrogen stream carbazole (60.2 g, 107.0 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd (PPh 3 ) 4 (6.21 g, 5.37 mmol), K 2 CO 3 (37.1 g, 268.3 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole (50.1 g, 수율 84%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-oxazolo [ 5,4-a] carbazole (50.1 g, yield 84%) was obtained.
1H-NMR: δ7.23 (d, 1H) 7.41-7.70 (m, 13H), 7.77 (s, 1H), 7.90 (dd, 1H), 8.00-8.18 (m, 7H) 1 H-NMR: δ7.23 (d, 1H) 7.41-7.70 (m, 13H), 7.77 (s, 1H), 7.90 (dd, 1H), 8.00-8.18 (m, 7H)
<단계 5> BOC-5과 BOC-6의 합성Step 5 Synthesis of BOC-5 and BOC-6
질소 기류 하에서 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-oxazolo[5,4-a]carbazole (50.1 g, 89.9 mmol), triphenylphosphine (58.4 g, 222.7 mmol), 1,2-dichlorobenzene 500 ml를 넣은 후, 12시간 동안 교반하였다.7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-oxazolo [5,4-a] carbazole (50.1 g, 89.9 mmol), triphenylphosphine (58.4 g, 222.7 mmol) under a nitrogen stream, 500 ml of 1,2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BOC-5 (26.0g, 수율 55 %)과 BOC-6 (14.2g, 수율 30 %)을 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and the residue was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain BOC-5 (26.0 g, 55% yield) and BOC-6 (14.2g, yield). 30%) was obtained.
BOC-5의 1H-NMR : δ7.23-7.29 (m, 2H), 7.41-7.69 (m, 11H), 7.77-7.87 (m, 3H), 8.00-8.18 (m, 6H), 10.1 (b, 1H) 1 H-NMR of BOC-5: δ7.23-7.29 (m, 2H), 7.41-7.69 (m, 11H), 7.77-7.87 (m, 3H), 8.00-8.18 (m, 6H), 10.1 (b , 1H)
BOC-6의 1H-NMR : δ7.23-7.63 (m, 13H), 7.77-7.87 (m, 2H), 8.00-8.18 (m, 7H), 10.1 (b, 1H) 1 H-NMR of BOC-6: δ7.23-7.63 (m, 13H), 7.77-7.87 (m, 2H), 8.00-8.18 (m, 7H), 10.1 (b, 1H)
[준비예 4] BOC-7 & BOC-8의 합성Preparation Example 4 Synthesis of BOC-7 & BOC-8
<단계 1> 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 [준비예 2]의 <단계 1>에서 제조된 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 96.0 mmol), Iodobenzene (12.8 mL, 115.2 mmol), CuI (1.8 g, 9.6 mmol), 1,10-phenanthroline (3.5 g, 19.2 mmol), Cs2CO3 (62.6 g, 192.0 mmol) 및 nitrobenzene (400 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (41.6 g, 수율 89%)을 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [prepared in <Step 1> of [Preparation Example 2] under a nitrogen stream. 4,5-b] carbazole (39.4 g, 96.0 mmol), Iodobenzene (12.8 mL, 115.2 mmol), CuI (1.8 g, 9.6 mmol), 1,10-phenanthroline (3.5 g, 19.2 mmol), Cs 2 CO 3 (62.6 g, 192.0 mmol) and nitrobenzene (400 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to give 2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (41.6 g, yield 89%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.40-7.63 (m, 12H), 7.98 (s, 1H), 8.05 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H), 7.40-7.63 (m, 12H), 7.98 (s, 1H), 8.05 (d, 2H)
<단계 2> 8-(3-bromophenyl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole의 합성Step 2 Synthesis of 8- (3-bromophenyl) -2,5-diphenyl-5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (41.6 g, 85.4 mmol), 1-bromo-3-iodobenzene (26.6 g, 93.9 mmol), Pd(PPh3)4 (5.0 g, 4.3 mmol), K2CO3(35.4 g, 256.2 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (41.6 g, 85.4 mmol), 1-bromo-3-iodobenzene (26.6 g, 93.9 mmol), Pd (PPh 3 ) 4 (5.0 g, 4.3 mmol), K 2 CO 3 (35.4 g, 256.2 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(3-bromophenyl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole (38.7 g, 수율 88%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 8- (3-bromophenyl) -2,5-diphenyl-5H-oxazolo [4,5-b ] carbazole (38.7 g, yield 88%) was obtained.
1H-NMR: δ7.40-7.58 (m, 14H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H) 1 H-NMR: δ 7.40-7.58 (m, 14H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H)
<단계 3> 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-oxazolo[4,5-b]carbazole의 합성<Step 3> 2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-oxazolo [4,5-b ] Synthesis of carbazole
질소 기류 하에서 8-(3-bromophenyl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole (38.7 g, 75.1 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (20.9 g, 82.6 mmol), Pd(dppf)Cl2 (8.68 g, 7.51 mmol), KOAc (21.2 g, 225.3 mmol) 및 1,4-Dioxane (250 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.8- (3-bromophenyl) -2,5-diphenyl-5H-oxazolo [4,5-b] carbazole (38.7 g, 75.1 mmol), 4,4,4 ', 4', 5,5, under a stream of nitrogen 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (20.9 g, 82.6 mmol), Pd (dppf) Cl 2 (8.68 g, 7.51 mmol), KOAc (21.2 g, 225.3 mmol) and 1,4-Dioxane (250 ml) were mixed and stirred at 130 ° C. for 12 hours.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-oxazolo[4,5-b]carbazole (39.7 g, 수율 94%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)) and purified by 2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-oxazolo [4,5-b] carbazole (39.7 g, 94% yield) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.40-7.58 (m, 12H), 7.66-7.71(m, 3H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H), 7.40-7.58 (m, 12H), 7.66-7.71 (m, 3H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H)
<단계 4> 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole의 합성Step 4 Synthesis of 8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-oxazolo [4,5-b] carbazole
질소 기류 하에서 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-oxazolo[4,5-b]carbazole (39.7 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd(PPh3)4 (4.05 g, 3.51 mmol), K2CO3 (24.2 g, 175.3 mmol), 1,4-dioxane/H2O (80 ml/20 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-oxazolo [4,5-b] under nitrogen stream carbazole (39.7 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd (PPh 3 ) 4 (4.05 g, 3.51 mmol), K 2 CO 3 (24.2 g, 175.3 mmol), 1,4-dioxane / H 2 O (80 ml / 20 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole (33.6 g, 수율 86%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-oxazolo [ 4,5-b] carbazole (33.6 g, yield 86%) was obtained.
1H-NMR: δ7.40-7.70 (m, 16H), 7.77 (s, 1H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H) 1 H-NMR: δ 7.40-7.70 (m, 16H), 7.77 (s, 1 H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H)
<단계 5> BOC-7과 BOC-8의 합성Step 5 Synthesis of BOC-7 and BOC-8
질소 기류 하에서 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-oxazolo[4,5-b]carbazole (33.6 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol), 1,2-dichlorobenzene 300 ml를 넣은 후, 12시간 동안 교반하였다.8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-oxazolo [4,5-b] carbazole (33.6 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol) under a nitrogen stream, After adding 300 ml of 1,2-dichlorobenzene, the mixture was stirred for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BOC-7 (15.8g, 수율 50 %)과 BOC-8 (9.8 g, 수율 31 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain BOC-7 (15.8g, yield 50%) and BOC-8 (9.8 g, yield) as target compounds. 31%) was obtained.
BOC-7의 1H-NMR : δ7.29 (dd, 1H), 7.40-7.77 (m, 16H), 7.85-7.86 (m, 2H), 8.05-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR of BOC-7: δ 7.29 (dd, 1H), 7.40-7.77 (m, 16H), 7.85-7.86 (m, 2H), 8.05-8.12 (m, 3H), 10.1 (b, 1H )
BOC-8의 1H-NMR : δ7.29-7.69 (m, 15H), 7.77 (s, 1H), 7.85-7.86 (m, 2H), 8.05-8.12 (m, 4H), 10.1 (b, 1H) 1 H-NMR of BOC-8: δ 7.29-7.69 (m, 15H), 7.77 (s, 1H), 7.85-7.86 (m, 2H), 8.05-8.12 (m, 4H), 10.1 (b, 1H )
[준비예 5] BTC-1 & BTC-2의 합성Preparation Example 5 Synthesis of BTC-1 & BTC-2
<단계 1> N-(2,4-dibromophenyl)benzothioamide의 합성Step 1 Synthesis of N- (2,4-dibromophenyl) benzothioamide
반응기에 [준비예 1]의 <단계 1>에서 제조된 N-(2,4-dibromophenyl)benzamide (266.2 g, 0.75 mol) 을 투입하고, toluene (3,000 ml)를 가한 후 교반하였다. 이후, 반응기에 Lawesson's reagent (229.2 g, 0.53 mol), 적가하고 혼합하고, 110℃ 에서 4시간 동안 교반하였다.N- (2,4-dibromophenyl) benzamide (266.2 g, 0.75 mol) prepared in <Step 1> of [Preparation Example 1] was added to the reactor, toluene (3,000 ml) was added thereto, followed by stirring. Thereafter, Lawesson's reagent (229.2 g, 0.53 mol) was added dropwise to the reactor, mixed, and stirred at 110 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 N-(2,4-dibromophenyl)benzothioamide (263.5 g, 수율 95%)를 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride and then water was removed with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)) and purified by N- (2,4-dibromophenyl) benzothioamide ( 263.5 g, yield 95%).
1H-NMR: δ6.41 (d, 1H), 7.29 (d, 1H), 7.44-7.45 (m, 3H), 7.75 (s, 1H), 7.98 (d, 2H), 8.59 (b, 1H) 1 H-NMR: δ6.41 (d, 1H), 7.29 (d, 1H), 7.44-7.45 (m, 3H), 7.75 (s, 1H), 7.98 (d, 2H), 8.59 (b, 1H)
<단계 2> 6-bromo-2-phenylbenzo[d]thiazole의 합성<Step 2> Synthesis of 6-bromo-2-phenylbenzo [d] thiazole
질소 기류 하에서 N-(2,4-dibromophenyl)benzothioamide (263.5 g, 710 mmol), K2CO3 (196.3 g, 1420 mmol) 및 DMSO (7100 ml)를 혼합하고, 140℃에서 1.5시간 동안 교반하였다.N- (2,4-dibromophenyl) benzothioamide (263.5 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. .
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 6-bromo-2-phenylbenzo[d]thiazole (156.6 g, 수율 76%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)), and purified by 6-bromo-2-phenylbenzo [d] thiazole. (156.6 g, yield 76%) were obtained.
1H-NMR: δ7.41 (t, 1H) 7.51 (dd, 2H), 7.64 (d, 1H), 7.72 (d, 1H), 8.03 (d, 2H), 8.83 (s, 1H) 1 H-NMR: δ 7.41 (t, 1H) 7.51 (dd, 2H), 7.64 (d, 1H), 7.72 (d, 1H), 8.03 (d, 2H), 8.83 (s, 1H)
<단계 3> 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole의 합성<Step 3> Synthesis of 2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole
질소 기류 하에서 6-bromo-2-phenylbenzo[d]thiazole (156.6 g, 540.0 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.6-bromo-2-phenylbenzo [d] thiazole (156.6 g, 540.0 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (140.2 g, 수율 77%)을 얻었다.After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removal of water with MgSO 4 , and purification by column chromatography (Hexane: EA = 8: 1 (v / v)) to 2-phenyl-6- (4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole (140.2 g, yield 77%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.38 (d, 1H), 7.41 (t, 1H), 7.51 (dd, 2H), 7.75 (d, 1H), 7.95 (s, 1H), 8.03 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H) 7.38 (d, 1H), 7.41 (t, 1H), 7.51 (dd, 2H), 7.75 (d, 1H), 7.95 (s, 1H), 8.03 ( d, 2H)
<단계 4> 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole의 합성Step 4 Synthesis of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole
질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (140.2 g, 415.7 mmol), 4-bromo-2-iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole (140.2 g, 415.7 mmol), 4-bromo-2 under nitrogen stream -iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O ( 400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole (143.5 g, 수율 84%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to give 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole (143.5 g, Yield 84%).
1H-NMR: δ7.41 (t, 1H), 7.51 (dd, 2H), 7.72 (s, 1H), 7.77 (d, 1H), 7.81 (d, 1H), 7.98 (d, 1H), 8.03 (d, 2H), 8.21 (d, 1H), 8.34 (s, 1H) 1 H-NMR: δ 7.41 (t, 1H), 7.51 (dd, 2H), 7.72 (s, 1H), 7.77 (d, 1H), 7.81 (d, 1H), 7.98 (d, 1H), 8.03 (d, 2H), 8.21 (d, 1H), 8.34 (s, 1H)
<단계 5> 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole (C)과 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole (D)의 합성<Step 5> of 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (C) and 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (D) synthesis
질소 기류 하에서 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole (143.5g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene (1500 ml)를 넣은 후, 12시간 동안 교반하였다.6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole (143.5 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene (1500 ml) under nitrogen stream Then stirred for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 5:1 (v/v))로 정제하여 목적 화합물인 C (73.2 g, 수율 55 %)와 D (42.8g, 수율 32 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and then purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain the target compounds C (73.2 g, yield 55%) and D (42.8g, yield 32%). Obtained.
화합물 C의 1H-NMR : δ7.41-7.42 (m, 2H), 7.51-7.55 (m, 4H), 7.75 (d, 1H), 8.03-8.05 (m, 3H), 10.1 (b, 1H) 1 H-NMR of Compound C: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 4H), 7.75 (d, 1H), 8.03-8.05 (m, 3H), 10.1 (b, 1H)
화합물 D의 1H-NMR : δ7.41-7.42 (m, 2H), 7.51-7.55 (m, 3H), 8.03 (d, 2H), 8.05 (s, 1H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR of Compound D: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 3H), 8.03 (d, 2H), 8.05 (s, 1H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)
<단계 6> 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole의 합성Step 6 Synthesis of 2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole (73.2 g, 193.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd(dppf)Cl2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) 및 1,4-Dioxane (1000 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (73.2 g, 193.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd (dppf) Cl 2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) and 1, 4-Dioxane (1000 ml) was mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 수율 81%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then water was removed with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 2-phenyl-7- (4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, yield 81%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.41 (t, 1H), 7.51-7.55 (m, 4H), 7.63 (d, 1H) , 7.75 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.51-7.55 (m, 4H), 7.63 (d, 1H), 7.75 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 10.1 (b, 1H)
<단계 7> 7-(3-bromophenyl)-2-phenyl-10H-thiazolo[5,4-a]carbazole의 합성Step 7 Synthesis of 7- (3-bromophenyl) -2-phenyl-10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 156.2 mmol), 1-bromo-3-iodobenzene (48.6 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 m mol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, 156.2 mmol) under a nitrogen stream ), 1-bromo-3-iodobenzene (48.6 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 m mol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(3-bromophenyl)-2-phenyl-10H-thiazolo[5,4-a]carbazole (62.6 g, 수율 88%)을 얻었다.After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (3-bromophenyl) -2-phenyl-10H-thiazolo [5,4-a] carbazole (62.6 g, yield 88%) was obtained.
1H-NMR: δ7.40-7.56 (m, 8H), 7.69 (d, 1H), 7.75 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 7.40-7.56 (m, 8H), 7.69 (d, 1H), 7.75 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H) , 10.1 (b, 1H)
<단계 8> 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole의 합성<Step 8> 2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a] carbazole Synthesis of
질소 기류 하에서 7-(3-bromophenyl)-2-phenyl-10H-thiazolo[5,4-a]carbazole (62.6 g, 137.5 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (39.4 g, 151.2 mmol), Pd(dppf)Cl2 (15.9 g, 13.8 mmol), KOAc (38.8 g, 412.5 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7- (3-bromophenyl) -2-phenyl-10H-thiazolo [5,4-a] carbazole (62.6 g, 137.5 mmol), 4,4,4 ', 4', 5,5,5 'under nitrogen stream , 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (39.4 g, 151.2 mmol), Pd (dppf) Cl 2 (15.9 g, 13.8 mmol), KOAc (38.8 g, 412.5 mmol ) And 1,4-Dioxane (500 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole (53.9 g, 수율 78%)을 얻었다. After completion of the reaction, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)), and 2-phenyl-7- (3- (4 , 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a] carbazole (53.9 g, yield 78%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41 (t, 1H), 7.51-7.55 (m, 5H), 7.66-7.77 (m, 5H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41 (t, 1H), 7.51-7.55 (m, 5H), 7.66-7.77 (m, 5H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H)
<단계 9> 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-thiazolo[5,4-a]carbazole의 합성Step 9 Synthesis of 7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 2-phenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole (53.9 g, 107.3 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd(PPh3)4 (6.21 g, 5.37 mmol), K2CO3(37.1 g, 268.3 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a] carbazole ( 53.9 g, 107.3 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd (PPh 3 ) 4 (6.21 g, 5.37 mmol), K 2 CO 3 (37.1 g, 268.3 mmol), 1, 4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-thiazolo[5,4-a]carbazole (44.3 g, 수율 83%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-thiazolo [5, 4-a] carbazole (44.3 g, yield 83%) was obtained.
1H-NMR: δ7.23 (d, 1H) 7.41-7.77 (m, 10H), 7.87-8.00 (m, 3H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR: δ7.23 (d, 1H) 7.41-7.77 (m, 10H), 7.87-8.00 (m, 3H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H )
<단계 10> BTC-1과 BTC-2의 합성Step 10 Synthesis of BTC-1 and BTC-2
질소 기류 하에서 7-(2'-nitrobiphenyl-3-yl)-2-phenyl-10H-thiazolo[5,4-a]carbazole (44.3g, 89.1 mmol), triphenylphosphine (58.4 g, 222.7 mmol), 1,2-dichlorobenzene 500 ml를 넣은 후, 12시간 동안 교반하였다.7- (2'-nitrobiphenyl-3-yl) -2-phenyl-10H-thiazolo [5,4-a] carbazole (44.3 g, 89.1 mmol), triphenylphosphine (58.4 g, 222.7 mmol) under nitrogen stream, 1, 500 ml of 2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 6:1 (v/v))로 정제하여 목적 화합물인 BTC-1 (23.2g, 수율 56 %)과 BTC-2 (10.0g, 수율 24 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: MC = 6: 1 (v / v)) to obtain the target compounds BTC-1 (23.2g, yield 56%) and BTC-2 (10.0g, yield). 24%) was obtained.
BTC-1의 1H-NMR : δ7.29 (dd, 1H), 7.41-7.87 (m, 13H), 8.03 (d, 2H), 8.12 (d, 1H), 10.1 (b, 2H) 1 H-NMR of BTC-1: δ 7.29 (dd, 1H), 7.41-7.87 (m, 13H), 8.03 (d, 2H), 8.12 (d, 1H), 10.1 (b, 2H)
BTC-2의 1H-NMR : δ7.29-7.77 (m, 11H), 7.87-7.89 (m, 2H), 8.03-8.12 (m, 4H), 10.1 (b, 2H) 1 H-NMR of BTC-2: δ 7.29-7.77 (m, 11H), 7.87-7.89 (m, 2H), 8.03-8.12 (m, 4H), 10.1 (b, 2H)
[준비예 6] BTC-3 & BTC-4의 합성Preparation Example 6 Synthesis of BTC-3 & BTC-4
<단계 1> 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 [준비예 5]의 <단계 5>에서 제조된 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole (42.8 g, 112.8 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd(dppf)Cl2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) 및 1,4-Dioxane (700 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (42.8 g, 112.8 mmol), 4,4,4 ', prepared in <Step 5> of Preparation 5 under nitrogen stream 4 ', 5,5, 5', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd (dppf) Cl 2 (13.1 g, 11.3 mmol ), KOAc (31.9 g, 338.7 mmol) and 1,4-Dioxane (700 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 수율 85%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to 2-phenyl-8- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, yield 85%) was obtained.
1H-NMR: δ1.24 (s, 12H) 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)
<단계 2> 8-(3-bromophenyl)-2-phenyl-5H-thiazolo[4,5-b]carbazole의 합성Step 2 Synthesis of 8- (3-bromophenyl) -2-phenyl-5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 96.0 mmol), 1-bromo-3-iodobenzene (29.9 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, 96.0 mmol under nitrogen stream ), 1-bromo-3-iodobenzene (29.9 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 8-(3-bromophenyl)-2-phenyl-5H-thiazolo[4,5-b]carbazole (38.9 g, 수율 89%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 8- (3-bromophenyl) -2-phenyl-5H-thiazolo [4,5-b] carbazole (38.9 g, yield 89%) was obtained.
1H-NMR: δ7.40-7.56 (m, 7H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 7.40-7.56 (m, 7H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H) , 8.23 (s, 1H), 10.1 (b, 1H)
<단계 3> 2-phenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole의 합성<Step 3> 2-phenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b] carbazole Synthesis of
질소 기류 하에서 8-(3-bromophenyl)-2-phenyl-5H-thiazolo[4,5-b]carbazole (38.9 g, 85.4 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (23.8 g, 93.9 mmol), Pd(dppf)Cl2 (9.87 g, 8.54 mmol), KOAc (24.1 g, 256.2 mmol) 및 1,4-Dioxane (300 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.8- (3-bromophenyl) -2-phenyl-5H-thiazolo [4,5-b] carbazole (38.9 g, 85.4 mmol), 4,4,4 ', 4', 5,5,5'under nitrogen stream , 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (23.8 g, 93.9 mmol), Pd (dppf) Cl 2 (9.87 g, 8.54 mmol), KOAc (24.1 g, 256.2 mmol ) And 1,4-Dioxane (300 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole (35.2 g, 수율 82%)을 얻었다. After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 2-phenyl-8- (3- (4 , 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b] carbazole (35.2 g, yield 82%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41 (t, 1H), 7.51-7.52 (m, 4H), 7.66 (s, 1H), 7.69 (d, 1H), 7.71(d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41 (t, 1H), 7.51-7.52 (m, 4H), 7.66 (s, 1H), 7.69 (d, 1H), 7.71 (d, 1H) , 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)
<단계 4> 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-thiazolo[4,5-b]carbazole 의 합성Step 4 Synthesis of 8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 2-phenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole (35.2 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd(PPh3)4 (4.05 g, 3.51 mmol), K2CO3 (24.2 g, 175.3 mmol), 1,4-dioxane/H2O (80 ml/20 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2-phenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b] carbazole ( 35.2 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd (PPh 3 ) 4 (4.05 g, 3.51 mmol), K 2 CO 3 (24.2 g, 175.3 mmol), 1, 4-dioxane / H 2 O (80 ml / 20 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-thiazolo[4,5-b]carbazole (30.0 g, 수율 86%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-thiazolo [4, 5-b] carbazole (30.0 g, yield 86%) was obtained.
1H-NMR: δ7.41-7.77 (m, 10H), 7.87 (d, 1H), 7.90 (dd, 1H), 8.00-8.05 (m, 4H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 7.41-7.77 (m, 10H), 7.87 (d, 1H), 7.90 (dd, 1H), 8.00-8.05 (m, 4H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)
<단계 5> BTC-3과 BTC-4의 합성Step 5 Synthesis of BTC-3 and BTC-4
질소 기류 하에서 8-(2'-nitrobiphenyl-3-yl)-2-phenyl-5H-thiazolo[4,5-b]carbazole (30.0 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol), 1,2-dichlorobenzene 300 ml를 넣은 후, 12시간 동안 교반하였다.8- (2'-nitrobiphenyl-3-yl) -2-phenyl-5H-thiazolo [4,5-b] carbazole (30.0 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol) under nitrogen stream, 1, 300 ml of 2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응 종료 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 6:1 (v/v))로 정제하여 목적 화합물인 BTC-3 (15.4 g, 수율 55 %)과 BTC-4 (8.98 g, 수율 28 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and then purified by column chromatography (Hexane: MC = 6: 1 (v / v)) to obtain the target compounds BTC-3 (15.4 g, yield 55%) and BTC-4 (8.98 g, yield). 28%) was obtained.
BTC-3의 1H-NMR : δ7.29 (dd, 1H), 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63-7.87 (m, 7H), 8.03 (d, 2H), 8.11-8.12 (m, 2H), 8.23 (s, 1H), 10.1 (b, 2H) 1 H-NMR of BTC-3: δ 7.29 (dd, 1H), 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63-7.87 (m, 7H), 8.03 (d, 2H), 8.11-8.12 (m, 2H), 8.23 (s, 1H), 10.1 (b, 2H)
BTC-4의 1H-NMR : δ7.29 (dd, 1H), 7.35 (dd, 1H), 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.69 (d, 1H), 7.77 (s, 1H), 7.86-7.87 (m, 2H), 8.03 (d, 2H), 8.08-8.12 (m, 3H), 8.23 (s, 1H), 10.1 (b, 2H) 1 H-NMR of BTC-4: δ 7.29 (dd, 1H), 7.35 (dd, 1H), 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.69 ( d, 1H), 7.77 (s, 1H), 7.86-7.87 (m, 2H), 8.03 (d, 2H), 8.08-8.12 (m, 3H), 8.23 (s, 1H), 10.1 (b, 2H)
[준비예 7] BTC-5 & BTC-6의 합성Preparation Example 7 Synthesis of BTC-5 & BTC-6
<단계 1> 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole의 합성Step 1 Synthesis of 2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 [준비예 5]의 <단계 6>에서 제조된 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 156.2 mmol), Iodobenzene (21.0 mL, 187.44 mmol), CuI (3.0 g, 15.6 mmol), 1,10-phenanthroline (5.6 g, 31.2 mmol), Cs2CO3 (101.8 g, 312.4 mmol) 및 nitrobenzene (500 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (69.0 g, 수율 88%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [prepared in <Step 6> of [Preparation 5] under a nitrogen stream. 5,4-a] carbazole (66.6 g, 156.2 mmol), Iodobenzene (21.0 mL, 187.44 mmol), CuI (3.0 g, 15.6 mmol), 1,10-phenanthroline (5.6 g, 31.2 mmol), Cs 2 CO 3 (101.8 g, 312.4 mmol) and nitrobenzene (500 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to give 2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (69.0 g, yield 88%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41-7.58 (m, 10H), 7.75 (d, 1H), 7.94-8.03 (m, 4H) 1 H-NMR: δ 1.24 (s, 12H), 7.41-7.58 (m, 10H), 7.75 (d, 1H), 7.94-8.03 (m, 4H)
<단계 2> 7-(3-bromophenyl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole 의 합성<Step 2> Synthesis of 7- (3-bromophenyl) -2,10-diphenyl-10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 2,10-diphenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (69.0 g, 137.4 mmol), 1-bromo-3-iodobenzene (42.7 g, 151.1 mmol), Pd(PPh3)4 (7.94 g, 6.87 mmol), K2CO3(47.5 g, 343.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,10-diphenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (69.0 g, 137.4 mmol), 1-bromo-3-iodobenzene (42.7 g, 151.1 mmol), Pd (PPh 3 ) 4 (7.94 g, 6.87 mmol), K 2 CO 3 (47.5 g, 343.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 7-(3-bromophenyl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole (65.0 g, 수율 89%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to obtain 7- (3-bromophenyl) -2,10-diphenyl-10H-thiazolo [5,4-a. ] carbazole (65.0 g, yield 89%) was obtained.
1H-NMR: δ7.40-7.58 (m, 13H), 7.75-7.77 (m, 2H), 8.00-8.03 (m, 3H), 8.18 (d, 1H) 1 H-NMR: δ 7.40-7.58 (m, 13H), 7.75-7.77 (m, 2H), 8.00-8.03 (m, 3H), 8.18 (d, 1H)
<단계 3> 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole의 합성<Step 3> 2,10-diphenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a ] Synthesis of carbazole
질소 기류 하에서 7-(3-bromophenyl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole (65.0 g, 122.3 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (34.2 g, 134.5 mmol), Pd(dppf)Cl2 (14.1 g, 12.2 mmol), KOAc (34.5 g, 366.9 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.7- (3-bromophenyl) -2,10-diphenyl-10H-thiazolo [5,4-a] carbazole (65.0 g, 122.3 mmol), 4,4,4 ', 4', 5,5, under a stream of nitrogen 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (34.2 g, 134.5 mmol), Pd (dppf) Cl 2 (14.1 g, 12.2 mmol), KOAc (34.5 g, 366.9 mmol) and 1,4-Dioxane (500 ml) were mixed and stirred at 130 ° C. for 12 h.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole (61.9 g, 수율 87.5%)을 얻었다. After the reaction was completed, the resultant was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , followed by column chromatography (Hexane: EA = 7: 1 (v / v)) to 2,10-diphenyl-7- (3- (4 , 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a] carbazole (61.9 g, yield 87.5%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41-7.58 (m, 11H), 7.66-7.77 (m, 4H), 8.00-8.05 (m, 3H), 8.18 (d, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41-7.58 (m, 11H), 7.66-7.77 (m, 4H), 8.00-8.05 (m, 3H), 8.18 (d, 1H)
<단계 4> 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole의 합성Step 4 Synthesis of 7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-thiazolo [5,4-a] carbazole
질소 기류 하에서 2,10-diphenyl-7-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-10H-thiazolo[5,4-a]carbazole (61.9 g, 107.0 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd(PPh3)4 (6.21 g, 5.37 mmol), K2CO3(37.1 g, 268.3 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,10-diphenyl-7- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -10H-thiazolo [5,4-a] under nitrogen stream carbazole (61.9 g, 107.0 mmol), 1-bromo-2-nitrobenzene (23.9 g, 118.1 mmol), Pd (PPh 3 ) 4 (6.21 g, 5.37 mmol), K 2 CO 3 (37.1 g, 268.3 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole (51.6 g, 수율 84%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-thiazolo [ 5,4-a] carbazole (51.6 g, yield 84%) was obtained.
1H-NMR: δ7.41-7.77 (m, 16H), 7.90 (dd, 1H), 8.00-8.05 (m, 5H), 8.18 (d, 1H) 1 H-NMR: δ 7.41-7.77 (m, 16H), 7.90 (dd, 1H), 8.00-8.05 (m, 5H), 8.18 (d, 1H)
<단계 5> BTC-5와 BTC-6의 합성Step 5 Synthesis of BTC-5 and BTC-6
질소 기류 하에서 7-(2'-nitrobiphenyl-3-yl)-2,10-diphenyl-10H-thiazolo[5,4-a]carbazole (51.6 g, 89.9 mmol), triphenylphosphine (58.4 g, 222.7 mmol), 1,2-dichlorobenzene 500 ml를 넣은 후, 12시간 동안 교반하였다.7- (2'-nitrobiphenyl-3-yl) -2,10-diphenyl-10H-thiazolo [5,4-a] carbazole (51.6 g, 89.9 mmol), triphenylphosphine (58.4 g, 222.7 mmol) under a nitrogen stream, 500 ml of 1,2-dichlorobenzene was added thereto, followed by stirring for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BTC-5 (26.03g, 수율 54 %)과 BTC-6 (15.1g, 수율 31 %)을 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain the target compounds BTC-5 (26.03g, yield 54%) and BTC-6 (15.1g, yield). 31%) was obtained.
BTC-5의 1H-NMR : δ7.29 (dd, 1H), 7.41-7.77 (m, 15H), 7.87 (d, 1H), 8.00-8.03 (m, 3H). 8.12-8.18 (m, 2H), 10.1 (b, 1H) 1 H-NMR of BTC-5: δ 7.29 (dd, 1H), 7.41-7.77 (m, 15H), 7.87 (d, 1H), 8.00-8.03 (m, 3H). 8.12-8.18 (m, 2H), 10.1 (b, 1H)
BTC-6의 1H-NMR : δ7.29-7.63 (m, 13H), 7.75-7.87 (m, 3H), 8.03-8.18 (m, 6H), 10.1 (b, 1H) 1 H-NMR of BTC-6: δ 7.29-7.63 (m, 13H), 7.75-7.87 (m, 3H), 8.03-8.18 (m, 6H), 10.1 (b, 1H)
[준비예 8] BTC-7 & BTC-8의 합성Preparation Example 8 Synthesis of BTC-7 & BTC-8
<단계 1> 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 [준비예 6]의 <단계 1>에서 제조된 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 96.0 mmol), Iodobenzene (12.8 mL, 115.2 mmol), CuI (1.8 g, 9.6 mmol), 1,10-phenanthroline (3.5 g, 19.2 mmol), Cs2CO3 (62.6 g, 192.0 mmol) 및 nitrobenzene (400 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [prepared in <Step 1> of [Preparation Example 6] under a nitrogen stream. 4,5-b] carbazole (40.9 g, 96.0 mmol), Iodobenzene (12.8 mL, 115.2 mmol), CuI (1.8 g, 9.6 mmol), 1,10-phenanthroline (3.5 g, 19.2 mmol), Cs 2 CO 3 (62.6 g, 192.0 mmol) and nitrobenzene (400 ml) were mixed and stirred at 210 ° C. for 3 hours.
반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (42.9 g, 수율 89%)을 얻었다.After the reaction was completed, the solid salt was filtered and purified by column chromatography to give 2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (42.9 g, yield 89%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41-7.63 (m, 10H), 7.98-8.03 (m, 3H), 8.12 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41-7.63 (m, 10H), 7.98-8.03 (m, 3H), 8.12 (s, 1H), 8.23 (s, 1H)
<단계 2> 8-(3-bromophenyl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole의 합성Step 2 Synthesis of 8- (3-bromophenyl) -2,5-diphenyl-5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 2,5-diphenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (42.9 g, 85.4 mmol), 1-bromo-3-iodobenzene (26.6 g, 93.9 mmol), Pd(PPh3)4 (5.0 g, 4.3 mmol), K2CO3(35.4 g, 256.2 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,5-diphenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (42.9 g, 85.4 mmol), 1-bromo-3-iodobenzene (26.6 g, 93.9 mmol), Pd (PPh 3 ) 4 (5.0 g, 4.3 mmol), K 2 CO 3 (35.4 g, 256.2 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(3-bromophenyl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole (39.9 g, 수율 88%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 8- (3-bromophenyl) -2,5-diphenyl-5H-thiazolo [4,5-b ] carbazole (39.9 g, yield 88%) was obtained.
1H-NMR: δ7.40-7.58 (m, 12H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 7.40-7.58 (m, 12H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H) , 8.23 (s, 1H)
<단계 3> 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole의 합성<Step 3> 2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b ] Synthesis of carbazole
질소 기류 하에서 8-(3-bromophenyl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole (39.9 g, 75.1 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (20.9 g, 82.6 mmol), Pd(dppf)Cl2 (8.68 g, 7.51 mmol), KOAc (21.2 g, 225.3 mmol) 및 1,4-Dioxane (250 ml)를 혼합하고, 130℃에서 12시간 동안 교반하였다.8- (3-bromophenyl) -2,5-diphenyl-5H-thiazolo [4,5-b] carbazole (39.9 g, 75.1 mmol), 4,4,4 ', 4', 5,5, under a stream of nitrogen 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (20.9 g, 82.6 mmol), Pd (dppf) Cl 2 (8.68 g, 7.51 mmol), KOAc (21.2 g, 225.3 mmol) and 1,4-Dioxane (250 ml) were mixed and stirred at 130 ° C. for 12 hours.
반응이 종결된 후, 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 6:1 (v/v))로 정제하여 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole (40.6 g, 수율 94%)을 얻었다. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 6: 1 (v / v)), and purified by 2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b] carbazole (40.6 g, yield 94%) was obtained.
1H-NMR: δ1.24 (s, 12H), 7.41-7.58 (m, 10H), 7.66-7.71(m, 3H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41-7.58 (m, 10H), 7.66-7.71 (m, 3H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H)
<단계 4> 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole의 합성Step 4 Synthesis of 8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-thiazolo [4,5-b] carbazole
질소 기류 하에서 2,5-diphenyl-8-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5H-thiazolo[4,5-b]carbazole (40.6 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd(PPh3)4 (4.05 g, 3.51 mmol), K2CO3 (24.2 g, 175.3 mmol), 1,4-dioxane/H2O (80 ml/20 ml)를 혼합하고, 120℃에서 4시간 동안 교반하였다.2,5-diphenyl-8- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -5H-thiazolo [4,5-b] under nitrogen stream carbazole (40.6 g, 70.1 mmol), 1-bromo-2-nitrobenzene (15.6 g, 77.11 mmol), Pd (PPh 3 ) 4 (4.05 g, 3.51 mmol), K 2 CO 3 (24.2 g, 175.3 mmol), 1,4-dioxane / H 2 O (80 ml / 20 ml) was mixed and stirred at 120 ° C. for 4 hours.
반응이 종결된 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole (34.6 g, 수율 86%)을 얻었다. After the reaction was completed, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-thiazolo [ 4,5-b] carbazole (34.6 g, yield 86%) was obtained.
1H-NMR: δ7.41-7.70 (m, 14H), 7.77 (s, 1H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H), 8.12 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 7.41-7.70 (m, 14H), 7.77 (s, 1H), 7.87-7.90 (m, 2H), 8.00-8.05 (m, 4H), 8.12 (s, 1H), 8.23 ( s, 1 H)
<단계 5> BTC-7과 BTC-8의 합성Step 5 Synthesis of BTC-7 and BTC-8
질소 기류 하에서 8-(2'-nitrobiphenyl-3-yl)-2,5-diphenyl-5H-thiazolo[4,5-b]carbazole (34.6 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol), 1,2-dichlorobenzene 300 ml를 넣은 후, 12시간 동안 교반하였다.8- (2'-nitrobiphenyl-3-yl) -2,5-diphenyl-5H-thiazolo [4,5-b] carbazole (34.6 g, 60.3 mmol), triphenylphosphine (39.6 g, 150.8 mmol) under a nitrogen stream, After adding 300 ml of 1,2-dichlorobenzene, the mixture was stirred for 12 hours.
반응이 종결된 후, 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BTC-7 (16.7g, 수율 51 %)과 BTC-8 (9.5 g, 수율 29 %)를 획득하였다. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain the target compounds BTC-7 (16.7 g, yield 51%) and BTC-8 (9.5 g, yield). 29%) was obtained.
BTC-7의 1H-NMR : δ7.29 (dd, 1H), 7.41-7.77 (m, 14H), 7.86-7.87 (m, 2H), 8.03 (d, 2H), 8.10-8.11 (m, 2H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR of BTC-7: δ 7.29 (dd, 1H), 7.41-7.77 (m, 14H), 7.86-7.87 (m, 2H), 8.03 (d, 2H), 8.10-8.11 (m, 2H ), 8.23 (s, 1H), 10.1 (b, 1H)
BTC-8의 1H-NMR : δ7.29-7.69 (m, 13H), 7.77 (s, 1H), 7.86-7.87 (m, 2H), 8.03-8.12 (m, 5H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR of BTC-8: δ 7.29-7.69 (m, 13H), 7.77 (s, 1H), 7.86-7.87 (m, 2H), 8.03-8.12 (m, 5H), 8.23 (s, 1H ), 10.1 (b, 1H)
[합성예 1] A-1의 합성Synthesis Example 1 Synthesis of A-1
질소 기류 하에서 [준비예 1]에서 제조된 BOC-1 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 A-1 (4.33 g, 수율 71%)을 얻었다.BOC-1 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 1 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to give the title compound A-1 (4.33 g, 71% yield).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol) Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 2] A-2의 합성Synthesis Example 2 Synthesis of A-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-2 (4.2 g, 수율 69%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 1 was carried out to give the target compound A-2 ( 4.2 g, yield 69%).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol)Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 3] A-3의 합성Synthesis Example 3 Synthesis of A-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-3 (4.6 g, 수율 75%)을 얻었다.The same procedure as in Synthesis Example 1 was performed except that 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To give A-3 (4.6 g, yield 75%) as the target compound.
Mass (이론치: 911.31 g/mol, 측정치: 911 g/mol)Mass (Theoretical value: 911.31 g / mol, Measured value: 911 g / mol)
[합성예 4] A-4의 합성Synthesis Example 4 Synthesis of A-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-4 (4.4 g, 수율 62%)를 얻었다.Synthesis Example 1 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound A-4 (4.4 g, yield 62%).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 5] A-5의 합성Synthesis Example 5 Synthesis of A-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-5 (4.7 g, 수율 66%)를 얻었다.Synthesis Example 1 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the target compound A-5 (4.7 g, 66% yield).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 6] A-6의 합성Synthesis Example 6 Synthesis of A-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-6 (4.7 g, 수율 72%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 1 was carried out. Phosphorus A-6 (4.7 g, yield 72%) was obtained.
Mass (이론치: 966.18 g/mol, 측정치: 966 g/mol)Mass (Theoretical value: 966.18 g / mol, Measured value: 966 g / mol)
[합성예 7] A-7의 합성Synthesis Example 7 Synthesis of A-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-7 (4.0 g, 수율 77%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 1 was carried out to give the target compound A-7 ( 4.0 g, yield 77%).
Mass (이론치: 781.85 g/mol, 측정치: 781 g/mol)Mass (Theoretical value: 781.85 g / mol, Measured value: 781 g / mol)
[합성예 8] A-8의 합성Synthesis Example 8 Synthesis of A-8
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-8 (5.8 g, 수율 82%)을 얻었다.Same procedure as in Synthesis Example 1, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (6.13 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The obtained compound A-8 (5.8 g, yield 82%) was obtained.
Mass (이론치: 1054.24 g/mol, 측정치: 1054 g/mol)Mass (Theoretical value: 1054.24 g / mol, Measured value: 1054 g / mol)
[합성예 9] A-9의 합성Synthesis Example 9 Synthesis of A-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-9 (4.0 g, 수율 71%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 1 was carried out to provide the target compound A-9 (4.0 g , Yield 71%) was obtained.
Mass (이론치: 857.29 g/mol, 측정치: 857 g/mol)Mass (Theoretical value: 857.29 g / mol, Measured value: 857 g / mol)
[합성예 10] A-10의 합성Synthesis Example 10 Synthesis of A-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 목적 화합물인 A-10 (4.9 g, 수율 66%)을 얻었다.The same procedure as in Synthesis Example 1 except for using 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine The obtained compound A-10 (4.9 g, yield 66%) was obtained.
Mass (이론치: 1100.28 g/mol, 측정치: 1100 g/mol)Mass (Theoretical value: 1100.28 g / mol, Measured value: 1100 g / mol)
[합성예 11] B-1의 합성Synthesis Example 11 Synthesis of B-1
질소 기류 하에서 [준비에 1]에서 제조된 BOC-2 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 B-1 (4.39 g, 수율 72%)을 얻었다.BOC-2 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared under 1 in nitrogen stream 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound B-1 (4.39 g, yield 72%).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol) Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 12] B-2의 합성Synthesis Example 12 Synthesis of B-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-2 (3.9 g, 수율 64%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 11 was carried out to obtain the target compound B-2 ( 3.9 g, yield 64%).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol)Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 13] B-3의 합성Synthesis Example 13 Synthesis of B-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-3 (4.7 g, 수율 77%)을 얻었다.The same procedure as in Synthesis Example 11 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To give B-3 (4.7 g, yield 77%) as the target compound.
Mass (이론치: 911.31 g/mol, 측정치: 911 g/mol)Mass (Theoretical value: 911.31 g / mol, Measured value: 911 g / mol)
[합성예 14] B-4의 합성Synthesis Example 14 Synthesis of B-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-4 (4.3 g, 수율 60%)를 얻었다.Synthesis Example 11 and 2 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound B-4 (4.3 g, yield 60%).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 15] B-5의 합성Synthesis Example 15 Synthesis of B-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-5 (5.1 g, 수율 72%)를 얻었다.Synthesis Example 11 and 2 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound B-5 (5.1 g, 72% yield).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 16] B-6의 합성Synthesis Example 16 Synthesis of B-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-6 (4.8 g, 수율 74%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 11 was carried out. Phosphorus B-6 (4.8 g, yield 74%) was obtained.
Mass (이론치: 966.18 g/mol, 측정치: 966 g/mol)Mass (Theoretical value: 966.18 g / mol, Measured value: 966 g / mol)
[합성예 17] B-7의 합성Synthesis Example 17 Synthesis of B-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11 과 동일한 과정을 수행하여 목적 화합물인 B-7 (3.5 g, 수율 66%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 11 was carried out to obtain the target compound B-7 ( 3.5 g, yield 66%) was obtained.
Mass (이론치: 781.85 g/mol, 측정치: 781 g/mol)Mass (Theoretical value: 781.85 g / mol, Measured value: 781 g / mol)
[합성예 18] B-8의 합성Synthesis Example 18 Synthesis of B-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-8 (5.7 g, 수율 80%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 11 was carried out to obtain the target compound B-8 (5.7). g, yield 80%) was obtained.
Mass (이론치: 1054.24 g/mol, 측정치: 1054 g/mol)Mass (Theoretical value: 1054.24 g / mol, Measured value: 1054 g / mol)
[합성예 19] B-9의 합성Synthesis Example 19 Synthesis of B-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11 과 동일한 과정을 수행하여 목적 화합물인 B-9 (4.3 g, 수율 74%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 11 was carried out to obtain the target compound B-9 (4.3 g , Yield 74%).
Mass (이론치: 857.29 g/mol, 측정치: 857 g/mol)Mass (Theoretical value: 857.29 g / mol, Measured value: 857 g / mol)
[합성예 20] B-10의 합성Synthesis Example 20 Synthesis of B-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 목적 화합물인 B-10 (5.1 g, 수율 69%)을 얻었다.Same procedure as in Synthesis Example 11, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The obtained compound B-10 (5.1 g, 69% yield) was obtained.
Mass (이론치: 1100.28 g/mol, 측정치: 1100 g/mol)Mass (Theoretical value: 1100.28 g / mol, Measured value: 1100 g / mol)
[합성예 21] C-1의 합성Synthesis Example 21 Synthesis of C-1
질소 기류 하에서 [준비예 2]에서 제조된 BOC-3 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 C-1 (4.8 g, 수율 78%)을 얻었다.BOC-3 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 2 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound C-1 (4.8 g, yield 78%).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol) Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 22] C-2의 합성Synthesis Example 22 Synthesis of C-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-2 (4.0 g, 수율 65%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out to provide the target compound C-2 ( 4.0 g, yield 65%) was obtained.
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol)Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 23] C-3의 합성Synthesis Example 23 Synthesis of C-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-3 (4.3 g, 수율 71%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out. C-3 (4.3 g, yield 71%) was obtained as the target compound.
Mass (이론치: 911.31 g/mol, 측정치: 911 g/mol)Mass (Theoretical value: 911.31 g / mol, Measured value: 911 g / mol)
[합성예 24] C-4의 합성Synthesis Example 24 Synthesis of C-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-4 (4.3 g, 수율 60%)를 얻었다.Synthesis Example 21, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound C-4 (4.3 g, yield 60%).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 25] C-5의 합성Synthesis Example 25 Synthesis of C-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-5 (4.6 g, 수율 65%)를 얻었다.Synthesis Example 21, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound C-5 (4.6 g, 65% yield).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 26] C-6의 합성Synthesis Example 26 Synthesis of C-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-6 (4.5 g, 수율 70%)를 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out. Phosphorus C-6 (4.5 g, yield 70%) was obtained.
Mass (이론치: 966.18 g/mol, 측정치: 966 g/mol)Mass (Theoretical value: 966.18 g / mol, Measured value: 966 g / mol)
[합성예 27] C-7의 합성Synthesis Example 27 Synthesis of C-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-7 (4.0 g, 수율 65%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out to provide the title compound C-7 ( 4.0 g, yield 65%) was obtained.
Mass (이론치: 781.85 g/mol, 측정치: 781 g/mol)Mass (Theoretical value: 781.85 g / mol, Measured value: 781 g / mol)
[합성예 28] C-8의 합성Synthesis Example 28 Synthesis of C-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-8 (5.4 g, 수율 77%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out to provide the target compound C-8 (5.4 g, yield 77%).
Mass (이론치: 1054.24 g/mol, 측정치: 1054 g/mol)Mass (Theoretical value: 1054.24 g / mol, Measured value: 1054 g / mol)
[합성예 29] C-9의 합성Synthesis Example 29 Synthesis of C-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-9 (4.4 g, 수율 77%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 21 was carried out to provide the target compound C-9 (4.4 g , Yield 77%).
Mass (이론치: 857.29 g/mol, 측정치: 857 g/mol)Mass (Theoretical value: 857.29 g / mol, Measured value: 857 g / mol)
[합성예 30] C-10의 합성Synthesis Example 30 Synthesis of C-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 21과 동일한 과정을 수행하여 목적 화합물인 C-10 (4.6 g, 수율 63%)을 얻었다.The same procedure as in Synthesis Example 21 except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. C-10 (4.6 g, yield 63%) was obtained as a target compound.
Mass (이론치: 1100.28 g/mol, 측정치: 1100 g/mol)Mass (Theoretical value: 1100.28 g / mol, Measured value: 1100 g / mol)
[합성예 31] D-1의 합성Synthesis Example 31 Synthesis of D-1
질소 기류 하에서 [준비예 2]에서 제조된 BOC-4 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 D-1 (4.0 g, 수율 65%)을 얻었다.BOC-4 (3.0 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 2 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound D-1 (4.0 g, yield 65%).
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol) Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 32] D-2의 합성Synthesis Example 32 Synthesis of D-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-2 (4.3 g, 수율 70%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was carried out to obtain the target compound D-2 ( 4.3 g, yield 70%) was obtained.
Mass (이론치: 909.32 g/mol, 측정치: 909 g/mol)Mass (Theoretical value: 909.32 g / mol, Measured value: 909 g / mol)
[합성예 33] D-3의 합성Synthesis Example 33 Synthesis of D-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-3 (4.6 g, 수율 76%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was carried out. To give D-3 (4.6 g, yield 76%) as the target compound.
Mass (이론치: 911.31 g/mol, 측정치: 911 g/mol)Mass (Theoretical value: 911.31 g / mol, Measured value: 911 g / mol)
[합성예 34] D-4의 합성Synthesis Example 34 Synthesis of D-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-4 (5.4 g, 수율 76%)를 얻었다.Synthesis Example 31, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound D-4 (5.4 g, yield 76%).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 35] D-5의 합성Synthesis Example 35 Synthesis of D-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-5 (5.0 g, 수율 70%)를 얻었다.Synthesis Example 31, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound D-5 (5.0 g, yield 70%).
Mass (이론치: 1063.37 g/mol, 측정치: 1063 g/mol)Mass (Theoretical value: 1063.37 g / mol, Measured value: 1063 g / mol)
[합성예 36] D-6의 합성Synthesis Example 36 Synthesis of D-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-6 (4.3 g, 수율 67%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was performed. Phosphorus D-6 (4.3 g, yield 67%) was obtained.
Mass (이론치: 966.18 g/mol, 측정치: 966 g/mol)Mass (Theoretical value: 966.18 g / mol, Measured value: 966 g / mol)
[합성예 37] D-7의 합성Synthesis Example 37 Synthesis of D-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-7 (3.7 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was carried out to give the title compound D-7 ( 3.7 g, yield 70%) was obtained.
Mass (이론치: 781.85 g/mol, 측정치: 781 g/mol)Mass (Theoretical value: 781.85 g / mol, Measured value: 781 g / mol)
[합성예 38] D-8의 합성Synthesis Example 38 Synthesis of D-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-8 (5.4 g, 수율 76%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was carried out to provide the title compound D-8 (5.4 g, yield 76%).
Mass (이론치: 1054.24 g/mol, 측정치: 1054 g/mol)Mass (Theoretical value: 1054.24 g / mol, Measured value: 1054 g / mol)
[합성예 39] D-9의 합성Synthesis Example 39 Synthesis of D-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-9 (4.3 g, 수율 74%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 31 was carried out to provide the title compound D-9 (4.3 g). , Yield 74%).
Mass (이론치: 857.29 g/mol, 측정치: 857 g/mol)Mass (Theoretical value: 857.29 g / mol, Measured value: 857 g / mol)
[합성예 40] D-10의 합성Synthesis Example 40 Synthesis of D-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 31과 동일한 과정을 수행하여 목적 화합물인 D-10 (4.9 g, 수율 67%)을 얻었다.Same procedure as in Synthesis 31, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The target compound D-10 (4.9 g, yield 67%) was obtained.
Mass (이론치: 1100.28 g/mol, 측정치: 1100 g/mol)Mass (Theoretical value: 1100.28 g / mol, Measured value: 1100 g / mol)
[합성예 41] E-1의 합성Synthesis Example 41 Synthesis of E-1
질소 기류 하에서 [준비예 3]에서 제조된 BOC-5 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 E-1 (3.7 g, 수율 70%)을 얻었다.BOC-5 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 3 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound E-1 (3.7 g, yield 70%).
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol) Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 42] E-2의 합성Synthesis Example 42 Synthesis of E-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-2 (3.6 g, 수율 69%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out to give the target compound E-2 ( 3.6 g, yield 69%) was obtained.
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 43] E-3의 합성Synthesis Example 43 Synthesis of E-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-3 (3.4 g, 수율 65%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out. To obtain E-3 (3.4 g, yield 65%) as the target compound.
Mass (이론치: 756.85 g/mol, 측정치: 756 g/mol)Mass (Theoretical value: 756.85 g / mol, Measured value: 756 g / mol)
[합성예 44] E-4의 합성Synthesis Example 44 Synthesis of E-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-4 (3.8 g, 수율 66%)를 얻었다.Synthesis Example 41 and 2 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound E-4 (3.8 g, yield 66%).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 45] E-5의 합성Synthesis Example 45 Synthesis of E-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-5 (3.8 g, 수율 67%)를 얻었다.Synthesis Example 41 and 2 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the target compound E-5 (3.8 g, 67% yield).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 46] E-6의 합성Synthesis Example 46 Synthesis of E-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.71 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-6 (3.8 g, 수율 71%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.71 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out. Phosphorus E-6 (3.8 g, yield 71%) was obtained.
Mass (이론치: 783.23 g/mol, 측정치: 783 g/mol)Mass (Theoretical value: 783.23 g / mol, Measured value: 783 g / mol)
[합성예 47] E-7의 합성Synthesis Example 47 Synthesis of E-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-7 (3.3 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out to give the target compound E-7 ( 3.3 g, yield 70%) was obtained.
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 48] E-8의 합성Synthesis Example 48 Synthesis of E-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-8 (4.2 g, 수율 75%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out to give the target compound E-8 (4.2 g, yield 75%) was obtained.
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 49] E-9의 합성Synthesis Example 49 Synthesis of E-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.93 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-9 (3.9 g, 수율 78%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (1.93 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 41 was carried out to provide E-9 (3.9 g) as a target compound. , Yield 78%).
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 50] E-10의 합성Synthesis Example 50 Synthesis of E-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 41과 동일한 과정을 수행하여 목적 화합물인 E-10 (3.7 g, 수율 64%)을 얻었다.Same procedure as in Synthesis Example 41, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To obtain the target compound E-10 (3.7 g, 64% yield).
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 51] F-1의 합성Synthesis Example 51 Synthesis of F-1
질소 기류 하에서 [준비예 3]에서 제조된 BOC-6 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 F-1 (3.4 g, 수율 66%)을 얻었다.BOC-6 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 3 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound F-1 (3.4 g, 66% yield).
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 52] F-2의 합성Synthesis Example 52 Synthesis of F-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-2 (3.6 g, 수율 70%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 51 was carried out to give the target compound F-2 ( 3.6 g, yield 70%) was obtained.
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 53] F-3의 합성Synthesis Example 53 Synthesis of F-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-3 (3.3 g, 수율 64%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as Synthesis Example 51 was carried out. F-3 (3.3 g, yield 64%) was obtained as the target compound.
Mass (이론치: 756.26 g/mol, 측정치: 756 g/mol)Mass (Theoretical value: 756.26 g / mol, Measured value: 756 g / mol)
[합성예 54] F-4의 합성Synthesis Example 54 Synthesis of F-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-4 (3.9 g, 수율 69%)를 얻었다.Synthesis Example 51, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound F-4 (3.9 g, 69% yield).
Mass (이론치: 832.3 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.3 g / mol, Measured value: 832 g / mol)
[합성예 55] F-5의 합성Synthesis Example 55 Synthesis of F-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-5 (4.0 g, 수율 71%)를 얻었다.Synthesis Example 51 and 2 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound F-5 (4.0 g, 71% yield).
Mass (이론치: 832.3 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.3 g / mol, Measured value: 832 g / mol)
[합성예 56] F-6의 합성Synthesis Example 56 Synthesis of F-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.71 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-6 (3.6 g, 수율 68%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.71 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 51 was carried out. Phosphorus F-6 (3.6 g, yield 68%) was obtained.
Mass (이론치: 783.23 g/mol, 측정치: 783 g/mol)Mass (Theoretical value: 783.23 g / mol, Measured value: 783 g / mol)
[합성예 57] F-7의 합성Synthesis Example 57 Synthesis of F-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-7 (3.3 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 51 was carried out to obtain the target compound F-7 ( 3.3 g, yield 70%) was obtained.
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 58] F-8의 합성Synthesis Example 58 Synthesis of F-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-8 (4.1 g, 수율 72%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 51 was carried out to obtain the target compound F-8 (4.1 g, yield 72%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 59] F-9의 합성Synthesis Example 59 Synthesis of F-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-9 (3.8 g, 수율 77%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 51 was carried out to obtain the target compound F-9 (3.8 g , Yield 77%).
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 60] F-10의 합성Synthesis Example 60 Synthesis of F-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 51과 동일한 과정을 수행하여 목적 화합물인 F-10 (3.8 g, 수율 76%)을 얻었다.The same procedure as in Synthesis Example 51 except for using 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine. To give the title compound F-10 (3.8 g, yield 76%).
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 61] G-1의 합성Synthesis Example 61 Synthesis of G-1
질소 기류 하에서 [준비예 4]에서 제조된 BOC-7 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 G-1 (3.6 g, 수율 70%)을 얻었다.BOC-7 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 4 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to obtain the title compound G-1 (3.6 g, yield 70%).
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 62] G-2의 합성Synthesis Example 62 Synthesis of G-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-2 (3.3 g, 수율 64%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, G-2 (the target compound) 3.3 g, yield 64%).
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 63] G-3의 합성Synthesis Example 63 Synthesis of G-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-3 (3.8 g, 수율 73%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 61 was carried out. To obtain G-3 (3.8 g, yield 73%) as the target compound.
Mass (이론치: 756.26 g/mol, 측정치: 756 g/mol)Mass (Theoretical value: 756.26 g / mol, Measured value: 756 g / mol)
[합성예 64] G-4의 합성Synthesis Example 64 Synthesis of G-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-4 (3.7 g, 수율 65%)를 얻었다.Synthesis Example 61 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound G-4 (3.7 g, yield 65%).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 65] G-5의 합성Synthesis Example 65 Synthesis of G-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-5 (4.0 g, 수율 70%)를 얻었다.Synthesis Example 61 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound G-5 (4.0 g, yield 70%).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 66] G-6의 합성Synthesis Example 66 Synthesis of G-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.71 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-6 (3.5 g, 수율 65%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.71 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 61 was performed. Phosphorus G-6 (3.5 g, yield 65%) was obtained.
Mass (이론치: 783.23 g/mol, 측정치: 783 g/mol)Mass (Theoretical value: 783.23 g / mol, Measured value: 783 g / mol)
[합성예 67] G-7의 합성Synthesis Example 67 Synthesis of G-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-7 (3.3 g, 수율 69%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 61 was carried out to obtain the target compound G-7 ( 3.3 g, yield 69%).
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 68] G-8의 합성Synthesis Example 68 Synthesis of G-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-8 (4.0 g, 수율 71%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 61 was carried out to obtain the target compound G-8 (4.0 g, yield 71%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 69] G-9의 합성Synthesis Example 69 Synthesis of G-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-9 (3.7 g, 수율 74%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 61 was carried out to obtain the target compound G-9 (3.7 g , Yield 74%).
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 70] G-10의 합성Synthesis Example 70 Synthesis of G-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 61과 동일한 과정을 수행하여 목적 화합물인 G-10 (4.2 g, 수율 72%)을 얻었다.The same procedure as in Synthesis Example 61 except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The obtained compound G-10 (4.2 g, yield 72%) was obtained.
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 71] H-1의 합성Synthesis Example 71 Synthesis of H-1
질소 기류 하에서 [준비예 4]에서 제조된 BOC-8 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 H-1 (3.4 g, 수율 65%)을 얻었다.BOC-8 (3.52 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 4 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound H-1 (3.4 g, yield 65%).
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 72] H-2의 합성Synthesis Example 72 Synthesis of H-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-2 (3.6 g, 수율 70%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out to give the target compound H-2 ( 3.6 g, yield 70%) was obtained.
Mass (이론치: 755.27 g/mol, 측정치: 755 g/mol)Mass (Theoretical value: 755.27 g / mol, Measured value: 755 g / mol)
[합성예 73] H-3의 합성Synthesis Example 73 Synthesis of H-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-3 (3.7 g, 수율 71%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out. To obtain H-3 (3.7 g, yield 71%) as the target compound.
Mass (이론치: 756.26 g/mol, 측정치: 756 g/mol)Mass (Theoretical value: 756.26 g / mol, Measured value: 756 g / mol)
[합성예 74] H-4의 합성Synthesis Example 74 Synthesis of H-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-4 (3.7 g, 수율 65%)를 얻었다.Synthesis Example 71 and 2 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the target compound H-4 (3.7 g, yield 65%).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 75] H-5의 합성Synthesis Example 75 Synthesis of H-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-5 (3.9 g, 수율 69%)를 얻었다.Synthesis Example 71 and 2 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the target compound H-5 (3.9 g, 69% yield).
Mass (이론치: 832.30 g/mol, 측정치: 832 g/mol)Mass (Theoretical value: 832.30 g / mol, Measured value: 832 g / mol)
[합성예 76] H-6의 합성Synthesis Example 76 Synthesis of H-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (2.71 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-6 (3.9 g, 수율 72%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (2.71 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out. Phosphorus H-6 (3.9 g, yield 72%) was obtained.
Mass (이론치: 783.23 g/mol, 측정치: 783 g/mol)Mass (Theoretical value: 783.23 g / mol, Measured value: 783 g / mol)
[합성예 77] H-7의 합성Synthesis Example 77 Synthesis of H-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-7 (3.3 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out to obtain the target compound H-7 ( 3.3 g, yield 70%) was obtained.
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 78] H-8의 합성Synthesis Example 78 Synthesis of H-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-8 (3.4 g, 수율 61%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out to obtain the target compound H-8 (3.4 g, yield 61%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 79] H-9의 합성Synthesis Example 79 Synthesis of H-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-9 (3.5 g, 수율 70%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 71 was carried out to provide the target compound H-9 (3.5 g , Yield 70%) was obtained.
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 80] H-10의 합성Synthesis Example 80 Synthesis of H-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 71과 동일한 과정을 수행하여 목적 화합물인 H-10 (4.0 g, 수율 69%)을 얻었다.Same procedure as in Synthesis 71, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To obtain the target compound H-10 (4.0 g, 69% yield).
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 81] I-1의 합성Synthesis Example 81 Synthesis of I-1
질소 기류 하에서 [준비예 5]에서 제조된 BTC-1 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 I-1 (4.6 g, 수율 74%)을 얻었다.BTC-1 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in [Preparation 5] under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to give the title compound I-1 (4.6 g, 74% yield).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol) Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 82] I-2의 합성Synthesis Example 82 Synthesis of I-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-2 (4.1 g, 수율 66%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 81 was carried out to give the target compound I-2 ( 4.1 g, yield 66%).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol)Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 83] I-3의 합성Synthesis Example 83 Synthesis of I-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-3 (4.3 g, 수율 70%)을 얻었다.The same procedure as in Synthesis Example 81 was performed except that 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. I-3 (4.3 g, yield 70%) was obtained as the target compound.
Mass (이론치: 927.31 g/mol, 측정치: 927 g/mol)Mass (Theoretical value: 927.31 g / mol, Measured value: 927 g / mol)
[합성예 84] I-4의 합성Synthesis Example 84 Synthesis of I-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-4 (4.6 g, 수율 64%)를 얻었다.Synthesis Example 81 except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound I-4 (4.6 g, 64% yield).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 85] I-5의 합성Synthesis Example 85 Synthesis of I-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-5 (5.1 g, 수율 70%)를 얻었다.Synthesis Example 81 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound I-5 (5.1 g, yield 70%).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 86] I-6의 합성Synthesis Example 86 Synthesis of I-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-6 (4.7 g, 수율 71%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 81 was performed. Phosphorus I-6 (4.7 g, yield 71%) was obtained.
Mass (이론치: 982.18 g/mol, 측정치: 982 g/mol)Mass (Theoretical value: 982.18 g / mol, Measured value: 982 g / mol)
[합성예 87] I-7의 합성Synthesis Example 87 Synthesis of I-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-7 (3.7 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 81 was carried out to give the target compound I-7 ( 3.7 g, yield 70%) was obtained.
Mass (이론치: 797.85 g/mol, 측정치: 797 g/mol)Mass (Theoretical value: 797.85 g / mol, Measured value: 797 g / mol)
[합성예 88] I-8의 합성Synthesis Example 88 Synthesis of I-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-8 (5.7 g, 수율 79%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 81 was carried out to give the target compound I-8 (5.7). g, yield 79%).
Mass (이론치: 1070.24 g/mol, 측정치: 1070 g/mol)Mass (Theoretical value: 1070.24 g / mol, Measured value: 1070 g / mol)
[합성예 89] I-9의 합성Synthesis Example 89 Synthesis of I-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-9 (4.1 g, 수율 70%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 81 was performed to obtain the target compound I-9 (4.1 g). , Yield 70%) was obtained.
Mass (이론치: 873.29 g/mol, 측정치: 873 g/mol)Mass (Theoretical value: 873.29 g / mol, Measured value: 873 g / mol)
[합성예 90] I-10의 합성Synthesis Example 90 Synthesis of I-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 81과 동일한 과정을 수행하여 목적 화합물인 I-10 (5.3 g, 수율 71%)을 얻었다.The same procedure as in Synthesis Example 81 except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. This was carried out to obtain the title compound I-10 (5.3 g, yield 71%).
Mass (이론치: 1116.28 g/mol, 측정치: 1116 g/mol)Mass (Theoretical value: 1116.28 g / mol, Measured value: 1116 g / mol)
[합성예 91] J-1의 합성Synthesis Example 91 Synthesis of J-1
질소 기류 하에서 [준비예 5]에서 제조된 BTC-2 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 J-1 (4.6 g, 수율 72%)을 얻었다.BTC-2 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in [Preparation 5] under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound J-1 (4.6 g, 72% yield).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol) Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 92] J-2의 합성Synthesis Example 92 Synthesis of J-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-2 (3.9 g, 수율 63%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 91 was carried out to obtain the target compound J-2 ( 3.9 g, yield 63%).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol)Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 93] J-3의 합성Synthesis Example 93 Synthesis of J-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-3 (4.5 g, 수율 73%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as Synthesis 91 was carried out. To obtain J-3 (4.5 g, yield 73%) as the target compound.
Mass (이론치: 927.31 g/mol, 측정치: 927 g/mol)Mass (Theoretical value: 927.31 g / mol, Measured value: 927 g / mol)
[합성예 94] J-4의 합성Synthesis Example 94 Synthesis of J-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-4 (4.6 g, 수율 64%)를 얻었다.Synthesis Example 91, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound J-4 (4.6 g, yield 64%).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 95] J-5의 합성Synthesis Example 95 Synthesis of J-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-5 (5.6 g, 수율 77%)를 얻었다.Synthesis Example 91, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the target compound J-5 (5.6 g, yield 77%).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 96] J-6의 합성Synthesis Example 96 Synthesis of J-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-6 (4.6 g, 수율 70%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 91 was performed. Phosphorus J-6 (4.6 g, yield 70%) was obtained.
Mass (이론치: 982.18 g/mol, 측정치: 982 g/mol)Mass (Theoretical value: 982.18 g / mol, Measured value: 982 g / mol)
[합성예 97] J-7의 합성Synthesis Example 97 Synthesis of J-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91 과 동일한 과정을 수행하여 목적 화합물인 J-7 (3.7 g, 수율 69%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 91 was carried out to obtain the target compound J-7 ( 3.7 g, yield 69%).
Mass (이론치: 797.85 g/mol, 측정치: 797 g/mol)Mass (Theoretical value: 797.85 g / mol, Measured value: 797 g / mol)
[합성예 98] J-8의 합성Synthesis Example 98 Synthesis of J-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-8 (5.4 g, 수율 75%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 91 was carried out to obtain the target compound J-8 (5.4 g, yield 75%) was obtained.
Mass (이론치: 1070.24 g/mol, 측정치: 1070 g/mol)Mass (Theoretical value: 1070.24 g / mol, Measured value: 1070 g / mol)
[합성예 99] J-9의 합성Synthesis Example 99 Synthesis of J-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-9 (4.2 g, 수율 71%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 91 was carried out to provide the target compound J-9 (4.2 g , Yield 71%) was obtained.
Mass (이론치: 873.29 g/mol, 측정치: 873 g/mol)Mass (Theoretical value: 873.29 g / mol, Measured value: 873 g / mol)
[합성예 100] J-10의 합성Synthesis Example 100 Synthesis of J-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 91과 동일한 과정을 수행하여 목적 화합물인 J-10 (4.9 g, 수율 66%)을 얻었다.Same procedure as in Synthesis 91, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. This was carried out to obtain the target compound J-10 (4.9 g, yield 66%).
Mass (이론치: 1116.28 g/mol, 측정치: 1116 g/mol)Mass (Theoretical value: 1116.28 g / mol, Measured value: 1116 g / mol)
[합성예 101] K-1의 합성Synthesis Example 101 Synthesis of K-1
질소 기류 하에서 [준비예 6]에서 제조된 BTC-3 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 K-1 (4.5 g, 수율 73%)을 얻었다.BTC-3 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 6 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound K-1 (4.5 g, 73% yield).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol) Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 102] K-2의 합성Synthesis Example 102 Synthesis of K-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-2 (4.2 g, 수율 68%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 101 was carried out to obtain the target compound K-2 ( 4.2 g, yield 68%).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol)Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 103] K-3의 합성Synthesis Example 103 Synthesis of K-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-3 (4.6 g, 수율 74%)을 얻었다.The same procedure as in Synthesis Example 101 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To obtain K-3 (4.6 g, yield 74%) as the target compound.
Mass (이론치: 927.31 g/mol, 측정치: 927 g/mol)Mass (Theoretical value: 927.31 g / mol, Measured value: 927 g / mol)
[합성예 104] K-4의 합성Synthesis Example 104 Synthesis of K-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-4 (4.6 g, 수율 64%)를 얻었다.Synthesis Example 101, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound K-4 (4.6 g, 64% yield).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 105] K-5의 합성Synthesis Example 105 Synthesis of K-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-5 (4.9 g, 수율 68%)를 얻었다.Synthesis Example 101, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound K-5 (4.9 g, yield 68%).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 106] K-6의 합성Synthesis Example 106 Synthesis of K-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-6 (4.5 g, 수율 69%)를 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 101 was carried out. Phosphorus K-6 (4.5 g, yield 69%) was obtained.
Mass (이론치: 982.18 g/mol, 측정치: 982 g/mol)Mass (Theoretical value: 982.18 g / mol, Measured value: 982 g / mol)
[합성예 107] K-7의 합성Synthesis Example 107 Synthesis of K-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-7 (3.5 g, 수율 66%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 101 was carried out to form the target compound K-7 ( 3.5 g, yield 66%) was obtained.
Mass (이론치: 797.85 g/mol, 측정치: 797 g/mol)Mass (Theoretical value: 797.85 g / mol, Measured value: 797 g / mol)
[합성예 108] K-8의 합성Synthesis Example 108 Synthesis of K-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-8 (5.2 g, 수율 73%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 101 was carried out to provide the target compound K-8 (5.2 g, yield 73%).
Mass (이론치: 1070.24 g/mol, 측정치: 1070 g/mol)Mass (Theoretical value: 1070.24 g / mol, Measured value: 1070 g / mol)
[합성예 109] K-9의 합성Synthesis Example 109 Synthesis of K-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-9 (4.1 g, 수율 70%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 101 was carried out to form the target compound K-9 (4.1 g , Yield 70%) was obtained.
Mass (이론치: 873.29 g/mol, 측정치: 873 g/mol)Mass (Theoretical value: 873.29 g / mol, Measured value: 873 g / mol)
[합성예 110] K-10의 합성Synthesis Example 110 Synthesis of K-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 101과 동일한 과정을 수행하여 목적 화합물인 K-10 (4.6 g, 수율 61%)을 얻었다.Same procedure as in Synthesis 101, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To obtain the target compound K-10 (4.6 g, 61% yield).
Mass (이론치: 1116.28 g/mol, 측정치: 1116 g/mol)Mass (Theoretical value: 1116.28 g / mol, Measured value: 1116 g / mol)
[합성예 111] L-1의 합성Synthesis Example 111 Synthesis of L-1
질소 기류 하에서 [준비예 6]에서 제조된 BTC-4 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 L-1 (4.3 g, 수율 70%)을 얻었다.BTC-4 (3.1 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (5.0 g, 16.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 6 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to obtain the title compound L-1 (4.3 g, yield 70%).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol) Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 112] L-2의 합성Synthesis Example 112 Synthesis of L-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-2 (4.5 g, 수율 73%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (5.0 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was carried out to give the target compound L-2 ( 4.5 g, yield 73%).
Mass (이론치: 925.32 g/mol, 측정치: 925 g/mol)Mass (Theoretical value: 925.32 g / mol, Measured value: 925 g / mol)
[합성예 113] L-3의 합성Synthesis Example 113 Synthesis of L-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-3 (4.8 g, 수율 77%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (4.28 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was carried out. L-3 (4.8 g, yield 77%) was obtained as the target compound.
Mass (이론치: 927.31 g/mol, 측정치: 927 g/mol)Mass (Theoretical value: 927.31 g / mol, Measured value: 927 g / mol)
[합성예 114] L-4의 합성Synthesis Example 114 Synthesis of L-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-4 (5.1 g, 수율 71%)를 얻었다.Synthesis Example 111, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound L-4 (5.1 g, 71% yield).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 115] L-5의 합성Synthesis Example 115 Synthesis of L-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-5 (5.0 g, 수율 69%)를 얻었다.Synthesis Example 111, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.21 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound L-5 (5.0 g, 69% yield).
Mass (이론치: 1079.37 g/mol, 측정치: 1079 g/mol)Mass (Theoretical value: 1079.37 g / mol, Measured value: 1079 g / mol)
[합성예 116] L-6의 합성Synthesis Example 116 Synthesis of L-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-6 (4.6 g, 수율 70%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was performed. Phosphorus L-6 (4.6 g, yield 70%) was obtained.
Mass (이론치: 982.18 g/mol, 측정치: 982 g/mol)Mass (Theoretical value: 982.18 g / mol, Measured value: 982 g / mol)
[합성예 117] L-7의 합성Synthesis Example 117 Synthesis of L-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (3.95 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-7 (3.7 g, 수율 69%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (3.95 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was carried out to give the title compound L-7 ( 3.7 g, yield 69%).
Mass (이론치: 797.85 g/mol, 측정치: 797 g/mol)Mass (Theoretical value: 797.85 g / mol, Measured value: 797 g / mol)
[합성예 118] L-8의 합성Synthesis Example 118 Synthesis of L-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (6.13 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-8 (5.2 g, 수율 73%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (6.13 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was carried out to give the title compound L-8 (5.2 g, yield 73%).
Mass (이론치: 1070.24 g/mol, 측정치: 1070 g/mol)Mass (Theoretical value: 1070.24 g / mol, Measured value: 1070 g / mol)
[합성예 119] L-9의 합성Synthesis Example 119 Synthesis of L-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-9 (4.5 g, 수율 77%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.85 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 111 was carried out to give L-9 (4.5 g) as a target compound. , Yield 77%).
Mass (이론치: 873.29 g/mol, 측정치: 873 g/mol)Mass (Theoretical value: 873.29 g / mol, Measured value: 873 g / mol)
[합성예 120] L-10의 합성Synthesis Example 120 Synthesis of L-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (5.87 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 111과 동일한 과정을 수행하여 목적 화합물인 L-10 (5.1 g, 수율 68%)을 얻었다.Same procedure as in Synthesis 111, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (5.87 g, 16.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The obtained compound L-10 (5.1 g, yield 68%) was obtained.
Mass (이론치: 1116.28 g/mol, 측정치: 1116 g/mol)Mass (Theoretical value: 1116.28 g / mol, Measured value: 1116 g / mol)
[합성예 121] M-1의 합성Synthesis Example 121 Synthesis of M-1
질소 기류 하에서 [준비예 7]에서 제조된 BTC-5 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 M-1 (3.7 g, 수율 70%)을 얻었다.BTC-5 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 7 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound M-1 (3.7 g, yield 70%).
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol) Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 122] M-2의 합성Synthesis Example 122 Synthesis of M-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-2 (3.5 g, 수율 67%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 121 was carried out to obtain the target compound M-2 ( 3.5 g, yield 67%) was obtained.
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol)Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 123] M-3의 합성Synthesis Example 123 Synthesis of M-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-3 (3.6 g, 수율 69%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 121 was carried out. M-3 (3.6 g, 69% yield) was obtained as the target compound.
Mass (이론치: 772.24 g/mol, 측정치: 772 g/mol)Mass (Theoretical value: 772.24 g / mol, Measured value: 772 g / mol)
[합성예 124] M-4의 합성Synthesis Example 124 Synthesis of M-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-4 (4.1 g, 수율 71%)를 얻었다.Synthesis Example 121, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound M-4 (4.1 g, 71% yield).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 125] M-5의 합성Synthesis Example 125 Synthesis of M-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-5 (4.0 g, 수율 70%)를 얻었다.Synthesis Example 121, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The same procedure was followed to obtain the title compound M-5 (4.0 g, yield 70%).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 126] M-6의 합성Synthesis Example 126 Synthesis of M-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-6 (3.4 g, 수율 68%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 121 was carried out. Phosphorus M-6 (3.4 g, yield 68%) was obtained.
Mass (이론치: 728.23 g/mol, 측정치: 728 g/mol)Mass (Theoretical value: 728.23 g / mol, Measured value: 728 g / mol)
[합성예 127] M-7의 합성Synthesis Example 127 Synthesis of M-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-7 (3.4 g, 수율 72%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, M-7 ( 3.4 g, yield 72%).
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 128] M-8의 합성Synthesis Example 128 Synthesis of M-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-8 (4.0 g, 수율 70%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 121 was carried out to obtain the target compound M-8 (4.0 g, yield 70%) was obtained.
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 129] M-9의 합성Synthesis Example 129 Synthesis of M-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-9 (3.6 g, 수율 72%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 121 was carried out to provide the target compound M-9 (3.6 g) , Yield 72%) was obtained.
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 130] M-10의 합성Synthesis Example 130 Synthesis of M-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 121과 동일한 과정을 수행하여 목적 화합물인 M-10 (3.9 g, 수율 67%)을 얻었다.The same procedure as in Synthesis Example 121 except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. The obtained compound M-10 (3.9 g, yield 67%) was obtained.
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 131] N-1의 합성Synthesis Example 131 Synthesis of N-1
질소 기류 하에서 [준비예 7]에서 제조된 BTC-6 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 N-1 (3.9 g, 수율 74%)을 얻었다.BTC-6 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 7 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to obtain the title compound N-1 (3.9 g, 74% yield).
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol) Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 132] N-2의 합성Synthesis Example 132 Synthesis of N-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-2 (3.6 g, 수율 69%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, N-2 (the target compound) 3.6 g, yield 69%) was obtained.
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol)Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 133] N-3의 합성Synthesis Example 133 Synthesis of N-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-3 (3.7 g, 수율 71%)을 얻었다.The same procedure as in Synthesis Example 131 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. N-3 (3.7 g, yield 71%) was obtained as the target compound.
Mass (이론치: 772.24 g/mol, 측정치: 772 g/mol)Mass (Theoretical value: 772.24 g / mol, Measured value: 772 g / mol)
[합성예 134] N-4의 합성Synthesis Example 134 Synthesis of N-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-4 (3.8 g, 수율 66%)를 얻었다.Synthesis Example 131 except for using 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the title compound N-4 (3.8 g, yield 66%).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 135] N-5의 합성Synthesis Example 135 Synthesis of N-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-5 (4.0 g, 수율 69%)를 얻었다.Synthesis Example 131 except for using 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the title compound N-5 (4.0 g, 69% yield).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 136] N-6의 합성Synthesis Example 136 Synthesis of N-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-6 (3.5 g, 수율 71%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 131 was performed. Phosphorus N-6 (3.5 g, yield 71%) was obtained.
Mass (이론치: 728.23 g/mol, 측정치: 728 g/mol)Mass (Theoretical value: 728.23 g / mol, Measured value: 728 g / mol)
[합성예 137] N-7의 합성Synthesis Example 137 Synthesis of N-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-7 (3.3 g, 수율 69%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, N-7 ( 3.3 g, yield 69%).
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 138] N-8의 합성Synthesis Example 138 Synthesis of N-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-8 (4.3 g, 수율 76%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 131 was carried out to provide N-8 (4.3) as a target compound. g, yield 76%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 139] N-9의 합성Synthesis Example 139 Synthesis of N-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-9 (3.3 g, 수율 67%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 131 was carried out to provide N-9 (3.3 g) as a target compound. , Yield 67%) was obtained.
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 140] N-10의 합성Synthesis Example 140 Synthesis of N-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 131과 동일한 과정을 수행하여 목적 화합물인 N-10 (4.3 g, 수율 75%)을 얻었다.The same procedure as in Synthesis Example 131, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. This was carried out to obtain N-10 (4.3 g, yield 75%) as a target compound.
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 141] O-1의 합성Synthesis Example 141 Synthesis of O-1
질소 기류 하에서 [준비예 8]에서 제조된 BTC-7 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 O-1 (3.4 g, 수율 65%)을 얻었다.BTC-7 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 8 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was completed, the solid salt was filtered and purified by column chromatography to give the title compound O-1 (3.4 g, 65% yield).
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol) Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 142] O-2의 합성Synthesis Example 142 Synthesis of O-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-2 (3.8 g, 수율 72%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 141 was carried out to give the target compound O-2 ( 3.8 g, yield 72%).
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol)Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 143] O-3의 합성Synthesis Example 143 Synthesis of O-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-3 (3.9 g, 수율 73%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as Synthesis Example 141 was carried out. To give the title compound O-3 (3.9 g, 73% yield).
Mass (이론치: 772.24 g/mol, 측정치: 772 g/mol)Mass (Theoretical value: 772.24 g / mol, Measured value: 772 g / mol)
[합성예 144] O-4의 합성Synthesis Example 144 Synthesis of O-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-4 (3.8 g, 수율 71%)를 얻었다.Synthesis Example 141 with the exception of using 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the title compound O-4 (3.8 g, yield 71%).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 145] O-5의 합성Synthesis Example 145 Synthesis of O-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-5 (4.1 g, 수율 71%)를 얻었다.Synthesis Example 141 with the exception of using 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the title compound O-5 (4.1 g, 71% yield).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 146] O-6의 합성Synthesis Example 146 Synthesis of O-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-6 (3.3 g, 수율 66%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 141 was carried out. Phosphorus O-6 (3.3 g, yield 66%) was obtained.
Mass (이론치: 728.23 g/mol, 측정치: 728 g/mol)Mass (Theoretical value: 728.23 g / mol, Measured value: 728 g / mol)
[합성예 147] O-7의 합성Synthesis Example 147 Synthesis of O-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-7 (3.3 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 141 was carried out to give the title compound O-7 ( 3.3 g, yield 70%) was obtained.
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 148] O-8의 합성Synthesis Example 148 Synthesis of O-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-8 (3.7 g, 수율 65%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 141 was carried out to give the title compound O-8 (3.7 g, yield 65%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 149] O-9의 합성Synthesis Example 149 Synthesis of O-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-9 (3.5 g, 수율 70%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 141 was carried out to provide the title compound O-9 (3.5 g , Yield 70%) was obtained.
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 150] O-10의 합성Synthesis Example 150 Synthesis of O-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 141과 동일한 과정을 수행하여 목적 화합물인 O-10 (4.3 g, 수율 73%)을 얻었다.Same procedure as in Synthesis Example 141, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. To give the title compound O-10 (4.3 g, 73% yield).
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[합성예 151] P-1의 합성Synthesis Example 151 Synthesis of P-1
질소 기류 하에서 [준비예 8]에서 제조된 BTC-8 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고, 210℃ 에서 3시간 동안 교반하였다. 반응이 종결된 후, 고체염을 필터링한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 P-1 (3.8 g, 수율 72%)을 얻었다.BTC-8 (3.63 g, 6.7 mmol), 2-bromo-4,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1, prepared in Preparation Example 8 under a nitrogen stream. 10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C. for 3 hours. After the reaction was terminated, the solid salt was filtered and purified by column chromatography to give the title compound P-1 (3.8 g, 72% yield).
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol) Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 152] P-2의 합성Synthesis Example 152 Synthesis of P-2
2-bromo-4,6-diphenylpyrimidine 대신 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-2 (3.4 g, 수율 65%)를 얻었다.Except for using 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 151 was carried out to give the target compound P-2 ( 3.4 g, yield 65%) was obtained.
Mass (이론치: 771.25 g/mol, 측정치: 771 g/mol)Mass (Theoretical value: 771.25 g / mol, Measured value: 771 g / mol)
[합성예 153] P-3의 합성Synthesis Example 153 Synthesis of P-3
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-3 (3.7 g, 수율 71%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as Synthesis Example 151 was performed. P-3 (3.7 g, yield 71%) was obtained as the target compound.
Mass (이론치: 772.24 g/mol, 측정치: 772 g/mol)Mass (Theoretical value: 772.24 g / mol, Measured value: 772 g / mol)
[합성예 154] P-4의 합성Synthesis Example 154 Synthesis of P-4
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-4 (3.6 g, 수율 63%)를 얻었다.Synthesis Example 151, except that 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the title compound P-4 (3.6 g, yield 63%).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 155] P-5의 합성Synthesis Example 155 Synthesis of P-5
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-5 (3.9 g, 수율 67%)를 얻었다.Synthesis Example 151, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.15 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine The same procedure was followed to obtain the target compound P-5 (3.9 g, 67% yield).
Mass (이론치: 848.27 g/mol, 측정치: 848 g/mol)Mass (Theoretical value: 848.27 g / mol, Measured value: 848 g / mol)
[합성예 156] P-6의 합성Synthesis Example 156 Synthesis of P-6
2-bromo-4,6-diphenylpyrimidine 대신 2-(3-bromophenyl)dibenzo [b,d]thiophene (5.43 g, 16.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-6 (3.2 g, 수율 65%)을 얻었다.Except for using 2- (3-bromophenyl) dibenzo [b, d] thiophene (5.43 g, 16.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 151 was performed. Phosphorus P-6 (3.2 g, yield 65%) was obtained.
Mass (이론치: 728.23 g/mol, 측정치: 728 g/mol)Mass (Theoretical value: 728.23 g / mol, Measured value: 728 g / mol)
[합성예 157] P-7의 합성Synthesis Example 157 Synthesis of P-7
2-bromo-4,6-diphenylpyrimidine 대신 2-bromodibenzo[b,d]furan (1.98 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-7 (3.3 g, 수율 70%)을 얻었다.Except for using 2-bromodibenzo [b, d] furan (1.98 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 151 was carried out to give the target compound P-7 ( 3.3 g, yield 70%) was obtained.
Mass (이론치: 691.23 g/mol, 측정치: 691 g/mol)Mass (Theoretical value: 691.23 g / mol, Measured value: 691 g / mol)
[합성예 158] P-8의 합성Synthesis Example 158 Synthesis of P-8
2-bromo-4,6-diphenylpyrimidine 대신 2-(4-bromophenyl)triphenylene (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-8 (3.8 g, 수율 68%)을 얻었다.Except for using 2- (4-bromophenyl) triphenylene (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 151 was carried out to give P-8 (3.8) g, yield 68%).
Mass (이론치: 827.29 g/mol, 측정치: 827 g/mol)Mass (Theoretical value: 827.29 g / mol, Measured value: 827 g / mol)
[합성예 159] P-9의 합성Synthesis Example 159 Synthesis of P-9
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 151과 동일한 과정을 수행하여 목적 화합물인 P-9 (3.5 g, 수율 70%)을 얻었다.Except for using 2-chloro-4-phenylquinazoline (3.07 g, 8.0 mmol) instead of 2-bromo-4,6-diphenylpyrimidine, the same procedure as in Synthesis Example 151 was carried out to give the target compound P-9 (3.5 g). , Yield 70%) was obtained.
Mass (이론치: 729.25 g/mol, 측정치: 729 g/mol)Mass (Theoretical value: 729.25 g / mol, Measured value: 729 g / mol)
[합성예 160] P-10의 합성Synthesis Example 160 Synthesis of P-10
2-bromo-4,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.94 g, 8.0 mmol)을 사용하는 것을 제외하고는, 합성예 161과 동일한 과정을 수행하여 목적 화합물인 P-10 (3.9 g, 수율 66%)을 얻었다.Same procedure as in Synthesis Example 161, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.94 g, 8.0 mmol) was used instead of 2-bromo-4,6-diphenylpyrimidine. P-10 (3.9 g, yield 66%) was obtained as a target compound.
Mass (이론치: 855.30 g/mol, 측정치: 855 g/mol)Mass (Theoretical value: 855.30 g / mol, Measured value: 855 g / mol)
[실시예 1 내지 128] 녹색 유기 전계 발광 소자의 제조Examples 1 to 128 Fabrication of Green Organic Electroluminescent Device
합성예 1~8, 11~18, 21~28, 31~38, 41~48, 51~58, 61~68, 71~78, 81~88, 91~98, 101~108, 111~118, 121~128, 131~138, 141~148, 151~158 에서 각각 합성된 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 전계 발광 소자를 제조하였다.Synthesis Examples 1-8, 11-18, 21-28, 31-38, 41-48, 51-58, 61-68, 71-78, 81-88, 91-98, 101-108, 111-118, Subsequently, the compounds synthesized at 121 to 128, 131 to 138, 141 to 148, and 151 to 158 were subjected to high purity sublimation purification by a conventionally known method, and then green organic electroluminescent devices were manufactured according to the following procedure.
ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.A glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 Å was ultrasonically washed with distilled water. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech) and then the substrate is cleaned for 5 minutes using UV and vacuum evaporator. The substrate was transferred.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-1 ~ A-8, B-1 ~ B-8, C-1 ~ C-8, D-1 ~ D-8, E-1 ~ E-8, F-1 ~ F-8, G-1 ~ G-8, H-1 ~ H-8, I-1 ~ I-8, J-1 ~ J-8, K-1 ~ K-8, L-1 ~ L-8, M-1 ~ M-8, N-1 ~ N-8, O-1 ~ O-8, P-1 ~ P-8 각각의 화합물 + 10 % Ir(ppy)3 (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.M-MTDATA (60 nm) / TCTA (80 nm) / A-1 to A-8, B-1 to B-8, C-1 to C-8, D-1 on the prepared ITO transparent substrate (electrode) ~ D-8, E-1 ~ E-8, F-1 ~ F-8, G-1 ~ G-8, H-1 ~ H-8, I-1 ~ I-8, J-1 ~ J -8, K-1 to K-8, L-1 to L-8, M-1 to M-8, N-1 to N-8, O-1 to O-8, P-1 to P-8 Each compound was laminated in the order of 10% Ir (ppy) 3 (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) to prepare an organic EL device. .
사용된 m-MTDATA, TCTA, Ir(ppy)3 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 and BCP used are as follows.
[비교예 1] 녹색 유기 전계 발광 소자의 제조Comparative Example 1 Fabrication of Green Organic Electroluminescent Device
발광층 형성시 발광 호스트 물질로서 화합물 A-1 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제조하였다.A green organic electroluminescent device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound A-1 as a light emitting host material when forming the emission layer.
사용된 CBP의 구조는 하기와 같다.The structure of CBP used is as follows.
[평가예 1][Evaluation Example 1]
실시예 1 내지 128 및 비교예 1에서 각각 제조된 녹색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency, and emission peak at a current density of 10 mA / cm 2 were measured for green organic electroluminescent devices prepared in Examples 1 to 128 and Comparative Example 1, and the results are shown in Table 1 below.
표 1
Table 1
샘플 | 호스트 | 구동전압(V) | 발광피크(nm) | 전류효율(cd/A) |
실시예 1 | A-1 | 6.73 | 516 | 44.1 |
실시예 2 | A-2 | 6.48 | 517 | 41.4 |
실시예 3 | A-3 | 6.86 | 517 | 42.2 |
실시예 4 | A-4 | 6.61 | 515 | 43.1 |
실시예 5 | A-5 | 6.51 | 518 | 41.1 |
실시예 6 | A-6 | 6.77 | 518 | 42 |
실시예 7 | A-7 | 6.66 | 517 | 42.5 |
실시예 8 | A-8 | 6.65 | 515 | 41.3 |
실시예 9 | B-1 | 6.72 | 518 | 41.9 |
실시예 10 | B-2 | 6.75 | 518 | 41.6 |
실시예 11 | B-3 | 6.73 | 518 | 41.5 |
실시예 12 | B-4 | 6.73 | 517 | 41.4 |
실시예 13 | B-5 | 6.48 | 517 | 41.2 |
실시예 14 | B-6 | 6.86 | 515 | 40.7 |
실시예 15 | B-7 | 6.61 | 518 | 40.5 |
실시예 16 | B-8 | 6.51 | 517 | 40.4 |
실시예 17 | C-1 | 6.77 | 515 | 41.9 |
실시예 18 | C-2 | 6.66 | 518 | 41.5 |
실시예 19 | C-3 | 6.65 | 518 | 41.4 |
실시예 20 | C-4 | 6.65 | 517 | 41.2 |
실시예 21 | C-5 | 6.64 | 518 | 41.1 |
실시예 22 | C-6 | 6.64 | 518 | 42.5 |
실시예 23 | C-7 | 6.63 | 517 | 43.1 |
실시예 24 | C-8 | 6.63 | 515 | 39.2 |
실시예 25 | D-1 | 6.62 | 518 | 41.3 |
실시예 26 | D-2 | 6.62 | 518 | 39.7 |
실시예 27 | D-3 | 6.62 | 517 | 38.9 |
실시예 28 | D-4 | 6.48 | 515 | 41.3 |
실시예 29 | D-5 | 6.86 | 517 | 41.3 |
실시예 30 | D-6 | 6.61 | 515 | 41.3 |
실시예 31 | D-7 | 6.7 | 518 | 41.3 |
실시예 32 | D-8 | 6.73 | 518 | 41.2 |
실시예 33 | E-1 | 6.86 | 517 | 41.2 |
실시예 34 | E-2 | 6.61 | 515 | 42.9 |
실시예 35 | E-3 | 6.7 | 518 | 39.6 |
실시예 36 | E-4 | 6.73 | 518 | 40.4 |
실시예 37 | E-5 | 6.75 | 517 | 40.1 |
실시예 38 | E-6 | 6.77 | 515 | 40.8 |
실시예 39 | E-7 | 6.76 | 518 | 40.7 |
실시예 40 | E-8 | 6.72 | 518 | 40.5 |
실시예 41 | F-1 | 6.7 | 517 | 40.4 |
실시예 42 | F-2 | 6.66 | 515 | 41.7 |
실시예 43 | F-3 | 6.81 | 518 | 41.5 |
실시예 44 | F-4 | 6.66 | 518 | 42.7 |
실시예 45 | F-5 | 6.81 | 517 | 42.7 |
실시예 46 | F-6 | 6.68 | 515 | 43.1 |
실시예 47 | F-7 | 6.66 | 518 | 43.5 |
실시예 48 | F-8 | 6.81 | 517 | 41.4 |
실시예 49 | G-1 | 6.68 | 518 | 42.2 |
실시예 50 | G-2 | 6.66 | 515 | 42 |
실시예 51 | G-3 | 6.7 | 518 | 41.8 |
실시예 52 | G-4 | 6.7 | 515 | 42 |
실시예 53 | G-5 | 6.51 | 518 | 42.5 |
실시예 54 | G-6 | 6.77 | 518 | 41.3 |
실시예 55 | G-7 | 6.46 | 517 | 41.3 |
실시예 56 | G-8 | 6.71 | 517 | 41.6 |
실시예 57 | H-1 | 6.72 | 515 | 41.5 |
실시예 58 | H-2 | 6.7 | 518 | 42.7 |
실시예 59 | H-3 | 6.51 | 518 | 42.5 |
실시예 60 | H-4 | 6.7 | 517 | 42 |
실시예 61 | H-5 | 6.66 | 515 | 41.3 |
실시예 62 | H-6 | 6.7 | 518 | 41.9 |
실시예 63 | H-7 | 6.7 | 518 | 41.6 |
실시예 64 | H-8 | 6.51 | 518 | 43 |
실시예 65 | I-1 | 6.77 | 518 | 43.3 |
실시예 66 | I-2 | 6.46 | 518 | 44.1 |
실시예 67 | I-3 | 6.71 | 517 | 42.7 |
실시예 68 | I-4 | 6.72 | 515 | 42.7 |
실시예 69 | I-5 | 6.7 | 518 | 43.1 |
실시예 70 | I-6 | 6.51 | 518 | 43.5 |
실시예 71 | I-7 | 6.77 | 517 | 41.4 |
실시예 72 | I-8 | 6.66 | 518 | 42.2 |
실시예 73 | J-1 | 6.65 | 518 | 42 |
실시예 74 | J-2 | 6.65 | 517 | 41.8 |
실시예 75 | J-3 | 6.64 | 515 | 42 |
실시예 76 | J-4 | 6.64 | 518 | 42.5 |
실시예 77 | J-5 | 6.63 | 518 | 41.3 |
실시예 78 | J-6 | 6.63 | 518 | 41.3 |
실시예 79 | J-7 | 6.62 | 518 | 41.6 |
실시예 80 | J-8 | 6.62 | 517 | 41.5 |
실시예 81 | K-1 | 6.62 | 517 | 42.7 |
실시예 82 | K-2 | 6.48 | 515 | 41.7 |
실시예 83 | K-3 | 6.86 | 518 | 41.5 |
실시예 84 | K-4 | 6.61 | 518 | 42.7 |
실시예 85 | K-5 | 6.7 | 518 | 42.7 |
실시예 86 | K-6 | 6.73 | 518 | 43.1 |
실시예 87 | K-7 | 6.86 | 517 | 43.5 |
실시예 88 | K-8 | 6.61 | 515 | 41.4 |
실시예 89 | L-1 | 6.7 | 517 | 42.2 |
실시예 90 | L-2 | 6.73 | 515 | 42 |
실시예 91 | L-3 | 6.75 | 518 | 41.8 |
실시예 92 | L-4 | 6.77 | 518 | 42 |
실시예 93 | L-5 | 6.76 | 517 | 42.5 |
실시예 94 | L-6 | 6.72 | 515 | 41.3 |
실시예 95 | L-7 | 6.7 | 518 | 41.3 |
실시예 96 | L-8 | 6.66 | 518 | 41.6 |
실시예 97 | M-1 | 6.81 | 517 | 41.3 |
실시예 98 | M-2 | 6.81 | 518 | 39.7 |
실시예 99 | M-3 | 6.66 | 517 | 38.9 |
실시예 100 | M-4 | 6.81 | 518 | 41.3 |
실시예 101 | M-5 | 6.68 | 518 | 41.3 |
실시예 102 | M-6 | 6.72 | 518 | 41.3 |
실시예 103 | M-7 | 6.7 | 517 | 41.2 |
실시예 104 | M-8 | 6.51 | 517 | 41.2 |
실시예 105 | N-1 | 6.62 | 515 | 42.9 |
실시예 106 | N-2 | 6.62 | 518 | 39.6 |
실시예 107 | N-3 | 6.62 | 518 | 40.4 |
실시예 108 | N-4 | 6.48 | 518 | 42.9 |
실시예 109 | N-5 | 6.86 | 518 | 39.6 |
실시예 110 | N-6 | 6.61 | 517 | 40.4 |
실시예 111 | N-7 | 6.7 | 515 | 40.1 |
실시예 112 | N-8 | 6.66 | 517 | 40.8 |
실시예 113 | O-1 | 6.81 | 515 | 42 |
실시예 114 | O-2 | 6.81 | 518 | 42.5 |
실시예 115 | O-3 | 6.66 | 518 | 41.3 |
실시예 116 | O-4 | 6.81 | 517 | 41.3 |
실시예 117 | O-5 | 6.68 | 515 | 41.6 |
실시예 118 | O-6 | 6.72 | 518 | 41.3 |
실시예 119 | O-7 | 6.7 | 517 | 39.7 |
실시예 120 | O-8 | 6.51 | 515 | 38.9 |
실시예 121 | P-1 | 6.62 | 518 | 41.3 |
실시예 122 | P-2 | 6.62 | 518 | 41.3 |
실시예 123 | P-3 | 6.62 | 517 | 41.3 |
실시예 124 | P-4 | 6.48 | 515 | 42 |
실시예 125 | P-5 | 6.62 | 518 | 41.8 |
실시예 126 | P-6 | 6.62 | 517 | 42 |
실시예 127 | P-7 | 6.62 | 515 | 42.5 |
실시예 128 | P-8 | 6.48 | 518 | 40.2 |
비교예 1 | CBP | 6.93 | 516 | 38.2 |
Sample | Host | Driving voltage (V) | Light emitting peak (nm) | Current efficiency (cd / A) |
Example 1 | A-1 | 6.73 | 516 | 44.1 |
Example 2 | A-2 | 6.48 | 517 | 41.4 |
Example 3 | A-3 | 6.86 | 517 | 42.2 |
Example 4 | A-4 | 6.61 | 515 | 43.1 |
Example 5 | A-5 | 6.51 | 518 | 41.1 |
Example 6 | A-6 | 6.77 | 518 | 42 |
Example 7 | A-7 | 6.66 | 517 | 42.5 |
Example 8 | A-8 | 6.65 | 515 | 41.3 |
Example 9 | B-1 | 6.72 | 518 | 41.9 |
Example 10 | B-2 | 6.75 | 518 | 41.6 |
Example 11 | B-3 | 6.73 | 518 | 41.5 |
Example 12 | B-4 | 6.73 | 517 | 41.4 |
Example 13 | B-5 | 6.48 | 517 | 41.2 |
Example 14 | B-6 | 6.86 | 515 | 40.7 |
Example 15 | B-7 | 6.61 | 518 | 40.5 |
Example 16 | B-8 | 6.51 | 517 | 40.4 |
Example 17 | C-1 | 6.77 | 515 | 41.9 |
Example 18 | C-2 | 6.66 | 518 | 41.5 |
Example 19 | C-3 | 6.65 | 518 | 41.4 |
Example 20 | C-4 | 6.65 | 517 | 41.2 |
Example 21 | C-5 | 6.64 | 518 | 41.1 |
Example 22 | C-6 | 6.64 | 518 | 42.5 |
Example 23 | C-7 | 6.63 | 517 | 43.1 |
Example 24 | C-8 | 6.63 | 515 | 39.2 |
Example 25 | D-1 | 6.62 | 518 | 41.3 |
Example 26 | D-2 | 6.62 | 518 | 39.7 |
Example 27 | D-3 | 6.62 | 517 | 38.9 |
Example 28 | D-4 | 6.48 | 515 | 41.3 |
Example 29 | D-5 | 6.86 | 517 | 41.3 |
Example 30 | D-6 | 6.61 | 515 | 41.3 |
Example 31 | D-7 | 6.7 | 518 | 41.3 |
Example 32 | D-8 | 6.73 | 518 | 41.2 |
Example 33 | E-1 | 6.86 | 517 | 41.2 |
Example 34 | E-2 | 6.61 | 515 | 42.9 |
Example 35 | E-3 | 6.7 | 518 | 39.6 |
Example 36 | E-4 | 6.73 | 518 | 40.4 |
Example 37 | E-5 | 6.75 | 517 | 40.1 |
Example 38 | E-6 | 6.77 | 515 | 40.8 |
Example 39 | E-7 | 6.76 | 518 | 40.7 |
Example 40 | E-8 | 6.72 | 518 | 40.5 |
Example 41 | F-1 | 6.7 | 517 | 40.4 |
Example 42 | F-2 | 6.66 | 515 | 41.7 |
Example 43 | F-3 | 6.81 | 518 | 41.5 |
Example 44 | F-4 | 6.66 | 518 | 42.7 |
Example 45 | F-5 | 6.81 | 517 | 42.7 |
Example 46 | F-6 | 6.68 | 515 | 43.1 |
Example 47 | F-7 | 6.66 | 518 | 43.5 |
Example 48 | F-8 | 6.81 | 517 | 41.4 |
Example 49 | G-1 | 6.68 | 518 | 42.2 |
Example 50 | G-2 | 6.66 | 515 | 42 |
Example 51 | G-3 | 6.7 | 518 | 41.8 |
Example 52 | G-4 | 6.7 | 515 | 42 |
Example 53 | G-5 | 6.51 | 518 | 42.5 |
Example 54 | G-6 | 6.77 | 518 | 41.3 |
Example 55 | G-7 | 6.46 | 517 | 41.3 |
Example 56 | G-8 | 6.71 | 517 | 41.6 |
Example 57 | H-1 | 6.72 | 515 | 41.5 |
Example 58 | H-2 | 6.7 | 518 | 42.7 |
Example 59 | H-3 | 6.51 | 518 | 42.5 |
Example 60 | H-4 | 6.7 | 517 | 42 |
Example 61 | H-5 | 6.66 | 515 | 41.3 |
Example 62 | H-6 | 6.7 | 518 | 41.9 |
Example 63 | H-7 | 6.7 | 518 | 41.6 |
Example 64 | H-8 | 6.51 | 518 | 43 |
Example 65 | I-1 | 6.77 | 518 | 43.3 |
Example 66 | I-2 | 6.46 | 518 | 44.1 |
Example 67 | I-3 | 6.71 | 517 | 42.7 |
Example 68 | I-4 | 6.72 | 515 | 42.7 |
Example 69 | I-5 | 6.7 | 518 | 43.1 |
Example 70 | I-6 | 6.51 | 518 | 43.5 |
Example 71 | I-7 | 6.77 | 517 | 41.4 |
Example 72 | I-8 | 6.66 | 518 | 42.2 |
Example 73 | J-1 | 6.65 | 518 | 42 |
Example 74 | J-2 | 6.65 | 517 | 41.8 |
Example 75 | J-3 | 6.64 | 515 | 42 |
Example 76 | J-4 | 6.64 | 518 | 42.5 |
Example 77 | J-5 | 6.63 | 518 | 41.3 |
Example 78 | J-6 | 6.63 | 518 | 41.3 |
Example 79 | J-7 | 6.62 | 518 | 41.6 |
Example 80 | J-8 | 6.62 | 517 | 41.5 |
Example 81 | K-1 | 6.62 | 517 | 42.7 |
Example 82 | K-2 | 6.48 | 515 | 41.7 |
Example 83 | K-3 | 6.86 | 518 | 41.5 |
Example 84 | K-4 | 6.61 | 518 | 42.7 |
Example 85 | K-5 | 6.7 | 518 | 42.7 |
Example 86 | K-6 | 6.73 | 518 | 43.1 |
Example 87 | K-7 | 6.86 | 517 | 43.5 |
Example 88 | K-8 | 6.61 | 515 | 41.4 |
Example 89 | L-1 | 6.7 | 517 | 42.2 |
Example 90 | L-2 | 6.73 | 515 | 42 |
Example 91 | L-3 | 6.75 | 518 | 41.8 |
Example 92 | L-4 | 6.77 | 518 | 42 |
Example 93 | L-5 | 6.76 | 517 | 42.5 |
Example 94 | L-6 | 6.72 | 515 | 41.3 |
Example 95 | L-7 | 6.7 | 518 | 41.3 |
Example 96 | L-8 | 6.66 | 518 | 41.6 |
Example 97 | M-1 | 6.81 | 517 | 41.3 |
Example 98 | M-2 | 6.81 | 518 | 39.7 |
Example 99 | M-3 | 6.66 | 517 | 38.9 |
Example 100 | M-4 | 6.81 | 518 | 41.3 |
Example 101 | M-5 | 6.68 | 518 | 41.3 |
Example 102 | M-6 | 6.72 | 518 | 41.3 |
Example 103 | M-7 | 6.7 | 517 | 41.2 |
Example 104 | M-8 | 6.51 | 517 | 41.2 |
Example 105 | N-1 | 6.62 | 515 | 42.9 |
Example 106 | N-2 | 6.62 | 518 | 39.6 |
Example 107 | N-3 | 6.62 | 518 | 40.4 |
Example 108 | N-4 | 6.48 | 518 | 42.9 |
Example 109 | N-5 | 6.86 | 518 | 39.6 |
Example 110 | N-6 | 6.61 | 517 | 40.4 |
Example 111 | N-7 | 6.7 | 515 | 40.1 |
Example 112 | N-8 | 6.66 | 517 | 40.8 |
Example 113 | O-1 | 6.81 | 515 | 42 |
Example 114 | O-2 | 6.81 | 518 | 42.5 |
Example 115 | O-3 | 6.66 | 518 | 41.3 |
Example 116 | O-4 | 6.81 | 517 | 41.3 |
Example 117 | O-5 | 6.68 | 515 | 41.6 |
Example 118 | O-6 | 6.72 | 518 | 41.3 |
Example 119 | O-7 | 6.7 | 517 | 39.7 |
Example 120 | O-8 | 6.51 | 515 | 38.9 |
Example 121 | P-1 | 6.62 | 518 | 41.3 |
Example 122 | P-2 | 6.62 | 518 | 41.3 |
Example 123 | P-3 | 6.62 | 517 | 41.3 |
Example 124 | P-4 | 6.48 | 515 | 42 |
Example 125 | P-5 | 6.62 | 518 | 41.8 |
Example 126 | P-6 | 6.62 | 517 | 42 |
Example 127 | P-7 | 6.62 | 515 | 42.5 |
Example 128 | P-8 | 6.48 | 518 | 40.2 |
Comparative Example 1 | CBP | 6.93 | 516 | 38.2 |
상기 표 1과 같이 본 발명에 따른 화합물을 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 1 내지 128)가 종래의 CBP를 발광층에 사용한 경우(비교예 1)보다 전류효율 및 구동전압이 우수한 것을 확인할 수 있다.When the compound according to the present invention is used in the light emitting layer of the green organic electroluminescent device as shown in Table 1 (Examples 1 to 128), the current efficiency and the driving voltage are superior to those of the conventional CBP used in the light emitting layer (Comparative Example 1) You can see that.
[실시예 129 내지 160] 적색 유기 전계 발광 소자의 제조Examples 129 to 160 Fabrication of Red Organic Electroluminescent Device
합성예 9~10, 19~20, 29~30, 39~40, 49~50, 59~60, 69~70, 79~80, 89~90, 99~100, 109~110, 119~120, 129~130, 139~140, 149~150, 159~160에서 각각 합성된 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 적색 유기 전계 발광 소자를 제조하였다.Synthesis Examples 9-10, 19-20, 29-30, 39-40, 49-50, 59-60, 69-70, 79-80, 89-90, 99-100, 109-110, 119-120, The compounds synthesized at 129-130, 139-140, 149-150, and 159-160 were subjected to high purity sublimation purification by a conventionally known method, and then a red organic electroluminescent device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 된 was ultrasonically washed with distilled water. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech) and then the substrate is cleaned for 5 minutes using UV and vacuum evaporator. The substrate was transferred.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-9 ~ A-10, B-9 ~ B-10, C-9 ~ C-10, D-9 ~ D-10, E-9 ~ E-10, F-9 ~ F-10, G-9 ~ G-10, H-9 ~ H-10, I-9 ~ I-10, J-9 ~ J-10, K-9 ~ K-10, L-9 ~ L-10, M-9 ~ M-10, N-9 ~ N-10, O-9 ~ O-10, P-9 ~ P-10 각각의 화합물 + 10 % (piq)2Ir(acac) (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.M-MTDATA (60 nm) / TCTA (80 nm) / A-9 to A-10, B-9 to B-10, C-9 to C-10, D-9 on the prepared ITO transparent substrate (electrode) ~ D-10, E-9 ~ E-10, F-9 ~ F-10, G-9 ~ G-10, H-9 ~ H-10, I-9 ~ I-10, J-9 ~ J -10, K-9 to K-10, L-9 to L-10, M-9 to M-10, N-9 to N-10, O-9 to O-10, P-9 to P-10 Each compound + 10% (piq) 2 Ir (acac) (300nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) laminated in the organic electroluminescent device Was prepared.
사용된 m-MTDATA, TCTA 및 BCP의 구조는 실시예 1과 같고, (piq)2Ir(acac)의 구조는 하기와 같다.The structures of m-MTDATA, TCTA and BCP used are the same as in Example 1, and the structure of (piq) 2 Ir (acac) is as follows.
[비교예 2]Comparative Example 2
발광층 형성시 발광 호스트 물질로서 화합물 A-9 대신 CBP를 사용하는 것을 제외하고는, 상기 실시예 129와 동일한 과정으로 적색 유기 전계 발광 소자를 제조하였다. 사용된 CBP의 구조는 상기 비교예 1과 같다.A red organic electroluminescent device was manufactured in the same manner as in Example 129, except that CBP was used instead of Compound A-9 as a light emitting host material when forming the emission layer. The structure of CBP used is the same as in Comparative Example 1.
[평가예 2][Evaluation Example 2]
실시예 129 내지 160 및 비교예 2에서 각각 제조한 적색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.The driving voltage and current efficiency at a current density of 10 mA / cm 2 were measured for the red organic electroluminescent devices manufactured in Examples 129 to 160 and Comparative Example 2, and the results are shown in Table 2 below.
표 2
TABLE 2
샘플 | 호스트 | 구동전압(V) | 전류효율(cd/A) |
실시예 129 | A-9 | 4.66 | 9.6 |
실시예 130 | A-10 | 4.75 | 8.9 |
실시예 131 | B-9 | 4.87 | 11.9 |
실시예 132 | B-10 | 4.56 | 13.2 |
실시예 133 | C-9 | 4.65 | 9.9 |
실시예 134 | C-10 | 4.32 | 10.1 |
실시예 135 | D-9 | 4.74 | 12.7 |
실시예 136 | D-10 | 4.76 | 13.1 |
실시예 137 | E-9 | 4.64 | 10.1 |
실시예 138 | E-10 | 4.55 | 9.2 |
실시예 139 | F-9 | 4.68 | 9.1 |
실시예 140 | F-10 | 4.35 | 9.2 |
실시예 141 | G-9 | 4.53 | 11.5 |
실시예 142 | G-10 | 4.55 | 11.8 |
실시예 143 | H-9 | 4.32 | 9.6 |
실시예 144 | H-10 | 4.74 | 9.7 |
실시예 145 | I-9 | 4.87 | 11.3 |
실시예 146 | I-10 | 4.56 | 11.9 |
실시예 147 | J-9 | 4.65 | 13.2 |
실시예 148 | J-10 | 4.32 | 9.9 |
실시예 149 | K-9 | 4.74 | 10.1 |
실시예 150 | K-10 | 4.76 | 12.7 |
실시예 151 | L-9 | 4.64 | 13.1 |
실시예 152 | L-10 | 4.55 | 10.1 |
실시예 153 | M-9 | 4.68 | 9.2 |
실시예 154 | M-10 | 4.35 | 13.2 |
실시예 155 | N-9 | 4.53 | 9.9 |
실시예 156 | N-10 | 4.55 | 10.1 |
실시예 157 | O-9 | 4.32 | 13.2 |
실시예 158 | O-10 | 4.35 | 9.9 |
실시예 159 | P-9 | 4.53 | 10.1 |
실시예 160 | P-10 | 4.55 | 12.7 |
비교예 2 | CBP | 5.25 | 8.2 |
Sample | Host | Driving voltage (V) | Current efficiency (cd / A) |
Example 129 | A-9 | 4.66 | 9.6 |
Example 130 | A-10 | 4.75 | 8.9 |
Example 131 | B-9 | 4.87 | 11.9 |
Example 132 | B-10 | 4.56 | 13.2 |
Example 133 | C-9 | 4.65 | 9.9 |
Example 134 | C-10 | 4.32 | 10.1 |
Example 135 | D-9 | 4.74 | 12.7 |
Example 136 | D-10 | 4.76 | 13.1 |
Example 137 | E-9 | 4.64 | 10.1 |
Example 138 | E-10 | 4.55 | 9.2 |
Example 139 | F-9 | 4.68 | 9.1 |
Example 140 | F-10 | 4.35 | 9.2 |
Example 141 | G-9 | 4.53 | 11.5 |
Example 142 | G-10 | 4.55 | 11.8 |
Example 143 | H-9 | 4.32 | 9.6 |
Example 144 | H-10 | 4.74 | 9.7 |
Example 145 | I-9 | 4.87 | 11.3 |
Example 146 | I-10 | 4.56 | 11.9 |
Example 147 | J-9 | 4.65 | 13.2 |
Example 148 | J-10 | 4.32 | 9.9 |
Example 149 | K-9 | 4.74 | 10.1 |
Example 150 | K-10 | 4.76 | 12.7 |
Example 151 | L-9 | 4.64 | 13.1 |
Example 152 | L-10 | 4.55 | 10.1 |
Example 153 | M-9 | 4.68 | 9.2 |
Example 154 | M-10 | 4.35 | 13.2 |
Example 155 | N-9 | 4.53 | 9.9 |
Example 156 | N-10 | 4.55 | 10.1 |
Example 157 | O-9 | 4.32 | 13.2 |
Example 158 | O-10 | 4.35 | 9.9 |
Example 159 | P-9 | 4.53 | 10.1 |
Example 160 | P-10 | 4.55 | 12.7 |
Comparative Example 2 | CBP | 5.25 | 8.2 |
상기 표 2와 같이 본 발명에 따른 화합물을 적색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 129 내지 160)가 종래의 CBP를 발광층에 사용한 경우(비교예2)보다 전류효율 및 구동전압이 우수한 것을 확인할 수 있다.As shown in Table 2, when the compound according to the present invention was used in the light emitting layer of the red organic electroluminescent device (Examples 129 to 160), the current efficiency and the driving voltage were superior to those of the conventional CBP used in the light emitting layer (Comparative Example 2). You can see that.
본 발명에 따른 화합물은 발광능, 정공 수송능 및 정공 주입능이 우수하고, 열적 안정성도 높기 때문에 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 정공 주입층 재료, 정공 수송층 재료 또는 발광층 재료로 사용될 수 있다.The compound according to the present invention can be used as an organic material layer material of the organic electroluminescent device, preferably a hole injection layer material, a hole transport layer material or a light emitting layer material because of excellent light emitting ability, hole transporting ability and hole injection ability and high thermal stability. .
또한 본 발명에 따른 화합물을 정공 주입층, 정공 수송층 및/또는 발광층에 포함하는 유기 전계 발광 소자는 발광성능, 구동전압, 수명, 효율 등의 측면이 크게 향상되어 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.In addition, the organic electroluminescent device including the compound according to the present invention in the hole injection layer, the hole transport layer, and / or the light emitting layer can be effectively applied to a full color display panel because the aspects of light emission performance, driving voltage, lifetime, and efficiency are greatly improved. .
Claims (11)
- 하기 화학식 1로 표시되는 화합물:Compound represented by the following formula (1):[화학식 1][Formula 1]상기 화학식 1에서,In Chemical Formula 1,A는 C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,A is a C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 ~ C 40 Alkyloxy group, C 6 ~ C 60 An aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 An arylsilyl group, C 1 ~ C 40 Alkyl boron group, is selected from the group C 6 ~ C 60 aryl group of boron, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amine, consisting of,R1과 R2는 하기 화학식 2의 R7과 R8, R8와 R9, R9와 R10 중 하나와 축합 고리를 형성하며,R 1 and R 2 form a condensed ring with one of R 7 and R 8 , R 8 and R 9 , R 9 and R 10 of Formula 2,[화학식 2][Formula 2]R3 내지 R6, 축합고리를 형성하지 않는 R7 내지 R10 및 R11은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring are the same or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear hetero atoms 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group and C 6 ~ C 60 An arylamine group,다만, R3 내지 R6, 축합 고리를 형성하지 않는 R7 내지 R10 및 R11 중 적어도 하나는 하기 화학식 3으로 표시되는 치환체이며,However, at least one of R 3 to R 6 , R 7 to R 10 and R 11 which do not form a condensed ring is a substituent represented by the following Chemical Formula 3,[화학식 3][Formula 3]X1은 O 또는 S이고,X 1 is O or S,X2는 O, S, N(R31), C(R32)(R33) 및 Si(R34)(R35)로 이루어진 군에서 선택되며,X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32 ) (R 33 ) and Si (R 34 ) (R 35 ),L1은 단일결합, C6~C60의 아릴렌기 및 핵원자수 5 내지 60의 헤테로아릴렌기로 이루어진 군에서 선택되고, L1은 R21 내지 R28의 위치 및 R31 내지 R35의 위치 중에서 선택된 하나의 탄소와 연결되며,L 1 is selected from the group consisting of a single bond, a C 6 ~ C 60 arylene group and a heteroarylene group having 5 to 60 nuclear atoms, and L 1 is a position of R 21 to R 28 and a position of R 31 to R 35 Connected to one selected from carbon,L1과 연결되지 않은 R21 내지 R28 및 R31 내지 R35는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,R 21 to R 28 and R 31 to R 35 which are not connected to L 1 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 3 to C 40 cycloalkyl group, C 3 -C 40 heterocycloalkyl group, C 6 -C 60 aryl group, C 5-60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6- C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group and C 6 ~ C 60 arylamine group,상기 A, R1 내지 R11, R21 내지 R28 및 R31 내지 R35의 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기와, L1의 아릴렌기, 헤테로아릴렌기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되며, 상기 치환기는 인접한 기와 결합하여 축합 고리를 형성 또는 비형성하고, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.Wherein A, R 1 to R 11, R 21 to R 28 and R 31 alkyl of 1 to R 35, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an aryl Silyl group, alkyl boron group, aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl amine group, the arylene group and hetero arylene group of L 1 are each independently deuterium, halogen, cyano group, C 1 ~ C 40 An alkyl group, a C 3 to C 40 cycloalkyl group, a nuclear atom of 3 to 40 heterocycloalkyl group, a C 6 to C 60 aryl group, a nuclear atom of 5 to 60 heteroaryl group, a C 1 to C 40 alkyl Oxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide of the group and a C 6 ~ value to one or more of the substituents selected from the group consisting of C 60 arylamine Or unsubstituted ring, and, when the substituent is a bond or an adjacent tile to form a non-form a condensed ring, and the substituent of the plurality, which are the same or different from each other.
- 제1항에 있어서, The method of claim 1,상기 화학식 1 로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물에서 선택되는 화합물.The compound represented by Formula 1 is selected from the compounds represented by the following formulas 1a to 1f.[화학식 1a][Formula 1a][화학식 1b][Formula 1b][화학식 1c][Formula 1c][화학식 1d][Formula 1d][화학식 1e][Formula 1e][화학식 1f][Formula 1f]상기 화학식 1a 내지 화학식 1f에서,In Chemical Formulas 1a to 1f,A, X1 및 R3 내지 R11은 제1항에서 정의한 바와 같다.A, X 1 and R 3 to R 11 are as defined in claim 1.
- 제1항에 있어서,The method of claim 1,상기 화학식 1로 표시되는 화합물은 하기 화학식 1-1 내지 1-12로 표시되는 화합물에서 선택되는 화합물.The compound represented by Formula 1 is selected from the compounds represented by the following formula 1-1 to 1-12.상기 화학식 1-1 내지 1-12에서,In Chemical Formulas 1-1 to 1-12,A 및 R3 내지 R11은 제1항에서 정의한 바와 같다.A and R 3 to R 11 are as defined in claim 1.
- 제1항에 있어서, The method of claim 1,상기 L1은 단일결합, 또는 치환 또는 비치환된 페닐렌기인 화합물.L 1 is a single bond or a substituted or unsubstituted phenylene group.
- 제1항에 있어서, The method of claim 1,상기 X2는 N(R31)인 화합물.X 2 is N (R 31 ).
- 제1항에 있어서, The method of claim 1,상기 A 및 R31은 서로 동일하거나 상이하며, 각각 독립적으로 C1~C40의 알킬기, C6~C60의 아릴기 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택되는 화합물.The A and R 31 are the same as or different from each other, each independently selected from the group consisting of C 1 ~ C 40 Alkyl group, C 6 ~ C 60 Aryl group and a heteroaryl group of 5 to 60 nuclear atoms.
- 제1항에 있어서, The method of claim 1,상기 A 및 R31은 각각 독립적으로 하기 화학식 4로 표시되는 치환체, 또는 페닐기인 화합물.A and R 31 are each independently a substituent represented by Formula 4 or a phenyl group.[화학식 4][Formula 4]상기 화학식 4에서,In Chemical Formula 4,L2는 단일결합, C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택되고,L 2 is selected from the group consisting of a single bond, an arylene group having 6 to 18 carbon atoms and a heteroarylene group having 5 to 18 nuclear atoms,Z1 내지 Z5는 서로 동일하거나 상이하고, 각각 독립적으로 N 또는 C(R12)이며, 이때, Z1 내지 Z5 중 적어도 하나는 N이고, C(R12)가 복수인 경우, 이들은 서로 동일하거나 상이하며,Z 1 to Z 5 are the same as or different from each other, and each independently N or C (R 12 ), wherein at least one of Z 1 to Z 5 is N and when C (R 12 ) is plural, they are each other. Same or different,R12은 수소, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성하며,R 12 is hydrogen, deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 6 -C 40 aryl group, nuclear atom 5-40 heteroaryl group, C 6 -C 40 aryloxy group C 1 ~ C 40 alkyloxy group of, C 6 ~ C 40 aryl amine group, C 1 ~ C 40 groups of the alkyl silyl group, C 1 ~ C 40 alkyl, boron, C 6 ~ C 40 group of the arylboronic, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl selected from the group consisting of a silyl or, by combining groups adjacent to form a fused ring,상기 R12의 알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되고, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.Alkyl group of the R 12, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an aryl silyl group Deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl groups, C 1 to C 40 alkylsilyl groups, C 1 to C 40 alkylboron groups, C 6 to C 40 arylboron groups, C 6 to C 40 arylphosphine groups, C 6 to C 40 is an aryl phosphine oxide groups and ring pins C 6 ~ C a substituted or unsubstituted by one or more substituents selected from the group consisting of aryl silyl group of 40, when the plurality of the substituents, these are equal to each other hageo It is different.
- 제1항에 있어서, The method of claim 1,상기 A 및 R31은 각각 독립적으로 하기 화학식 A1 내지 A15로 표시되는 치환기에서 선택되는 화합물.Wherein A and R 31 are each independently selected from substituents represented by Formulas A1 to A15.상기 화학식 A1 내지 A15에서,In Formulas A1 to A15,L2는 단일결합, C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택되고,L 2 is selected from the group consisting of a single bond, an arylene group having 6 to 18 carbon atoms and a heteroarylene group having 5 to 18 nuclear atoms,R12 및 R41은 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성하며, 복수의 R12는 서로 동일하거나 상이하고, 복수의 R41은 서로 동일하거나 상이하며,R 12 and R 41 are each independently hydrogen, deuterium, halogen, cyano group, C 1 ~ C 40 heteroaryl in the alkyl group, C 6 ~ C 40 aryl group, the number of nuclear atoms of 5 to 40 aryl group, C 6 ~ C 40 aryloxy group C 1 to C 40 alkyloxy group, C 6 to C 40 arylamine group, C 1 to C 40 alkylsilyl group, C 1 to C 40 alkylboron group, C 6 to C 40 the arylboronic group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 selected from an aryl silyl group the group consisting of or of, a condensed ring by combining tile adjacent A plurality of R 12 are the same as or different from each other, a plurality of R 41 are the same as or different from each other,n은 0 내지 4의 정수이고,n is an integer from 0 to 4,상기 R12 및 R41의 알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환되며, 상기 치환기가 복수인 경우, 이들은 서로 동일하거나 상이하다.An alkyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, an aryl phosphine oxide group of R 12 and R 41 ; The arylsilyl groups are each independently deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, nuclear atom from 5 to 40 heteroaryl group, C 6 ~ C 40 of the aryloxy group, C 1 ~ C 40 of the alkyloxy group, C 6 ~ C 40 aryl amine group, C 3 ~ C 40 cycloalkyl group, a nuclear atom C 3 to C 40 heterocycloalkyl group, C 1 to C 40 alkylsilyl group, C 1 to C 40 alkyl boron group, C 6 to C 40 aryl boron group, C 6 to C 40 arylphosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C is unsubstituted or substituted by one or more substituents selected from the group consisting of aryl silyl group of 40, when the plurality of the substituent, which each such Or it is different.
- 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, An organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode.상기 1층 이상의 유기물층 중 적어도 하나는 제1항 내지 제8항 중 어느 한 항에 기재된 화합물을 포함하는 유기 전계 발광 소자.At least one of the one or more organic material layers is an organic electroluminescent device comprising the compound according to any one of claims 1 to 8.
- 제9항에 있어서,The method of claim 9,상기 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층 및 발광층으로 이루어진 군에서 선택되는 유기 전계 발광 소자.The organic material layer including the compound is an organic electroluminescent device selected from the group consisting of a hole injection layer, a hole transport layer and a light emitting layer.
- 제9항에 있어서,The method of claim 9,상기 화합물을 포함하는 유기물층은 인광 발광층인 유기 전계 발광 소자.The organic material layer containing the compound is an organic electroluminescent device which is a phosphorescent light emitting layer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130092462A KR101571596B1 (en) | 2013-08-05 | 2013-08-05 | Organic compound and organic electroluminescent device comprising the same |
KR10-2013-0092462 | 2013-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015020399A1 true WO2015020399A1 (en) | 2015-02-12 |
Family
ID=52461650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2014/007223 WO2015020399A1 (en) | 2013-08-05 | 2014-08-05 | Organic compound and organic electroluminescent light emitting diode comprising same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101571596B1 (en) |
WO (1) | WO2015020399A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112851649A (en) * | 2019-11-28 | 2021-05-28 | 南京高光半导体材料有限公司 | Organic electroluminescent compound containing multi-heterocyclic structure, organic electroluminescent device and application |
CN113248520A (en) * | 2021-04-07 | 2021-08-13 | 浙江华显光电科技有限公司 | Organic compound and organic light-emitting device using same |
CN113248519A (en) * | 2021-04-07 | 2021-08-13 | 浙江华显光电科技有限公司 | Organic compound and organic light-emitting device using same |
CN115043852A (en) * | 2022-07-26 | 2022-09-13 | 武汉天马微电子有限公司 | Benzoxazole derivative and electroluminescent application thereof |
WO2023202502A1 (en) * | 2022-04-18 | 2023-10-26 | 上海传勤新材料有限公司 | Azole-containing organic compound and use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102656922B1 (en) * | 2017-12-28 | 2024-04-16 | 솔루스첨단소재 주식회사 | Organic compounds and organic electro luminescence device comprising the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751673B1 (en) * | 1990-05-17 | 1995-06-05 | ||
JP2000321276A (en) * | 1999-05-11 | 2000-11-24 | Fuji Photo Film Co Ltd | Agent for preventing fading of pigment |
KR20130064001A (en) * | 2011-12-07 | 2013-06-17 | 주식회사 두산 | Organic light-emitting compound and organic electroluminescent device using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4059585B2 (en) | 1999-03-24 | 2008-03-12 | 富士フイルム株式会社 | New methine dye |
JP7051673B2 (en) | 2018-12-27 | 2022-04-11 | 株式会社クボタ | Work platform |
-
2013
- 2013-08-05 KR KR1020130092462A patent/KR101571596B1/en active IP Right Grant
-
2014
- 2014-08-05 WO PCT/KR2014/007223 patent/WO2015020399A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751673B1 (en) * | 1990-05-17 | 1995-06-05 | ||
JP2000321276A (en) * | 1999-05-11 | 2000-11-24 | Fuji Photo Film Co Ltd | Agent for preventing fading of pigment |
KR20130064001A (en) * | 2011-12-07 | 2013-06-17 | 주식회사 두산 | Organic light-emitting compound and organic electroluminescent device using the same |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112851649A (en) * | 2019-11-28 | 2021-05-28 | 南京高光半导体材料有限公司 | Organic electroluminescent compound containing multi-heterocyclic structure, organic electroluminescent device and application |
CN112851649B (en) * | 2019-11-28 | 2023-09-29 | 南京高光半导体材料有限公司 | Organic electroluminescent compound containing multi-heterocyclic structure, organic electroluminescent device and application |
CN113248520A (en) * | 2021-04-07 | 2021-08-13 | 浙江华显光电科技有限公司 | Organic compound and organic light-emitting device using same |
CN113248519A (en) * | 2021-04-07 | 2021-08-13 | 浙江华显光电科技有限公司 | Organic compound and organic light-emitting device using same |
WO2023202502A1 (en) * | 2022-04-18 | 2023-10-26 | 上海传勤新材料有限公司 | Azole-containing organic compound and use thereof |
CN115043852A (en) * | 2022-07-26 | 2022-09-13 | 武汉天马微电子有限公司 | Benzoxazole derivative and electroluminescent application thereof |
CN115043852B (en) * | 2022-07-26 | 2023-12-29 | 武汉天马微电子有限公司 | Benzoxazole derivative and electroluminescent application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20150016704A (en) | 2015-02-13 |
KR101571596B1 (en) | 2015-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018080066A1 (en) | Organic compound and organic electroluminescent device comprising same | |
WO2015093812A1 (en) | Organic compound and organic electroluminescent element comprising same | |
WO2018110958A1 (en) | Organic light-emitting compound and organic electroluminescent element using same | |
WO2016089080A1 (en) | Organic luminescent compound and organic electroluminescent device comprising same | |
WO2018038401A1 (en) | Organic compound and organic electroluminescence device including same | |
WO2022015084A1 (en) | Organic light-emitting element | |
WO2013094999A2 (en) | Organic compound, and organic electroluminescent device using same | |
WO2011145876A2 (en) | Novel hybrid organic compound and organic electroluminescent device using same | |
WO2014142488A1 (en) | Organic compound and organic electroluminescent element including same | |
WO2018080067A1 (en) | Organic compound and organic electroluminescent device including same | |
WO2014065498A1 (en) | Organic electroluminescent device | |
WO2014025209A1 (en) | Novel compound and organic electroluminescence device comprising same | |
WO2014010810A1 (en) | Novel compound and electroluminescent device including same | |
WO2011081451A2 (en) | Tri-phenyl compounds and organic electro-luminescent device using same | |
WO2015020399A1 (en) | Organic compound and organic electroluminescent light emitting diode comprising same | |
WO2020130724A1 (en) | Organic light-emitting compound and organic electroluminescent device using same | |
WO2014092354A1 (en) | Organic compound and organic electroluminescent element comprising same | |
WO2015111943A1 (en) | Organic compound, and organic electroluminescent device containing same | |
WO2016105054A2 (en) | Organic light emitting compound and organic electroluminescent element using same | |
WO2015020409A1 (en) | Organic compound and organic electroluminescent light emitting diode comprising same | |
WO2014027822A1 (en) | Novel compound and organic electroluminescent device comprising same | |
WO2015125986A1 (en) | Organic compound and organic electroluminescent device comprising same | |
WO2017023125A1 (en) | Organic light-emitting compound and organic electroluminescent device using same | |
WO2016105123A2 (en) | Organic compound and organic electroluminescent device comprising same | |
WO2017023126A1 (en) | Organic light-emitting compound and organic electroluminescent device using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14835351 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 23/05/2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14835351 Country of ref document: EP Kind code of ref document: A1 |